AI 銘柄分析 · 10年

Smith & Nephew plc

SN. · GBP · 分析基準日 2026-11-06

{ "method": "旧株主の実日数別現金受取＋2037以降毎年固定株数のSBC交付・有償発行・申込金を同時評価する動的終価", "price_GBP": 11.61, "market_cap_oku": 97.20288656, "expected_PV_oku": 80.20475177, "expected_IRR": 0.0697092425, "expected_value_to_market": 0.82512726, "valuation_date": "2026-11-06", "calculation_status": "Verified actuals and explicit nonverified projections are distinguished.", "terminal_revision": "corrected_paid_issue_cash_and_nonconstant_dilution_per_year" }

10年期待年率6.97%

資本コスト9.50%

直近終値11.61 GBP2026-11-06

AIによるシナリオ分析です。基準日以降の出来事、株価や為替の変化は個別に確認が必要です。各数値は元の分析の単位と前提に従います。

分析の要約

{
"investment_thesis": "スポーツ医療の新製品回復と米国整形外科の再建が価値を左右。2026Q3の売上/利益見通し下方修正を起点に、SBCと資本配分を所有権台帳で別管理した。",
"principal_risks": "米国人工関節の売上構成下振れ、Bioactivesの米国償還による数量・価格減、股関節訴訟と製造品質、買収成果、FX、未確定の事業構成見直し。",
"cashflow_definition": "旧株主現金＝配当権利落ち日に確定した配当受取＋比例応募した買戻し代金。株式報酬交付・有償増資は旧株主の現金受領0。",
"terminal_definition": "2036-11-06時点の同一旧株主コホート価値。2037年以降の一定年株数を年次分母に反映。有償社員申込金は営業FCFEでなく調達資金として受け入れ、その年の発行前株主へ還元するという明示的な定常資本政策を適用。資本投入の受益を一度のみ計上し純負債を再控除しない。",
"status_and_limitation": "完全JSONは将来の定量モデルであり、日付と確率・為替・買戻し株価などは会社予想ではない。四半期末以降の正確な信託持分・株数・財務更新が必要。 2037以降の有償20万株/年・時価90%の想定は公表された制度確約ではない。将来の日付の再確認イベントはスケジュール上の目印で実際の監視や通知ではない。"
}

株数は2026年10月末の議決権株数から従業員信託20万株の未確認代理値を差し引く。予測はGBP/USD 1.3352固定。2037年以降の株式報酬と有償発行は仮定であり、毎年の希薄化と払込資金を反映する。予測の配当・買戻し・発行等の確認日を過ぎた場合、実績確認まで期待リターンを保留。2036年表示損益は暦年予測で、10年受取CFは終点まで。

事業

説明

関節置換・外傷/再建、スポーツ医療関節修復/関節鏡器具/耳鼻咽喉科、および高度創傷管理の医療機器・処置製品。病院の手術件数・保険償還・販売セット数に連動。

portfolio_2025_reported_usdm

orthopaedics: 2437
sports_medicine_ENT: 1934
advanced_wound: 1793

revenue_recognition

医療機器の大半は商品引渡しで売上認識。卸売向け創傷管理には流通在庫への曝露。

competitive_moat_and_risks

整形外科はZimmer Biomet、Stryker、DePuy Synthes等との技術・営業力競争が激しい。スポーツ分野ではREGENETEN、CARTIHEAL、TESSA、CORI等、創傷ではPICO、LEAF、ALLEVYN等が差別化要素。ただし製品承認と償還は販売保証ではない。

Orthopaedics_2026_Nov04_status

米国膝−7.3%、米国股関節−1.0%（2026Q3の基礎成長）、北米市場鈍化。LANDMARKセメントレス膝510(k)、CORI Hip 2027上市計画。DePuy Synthesとの協議は終了し事業売却/提携は未決定。

Sports_2026_Nov04_status

スポーツ関節修復2026Q3+11.2% underlying、REGENETEN/CARTIHEAL/TENDON SEAM。TESSAの追加FDA用途は申請段階。

Wound_2026_Nov04_status

2026Q3 Wound Bioactives−8.8% underlying。2026年米国皮膚代用物償還改定により数量・純価格がともに低下。PICO/LEAFデバイス+10.7%。

research_and_development

2026H1 R&D 150m USDはIFRS費用として営業利益に既に反映。予測も年次RD費用として営業利益に含め、無形資産への二重加算をしない。

manufacturing_litigation_legal_risks

金属対金属股関節訴訟、製造品質・供給制約、医療機器の回収、サイバー対策、薬機規制、訴訟賠償額超過。2025非IFRS調整にlegal and other 162m USDを含むため調整後利益を丸ごとIFRS基礎利益としない。

売上・利益の報告通貨はUSD。欧州・日本等の地域売上は為替で報告額と実質成長が乖離し得る。主計算はGBPUSD固定、FXの移動リスクは明記。

M_and_A

2026年1月Integrity Orthopaedics買収、H1現金買収支出221m USD。2025年末Bioventus持分の評価戻入109m USDは一過性のため永続化しない。

unverified_asp_volume_disclosure

処置件数×ネット単価を全製品全地域で会社が開示しているわけではない。実績数量・単価を捏造せず、2026=100指数・確定売上・仮定価格/数量成長率を完全台帳に分けた。

競争力・事業の質

score_10_assumed

strengths

内容を開く

1: スポーツ医療の二桁成長と新製品
2: 創傷管理の安定的な治療需要
3: 2025年実績FCF840m USD
4: 中期の営業効率改善余地

weaknesses

内容を開く

1: 米国Hip/Kneeのシェア・営業回復が遅延
2: 創傷Bioactives償還による数量・価格の同時圧迫
3: 金属対金属股関節訴訟
4: 買収ののれんと条件付対価
5: SBCと継続買戻しの資本配分リスク

NCI_treatment

FY2025・H1 2026のIFRS利益は親会社帰属利益、H1損益包括利益すべて親会社帰属。未公表将来NCI=0を仮定。

業界と環境

財務・資本配分

actual_reported_usdm

内容を開く

FY2025_parent_equity: 5289
H1_2026_parent_equity: 5180
FY2025_dividends_paid: 330
FY2025_own_share_purchases: 502
FY2025_equity_settled_SBC_expense: 43
H1_2026_equity_settled_SBC_expense: 34
H1_2026_own_share_purchase_equity_reduction: 250
H1_2026_own_share_purchase_cash_paid: 116
H1_2026_own_share_purchase_contingent_commitment: 113
H1_2026_lease_inclusive_gross_borrowings: 3785
H1_2026_cash: 754
H1_2026_reported_net_debt: 3019

2026_500m_USD_share_buyback_program

内容を開く

announcement_date: 2026-05-06
completed_USDm_end_Q3_2026: 250
programme_USDm_total: 500
not_yet_reported_as_completed_USDm: 250
full_completion_deadline_described: 2027-05頃、当初は発表から12か月内
注記: Remaining $250m is board programme not unconditional cash obligation; scenarios assume partial/full realization.

cohort_rule

基準日時点の外部実効株式の全てを旧株主コホートと置く。配当はex日の旧株主株数に確定した権利を支払日まで維持し、自己株取得には旧株主がその時点の外部保有比率で比例応札、受取現金と売却株数を同時記帳。非売却モデルに途中切替しない。

SBC_rule

売上原価・SG&A等に含まれるSBC費用控除後IFRS利益を採用。非現金SBCの資本繰入は利益計上の逆側であり株主の受取現金ではない。自己株/信託から従業員へ交付すると実効流通株が増え、旧コホート比率が減る。

buyback_rule

会社支払額は会社現金・資本を減らす。旧コホート応札受取は保有比率で按分。応札した旧株数は減るので、終価に全当初株数を掛け戻さない。

capital_ledger_identity

E_end=E_begin+IFRS_NI(after_SBC)+noncash_SBC_credit+issue_cash-issuer_cash_dividend-issuer_cash_buyback+OCI(assumed0); stock transfers within treasury/trust have no net total equity debit. Cash_end=Cash_begin+FCFE+issue_cash-company_payouts+borrowings-repayments. Debt_end=Debt_begin+borrowings-repayments.

fcfe_identity

FCFE_before_equity_payouts=IFRS_parent_NI+depreciation_amortization+noncash_SBC-charge-CAPEX-working_capital_investment-cash_acquisitions-lease_principal_paid. Interest/tax is already in NI. Avoid extra subtract of debt at terminal.

special_case_H1_buyback_commitment

At H1 2026 $250m is charged to total equity although only $116m has settled in cash; $113m future buyback obligation and $137m acquired consideration. Pre-basis cash proxy assumes $134m further settlement until Nov06, with zero duplicate equity debit.

unknown_and_sensitive

内容を開く

1: Nov06 precise trust shares not published: proxy 0.2m
2: Oct31-Nov06 precise treasury/issued movements not confirmed
3: Post-H1 2026 actual cash/balance/net debt unreported
4: All future buybacks/share issue/grants/ex-dates are assumptions

post_2036_employee_equity_financing_terminal_policy

内容を開く

full_year_old_holder_CFs_to_2036_are_unchanged: はい
paid_issuer_subscriptions_classification: employee cash -> company cash (equity financing, NOT trading FCFE or net income); same-year passes to pre-issuance stockholders in terminal policy; company does not retain or reinvest it
free_SBC_classification: no cash from new shares; IFRS SBC already expensed, FCFE noncash addback remains; extra effective economic shares dilute holders
repurchase_sensitivity: repurchase all employee shares at fair price and credit the same employee subscription proceeds against gross cost. No additional SBC accounting debit.
tranche_timing: annual aggregation at 2037-11-06 and each later anniversary, not actual forecast employee exercise dates
share_price_and_h_discount: future paid issue exercise price =90% x fair year-end stock price solved from continuation cash flows; hypothetical, not actual ShareSave plan exercise terms
source_key: company_fy2025_20f

評価の前提と確認

2025_revenue_usdm: 6164
2026_H1_revenue_usdm: 3097
2026_Q3_revenue_usdm: 1551
2026_FY_reported_revenue_proxy_usdm: 6411
計算式: Q4 estimated 1763 = FY reported growth target 6411 − H1 actual 3097 − Q3 actual 1551
2026_FY_revenue_growth_reported_proxy: 0.04007138
market_cap_oku_using_proxy: 97.20288656
2025_reported_EPS_USD: 0.721
FY2025_2026_H1_SBC_already_in_IFRS_profit: はい
FY2025_reporting_vs_normalization: 2025 IFRS親会社利益625mには金額・再現性の異なる一時要因があるため、調整後EPSAのみを終価へ延長しない。
market_PER_not_terminal_anchor: はい
market_PBR_not_terminal_anchor: はい
future_repayment_at_terminal_net_debt_not_subtracted: はい
initial_stock_price_not_used_for_perpetuity: 市場価格£11.61は旧株主投資額と2026-2036仮想買戻し価格曲線の起点のみ。2036終価は次期FCFE,k,g,希薄化で独立計算。
GBPUSD_fixed_conversion_is_scenario_assumption: はい
strict_calendar_ten_year_endpoint_note: 2026-11-06→2036-11-06は閏日3日を含み3653日、365.25除算の年数は10.001369。2026-11-06終値をt0、2036-11-06を指定終点として扱い、2036-11-07以降のキャッシュを期中CFに入れない。
post2036_market_multiple_not_used_to_set_issuer_subscription_price: はい
post2036_issuer_subscription_price_reference: Fair ex-issuance price solved from fundamental FCFE, 90% assumed discount. Market PER/PBR not used.

資本コストの前提

資本コスト

9.50%

applied_to

各旧株主コホートの時点別現金流入と同一集団の2036-11-06残存終価を現在価値に割り引く共通ハードル

currency

GBP

nominal

はい

component_based_reasoning

内容を開く

risk_free_nominal_assumed: 0.042
long_run_equity_risk_premium_assumed: 0.05
business_specific_risk_assumed: 0.003
sum: 0.095

注記

構成比率は分析上の仮定。英国債2026-11-06の実勢金利との厳密照合値ではない。各シナリオ終価のkは事業リスク別に別途設定。

事業別データ

事業別の内訳と、収録されている年度別データを確認できます。

事業別データを開く →

10年のシナリオ

シナリオごとの確率、期間内の株主還元・追加負担、終価です。金額は億GBP。株主の範囲や受取時点は各分析の前提を確認してください。

シナリオ	確率	株主還元・追加負担	終価
最良	8.0%	81.16	305.35
強気	22.0%	66.39	206.18
中立	40.0%	49.06	115.75
弱気	20.0%	26.02	42.30
最悪	10.0%	17.65	10.77

最良（確率 8.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.06
Sports_Medicine_ENT: 0.1
Advanced_Wound_Management: 0.07

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: 0.011
Sports_Medicine_ENT: 0.011
Advanced_Wound_Management: 0.011

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.215

terminal_cost_of_equity

0.084

terminal_perpetual_total_FCFE_growth

0.03

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.57

2026_announced_500m_buyback_remaining_completion_fraction_assumed

annual_2027_plus_ESPP_new_shares_m_assumed

0.24

annual_2027_plus_vested_awards_m_assumed

3.05

buyback_execution_GBP_per_share_growth_from_11_61_assumed

0.097

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

事業別の前提

内容を開く

id: consolidated
数量: 1
価格・単価: 112.82929606
営業利益: 24.25829865
注記: 2036年暦年の連結売上・SBC控除後のIFRS営業利益の予測。詳細内訳は年次台帳。

日付別キャッシュフロー

内容を開く

year: 0.106776180698
想定日: 2026-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.45
source_treasury_shares_m: 0.45
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9994628047

内容を開く

year: 0.112251882272
想定日: 2026-12-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.048
discounted_issuer_subscription_gbp: 10.558154
issuer_cash_proceeds_oku: 0.005067914
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9994055379

内容を開く

year: 0.11498973306
想定日: 2026-12-18
金額: 1.1227593671
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.1234272019
assumed_execution_price_gbp: 11.734256
bought_total_shares_m: 9.57391057
tendered_old_cohort_shares_m: 9.56821924
old_holder_fraction_before: 0.9994055379
old_holder_fraction_after: 0.9994055379
program_classification: announced_remaining_assumed
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 0.323066392882
想定日: 2027-03-04
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2026
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2027-03-25

内容を開く

year: 0.35318275154
想定日: 2027-03-15
金額: 0.7485062447
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.7489514679
assumed_execution_price_gbp: 11.995891
bought_total_shares_m: 6.24340013
tendered_old_cohort_shares_m: 6.23968867
old_holder_fraction_before: 0.9994055379
old_holder_fraction_after: 0.9994055379
program_classification: announced_remaining_assumed
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 0.355920602327
想定日: 2027-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.7965
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9984052072

内容を開く

year: 0.380561259411
想定日: 2027-03-25
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2026
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2027-03-26
payment_date: 2027-05-26
board_declaration_date_assumed: 2027-02-26
usd_per_share: 0.25
gbp_per_share: 0.18723787
entitled_old_cohort_shares_m: 821.4262571
issuer_economic_shares_m: 822.7383543
old_holder_entitlement_oku: 1.5380210026
issuer_dividend_liability_oku: 1.5404777455
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2027-03-04
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2027-03-25

内容を開く

year: 0.550308008214
想定日: 2027-05-26
金額: 1.5380210026
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.5404777455
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2026
dividend_kind: final

内容を開く

year: 0.607802874743
想定日: 2027-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.826
source_employee_trust_shares_m: 0.028
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9973699401

内容を開く

year: 0.777549623546
想定日: 2027-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 11.228904
issuer_cash_proceeds_oku: 0.0269493701
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9970793849

内容を開く

year: 0.859685147159
想定日: 2027-09-16
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2027
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2027-10-07

内容を開く

year: 0.859685147159
想定日: 2027-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.7965
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.996083703

内容を開く

year: 0.917180013689
想定日: 2027-10-07
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2027
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2027-10-08
payment_date: 2027-11-05
board_declaration_date_assumed: 2027-08-04
usd_per_share: 0.1624
gbp_per_share: 0.12162972
entitled_old_cohort_shares_m: 821.4262571
issuer_economic_shares_m: 824.6558543
old_holder_entitlement_oku: 0.9990984433
issuer_dividend_liability_oku: 1.0030265933
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2027-09-16
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2027-10-07

内容を開く

year: 0.996577686516
想定日: 2027-11-05
金額: 0.9990984433
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.0030265933
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2027
dividend_kind: interim

内容を開く

year: 1.108829568789
想定日: 2027-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.531
source_employee_trust_shares_m: 0.018
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9954210192

内容を開く

year: 1.338809034908
想定日: 2028-03-09
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2027
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2028-03-30

内容を開く

year: 1.357973990418
想定日: 2028-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.7965
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.994428645

内容を開く

year: 1.368925393566
想定日: 2028-03-20
金額: 0.4791190307
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.4818033281
assumed_execution_price_gbp: 13.178685
bought_total_shares_m: 3.65592857
tendered_old_cohort_shares_m: 3.6355601
old_holder_fraction_before: 0.994428645
old_holder_fraction_after: 0.994428645
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.396303901437
想定日: 2028-03-30
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2027
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2028-03-31
payment_date: 2028-05-24
board_declaration_date_assumed: 2028-02-25
usd_per_share: 0.2591715
gbp_per_share: 0.1941069
entitled_old_cohort_shares_m: 817.790697
issuer_economic_shares_m: 822.3724257
old_holder_entitlement_oku: 1.587388145
issuer_dividend_liability_oku: 1.5962815965
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2028-03-09
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2028-03-30

内容を開く

year: 1.54688569473
想定日: 2028-05-24
金額: 1.587388145
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.5962815965
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2027
dividend_kind: final

内容を開く

year: 1.609856262834
想定日: 2028-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.826
source_employee_trust_shares_m: 0.028
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9933970429

内容を開く

year: 1.620807665982
想定日: 2028-06-20
金額: 0.4786220014
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.4818033281
assumed_execution_price_gbp: 13.489611
bought_total_shares_m: 3.5716621
tendered_old_cohort_shares_m: 3.54807857
old_holder_fraction_before: 0.9933970429
old_holder_fraction_after: 0.9933970429
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.779603011636
想定日: 2028-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 12.32045
issuer_cash_proceeds_oku: 0.0295690796
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9931062553

内容を開く

year: 1.856262833676
想定日: 2028-09-14
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2028
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2028-10-05

内容を開く

year: 1.859000684463
想定日: 2028-09-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.7965
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.992109783

内容を開く

year: 1.872689938398
想定日: 2028-09-20
金額: 0.4780017952
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.4818033281
assumed_execution_price_gbp: 13.807872
bought_total_shares_m: 3.48933791
tendered_old_cohort_shares_m: 3.46180628
old_holder_fraction_before: 0.992109783
old_holder_fraction_after: 0.992109783
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.913757700205
想定日: 2028-10-05
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2028
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2028-10-06
payment_date: 2028-11-03
board_declaration_date_assumed: 2028-08-04
usd_per_share: 0.1686286
gbp_per_share: 0.12629465
entitled_old_cohort_shares_m: 810.7808121
issuer_economic_shares_m: 817.2289257
old_holder_entitlement_oku: 1.0239727575
issuer_dividend_liability_oku: 1.0321163797
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2028-09-14
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2028-10-05

内容を開く

year: 1.993155373032
想定日: 2028-11-03
金額: 1.0239727575
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.0321163797
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2028
dividend_kind: interim

内容を開く

year: 2.108145106092
想定日: 2028-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.531
source_employee_trust_shares_m: 0.018
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9914437485

内容を開く

year: 2.121834360027
想定日: 2028-12-20
金額: 0.4776808976
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.4818033281
assumed_execution_price_gbp: 14.130061
bought_total_shares_m: 3.40977539
tendered_old_cohort_shares_m: 3.38060049
old_holder_fraction_before: 0.9914437485
old_holder_fraction_after: 0.9914437485
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.335386721424
想定日: 2029-03-08
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2028
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2029-03-29

内容を開く

year: 2.357289527721
想定日: 2029-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9904422001

内容を開く

year: 2.368240930869
想定日: 2029-03-20
金額: 0.5991611166
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.6049430411
assumed_execution_price_gbp: 14.456102
bought_total_shares_m: 4.18468993
tendered_old_cohort_shares_m: 4.14469351
old_holder_fraction_before: 0.9904422001
old_holder_fraction_after: 0.9904422001
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.392881587953
想定日: 2029-03-29
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2028
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2029-03-30
payment_date: 2029-05-23
board_declaration_date_assumed: 2029-02-26
usd_per_share: 0.3017254
gbp_per_share: 0.22597769
entitled_old_cohort_shares_m: 803.2555181
issuer_economic_shares_m: 811.0069604
old_holder_entitlement_oku: 1.815178281
issuer_dividend_liability_oku: 1.8326948113
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2029-03-08
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2029-03-29

内容を開く

year: 2.543463381246
想定日: 2029-05-23
金額: 1.815178281
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.8326948113
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2028
dividend_kind: final

内容を開く

year: 2.60643394935
想定日: 2029-06-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9894003497

内容を開く

year: 2.620123203285
想定日: 2029-06-20
金額: 0.5985308565
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.6049430411
assumed_execution_price_gbp: 14.797166
bought_total_shares_m: 4.0882359
tendered_old_cohort_shares_m: 4.04490203
old_holder_fraction_before: 0.9894003497
old_holder_fraction_after: 0.9894003497
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.778918548939
想定日: 2029-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 13.514677
issuer_cash_proceeds_oku: 0.0324352249
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9891064731

内容を開く

year: 2.852840520192
想定日: 2029-09-13
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2029
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2029-10-04

内容を開く

year: 2.855578370979
想定日: 2029-09-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9880994346

内容を開く

year: 2.872005475702
想定日: 2029-09-20
金額: 0.5977438769
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.6049430411
assumed_execution_price_gbp: 15.146276
bought_total_shares_m: 3.99400506
tendered_old_cohort_shares_m: 3.94647414
old_holder_fraction_before: 0.9880994346
old_holder_fraction_after: 0.9880994346
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.910335386721
想定日: 2029-10-04
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2029
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2029-10-05
payment_date: 2029-11-05
board_declaration_date_assumed: 2029-08-03
usd_per_share: 0.1881416
gbp_per_share: 0.14090894
entitled_old_cohort_shares_m: 795.264142
issuer_economic_shares_m: 804.8422194
old_holder_entitlement_oku: 1.1205982349
issuer_dividend_liability_oku: 1.1340946019
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2029-09-13
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2029-10-04

内容を開く

year: 2.99794661191
想定日: 2029-11-05
金額: 1.1205982349
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.1340946019
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2029
dividend_kind: interim

内容を開く

year: 3.104722792608
想定日: 2029-12-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9874258904

内容を開く

year: 3.121149897331
想定日: 2029-12-20
金額: 0.597336421
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.6049430411
assumed_execution_price_gbp: 15.499694
bought_total_shares_m: 3.90293532
tendered_old_cohort_shares_m: 3.85385938
old_holder_fraction_before: 0.9874258904
old_holder_fraction_after: 0.9874258904
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.33196440794
想定日: 2030-03-07
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2029
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2030-03-28

内容を開く

year: 3.353867214237
想定日: 2030-03-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9864123876

内容を開く

year: 3.367556468172
想定日: 2030-03-20
金額: 0.7346516215
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.744771285
assumed_execution_price_gbp: 15.857339
bought_total_shares_m: 4.69669778
tendered_old_cohort_shares_m: 4.63288087
old_holder_fraction_before: 0.9864123876
old_holder_fraction_after: 0.9864123876
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.38945927447
想定日: 2030-03-28
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2029
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2030-03-29
payment_date: 2030-05-22
board_declaration_date_assumed: 2030-02-26
usd_per_share: 0.3504965
gbp_per_share: 0.26250489
entitled_old_cohort_shares_m: 786.7774017
issuer_economic_shares_m: 797.6150863
old_holder_entitlement_oku: 2.0653291728
issuer_dividend_liability_oku: 2.0937786251
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2030-03-07
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2030-03-28

内容を開く

year: 3.540041067762
想定日: 2030-05-22
金額: 2.0653291728
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.0937786251
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2029
dividend_kind: final

内容を開く

year: 3.603011635866
想定日: 2030-06-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9853573735

内容を開く

year: 3.619438740589
想定日: 2030-06-20
金額: 0.7338658772
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.744771285
assumed_execution_price_gbp: 16.231462
bought_total_shares_m: 4.58844234
tendered_old_cohort_shares_m: 4.52125549
old_holder_fraction_before: 0.9853573735
old_holder_fraction_after: 0.9853573735
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.775496235455
想定日: 2030-08-16
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 14.820904
issuer_cash_proceeds_oku: 0.0355701701
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9850595777

内容を開く

year: 3.849418206708
想定日: 2030-09-12
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2030
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2030-10-03

内容を開く

year: 3.860369609856
想定日: 2030-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.984039133

内容を開く

year: 3.871321013005
想定日: 2030-09-20
金額: 0.7328840896
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.744771285
assumed_execution_price_gbp: 16.614412
bought_total_shares_m: 4.48268211
tendered_old_cohort_shares_m: 4.41113462
old_holder_fraction_before: 0.984039133
old_holder_fraction_after: 0.984039133
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.906913073238
想定日: 2030-10-03
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2030
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2030-10-04
payment_date: 2030-11-05
board_declaration_date_assumed: 2030-08-02
usd_per_share: 0.2154553
gbp_per_share: 0.16136553
entitled_old_cohort_shares_m: 777.8450116
issuer_economic_shares_m: 790.4614619
old_holder_entitlement_oku: 1.2551737342
issuer_dividend_liability_oku: 1.2755323362
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2030-09-12
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2030-10-03

内容を開く

year: 3.997262149213
想定日: 2030-11-05
金額: 1.2551737342
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.2755323362
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2030
dividend_kind: interim

内容を開く

year: 4.109514031485
想定日: 2030-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9833561616

内容を開く

year: 4.120465434634
想定日: 2030-12-20
金額: 0.7323754321
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.744771285
assumed_execution_price_gbp: 17.002087
bought_total_shares_m: 4.38046974
tendered_old_cohort_shares_m: 4.30756191
old_holder_fraction_before: 0.9833561616
old_holder_fraction_after: 0.9833561616
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.328542094456
想定日: 2031-03-06
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2030
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2031-03-27

内容を開く

year: 4.350444900753
想定日: 2031-03-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9823277913

内容を開く

year: 4.366872005476
想定日: 2031-03-20
金額: 0.8866841188
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.9026356849
assumed_execution_price_gbp: 17.394399
bought_total_shares_m: 5.18923194
tendered_old_cohort_shares_m: 5.09752675
old_holder_fraction_before: 0.9823277913
old_holder_fraction_after: 0.9823277913
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.386036960986
想定日: 2031-03-27
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2030
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2031-03-28
payment_date: 2031-05-28
board_declaration_date_assumed: 2031-02-26
usd_per_share: 0.4026998
gbp_per_share: 0.30160263
entitled_old_cohort_shares_m: 768.4399229
issuer_economic_shares_m: 782.2642602
old_holder_entitlement_oku: 2.3176350419
issuer_dividend_liability_oku: 2.359329607
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2031-03-06
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2031-03-27

内容を開く

year: 4.555783709788
想定日: 2031-05-28
金額: 2.3176350419
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.359329607
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2030
dividend_kind: final

内容を開く

year: 4.607802874743
想定日: 2031-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9812565509

内容を開く

year: 4.618754277892
想定日: 2031-06-20
金額: 0.8857171789
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.9026356849
assumed_execution_price_gbp: 17.804786
bought_total_shares_m: 5.06962395
tendered_old_cohort_shares_m: 4.97460172
old_holder_fraction_before: 0.9812565509
old_holder_fraction_after: 0.9812565509
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.772073921971
想定日: 2031-08-15
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 16.253381
issuer_cash_proceeds_oku: 0.0390081155
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9809539619

内容を開く

year: 4.845995893224
想定日: 2031-09-11
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2031
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2031-10-02

内容を開く

year: 4.859685147159
想定日: 2031-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9799171207

内容を開く

year: 4.867898699521
想定日: 2031-09-19
金額: 0.8845081614
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.9026356849
assumed_execution_price_gbp: 18.220236
bought_total_shares_m: 4.95402837
tendered_old_cohort_shares_m: 4.85453721
old_holder_fraction_before: 0.9799171207
old_holder_fraction_after: 0.9799171207
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.903490759754
想定日: 2031-10-02
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2031
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2031-10-03
payment_date: 2031-11-05
board_declaration_date_assumed: 2031-08-04
usd_per_share: 0.247262
gbp_per_share: 0.18518727
entitled_old_cohort_shares_m: 758.610784
issuer_economic_shares_m: 774.1581079
old_holder_entitlement_oku: 1.4048505683
issuer_dividend_liability_oku: 1.4336422322
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2031-09-11
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2031-10-02

内容を開く

year: 4.996577686516
想定日: 2031-11-05
金額: 1.4048505683
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.4336422322
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2031
dividend_kind: interim

内容を開く

year: 5.108829568789
想定日: 2031-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9792226976

内容を開く

year: 5.11704312115
想定日: 2031-12-19
金額: 0.8838813503
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.9026356849
assumed_execution_price_gbp: 18.645381
bought_total_shares_m: 4.84106855
tendered_old_cohort_shares_m: 4.7404842
old_holder_fraction_before: 0.9792226976
old_holder_fraction_after: 0.9792226976
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.325119780972
想定日: 2032-03-04
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2031
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2032-03-25

内容を開く

year: 5.357973990418
想定日: 2032-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.978176375

内容を開く

year: 5.366187542779
想定日: 2032-03-19
金額: 1.0573671307
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.0809575428
assumed_execution_price_gbp: 19.080446
bought_total_shares_m: 5.66526348
tendered_old_cohort_shares_m: 5.54162689
old_holder_fraction_before: 0.978176375
old_holder_fraction_after: 0.978176375
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.382614647502
想定日: 2032-03-25
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2031
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2032-03-26
payment_date: 2032-05-26
board_declaration_date_assumed: 2032-02-26
usd_per_share: 0.463403
gbp_per_share: 0.34706636
entitled_old_cohort_shares_m: 748.3286729
issuer_economic_shares_m: 765.0242758
old_holder_entitlement_oku: 2.5971970896
issuer_dividend_liability_oku: 2.655141911
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2032-03-04
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2032-03-25

内容を開く

year: 5.552361396304
想定日: 2032-05-26
金額: 2.5971970896
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.655141911
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2031
dividend_kind: final

内容を開く

year: 5.609856262834
想定日: 2032-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9770856499

内容を開く

year: 5.615331964408
想定日: 2032-06-18
金額: 1.0561881033
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.0809575428
assumed_execution_price_gbp: 19.525663
bought_total_shares_m: 5.53608635
tendered_old_cohort_shares_m: 5.40923053
old_holder_fraction_before: 0.9770856499
old_holder_fraction_after: 0.9770856499
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.779603011636
想定日: 2032-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 17.842392
issuer_cash_proceeds_oku: 0.0428217406
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9767773327

内容を開く

year: 5.86173853525
想定日: 2032-09-16
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2032
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2032-10-07

内容を開く

year: 5.86173853525
想定日: 2032-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9757208971

内容を開く

year: 5.872689938398
想定日: 2032-09-20
金額: 1.0547128634
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.0809575428
assumed_execution_price_gbp: 19.996467
bought_total_shares_m: 5.40574256
tendered_old_cohort_shares_m: 5.27449598
old_holder_fraction_before: 0.9757208971
old_holder_fraction_after: 0.9757208971
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.91923340178
想定日: 2032-10-07
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2032
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2032-10-08
payment_date: 2032-11-05
board_declaration_date_assumed: 2032-08-04
usd_per_share: 0.284266
gbp_per_share: 0.21290145
entitled_old_cohort_shares_m: 737.6449464
issuer_economic_shares_m: 755.9999469
old_holder_entitlement_oku: 1.5704567903
issuer_dividend_liability_oku: 1.6095348526
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2032-09-16
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2032-10-07

内容を開く

year: 5.998631074606
想定日: 2032-11-05
金額: 1.5704567903
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.6095348526
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2032
dividend_kind: interim

内容を開く

year: 6.110882956879
想定日: 2032-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.975012852

内容を開く

year: 6.121834360027
想定日: 2032-12-20
金額: 1.0539474967
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.0809575428
assumed_execution_price_gbp: 20.463058
bought_total_shares_m: 5.28248293
tendered_old_cohort_shares_m: 5.15048875
old_holder_fraction_before: 0.975012852
old_holder_fraction_after: 0.975012852
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.340862422998
想定日: 2033-03-10
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2032
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2033-03-31

内容を開く

year: 6.357289527721
想定日: 2033-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9739452628

内容を開く

year: 6.362765229295
想定日: 2033-03-18
金額: 1.2493373359
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.2827592921
assumed_execution_price_gbp: 20.924619
bought_total_shares_m: 6.13038313
tendered_old_cohort_shares_m: 5.97065761
old_holder_fraction_before: 0.9739452628
old_holder_fraction_after: 0.9739452628
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.398357289528
想定日: 2033-03-31
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2032
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2033-04-01
payment_date: 2033-05-25
board_declaration_date_assumed: 2033-02-25
usd_per_share: 0.5344521
gbp_per_share: 0.4002787
entitled_old_cohort_shares_m: 726.5238
issuer_economic_shares_m: 745.9595809
old_holder_entitlement_oku: 2.9081199965
issuer_dividend_liability_oku: 2.9859172866
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2033-03-10
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2033-03-31

内容を開く

year: 6.54893908282
想定日: 2033-05-25
金額: 2.9081199965
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.9859172866
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2032
dividend_kind: final

内容を開く

year: 6.609171800137
想定日: 2033-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9728315321

内容を開く

year: 6.620123203285
想定日: 2033-06-20
金額: 1.2479086874
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.2827592921
assumed_execution_price_gbp: 21.429155
bought_total_shares_m: 5.98604699
tendered_old_cohort_shares_m: 5.82341526
old_holder_fraction_before: 0.9728315321
old_holder_fraction_after: 0.9728315321
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.778918548939
想定日: 2033-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 19.571864
issuer_cash_proceeds_oku: 0.0469724729
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9725164737

内容を開く

year: 6.858316221766
想定日: 2033-09-15
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2033
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2033-10-06

100

内容を開く

year: 6.861054072553
想定日: 2033-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9714369791

101

内容を開く

year: 6.872005475702
想定日: 2033-09-20
金額: 1.2461198116
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.2827592921
assumed_execution_price_gbp: 21.934735
bought_total_shares_m: 5.84807299
tendered_old_cohort_shares_m: 5.68103436
old_holder_fraction_before: 0.9714369791
old_holder_fraction_after: 0.9714369791
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

102

内容を開く

year: 6.915811088296
想定日: 2033-10-06
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2033
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2033-10-07
payment_date: 2033-11-04
board_declaration_date_assumed: 2033-08-04
usd_per_share: 0.3274873
gbp_per_share: 0.24527206
entitled_old_cohort_shares_m: 715.0193504
issuer_economic_shares_m: 736.0429609
old_holder_entitlement_oku: 1.7537426815
issuer_dividend_liability_oku: 1.8053077237
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2033-09-15
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2033-10-06

103

内容を開く

year: 6.995208761123
想定日: 2033-11-04
金額: 1.7537426815
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.8053077237
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2033
dividend_kind: interim

104

内容を開く

year: 7.110198494182
想定日: 2033-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9707129434

105

内容を開く

year: 7.121149897331
想定日: 2033-12-20
金額: 1.2451910481
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.2827592921
assumed_execution_price_gbp: 22.446552
bought_total_shares_m: 5.71472752
tendered_old_cohort_shares_m: 5.54735997
old_holder_fraction_before: 0.9707129434
old_holder_fraction_after: 0.9707129434
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

106

内容を開く

year: 7.337440109514
想定日: 2034-03-09
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2033
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2034-03-30

107

内容を開く

year: 7.356605065024
想定日: 2034-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9696204447

108

内容を開く

year: 7.367556468172
想定日: 2034-03-20
金額: 1.4650051276
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.5109057732
assumed_execution_price_gbp: 22.964491
bought_total_shares_m: 6.57931321
tendered_old_cohort_shares_m: 6.3794366
old_holder_fraction_before: 0.9696204447
old_holder_fraction_after: 0.9696204447
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

109

内容を開く

year: 7.394934976044
想定日: 2034-03-30
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2033
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2034-03-31
payment_date: 2034-05-24
board_declaration_date_assumed: 2034-02-24
usd_per_share: 0.618082
gbp_per_share: 0.46291344
entitled_old_cohort_shares_m: 703.0925538
issuer_economic_shares_m: 725.1214202
old_holder_entitlement_oku: 3.2547099298
issuer_dividend_liability_oku: 3.3566845127
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2034-03-09
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2034-03-30

110

内容を開く

year: 7.545516769336
想定日: 2034-05-24
金額: 3.2547099298
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 3.3566845127
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2033
dividend_kind: final

111

内容を開く

year: 7.60848733744
想定日: 2034-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9684798332

112

内容を開く

year: 7.619438740589
想定日: 2034-06-20
金額: 1.4632817712
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.5109057732
assumed_execution_price_gbp: 23.506294
bought_total_shares_m: 6.42766487
tendered_old_cohort_shares_m: 6.2250638
old_holder_fraction_before: 0.9684798332
old_holder_fraction_after: 0.9684798332
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

113

内容を開く

year: 7.778234086242
想定日: 2034-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 21.468974
issuer_cash_proceeds_oku: 0.0515255376
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9681569114

114

内容を開く

year: 7.854893908282
想定日: 2034-09-14
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2034
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2034-10-05

115

内容を開く

year: 7.857631759069
想定日: 2034-09-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9670505213

116

内容を開く

year: 7.871321013005
想定日: 2034-09-20
金額: 1.4611222155
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.5109057732
assumed_execution_price_gbp: 24.060879
bought_total_shares_m: 6.27951191
tendered_old_cohort_shares_m: 6.07260526
old_holder_fraction_before: 0.9670505213
old_holder_fraction_after: 0.9670505213
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

117

内容を開く

year: 7.912388774812
想定日: 2034-10-05
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2034
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2034-10-06
payment_date: 2034-11-03
board_declaration_date_assumed: 2034-08-04
usd_per_share: 0.3782277
gbp_per_share: 0.2832742
entitled_old_cohort_shares_m: 690.7948848
issuer_economic_shares_m: 714.3317434
old_holder_entitlement_oku: 1.9568436811
issuer_dividend_liability_oku: 2.0235175289
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2034-09-14
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2034-10-05

118

内容を開く

year: 7.991786447639
想定日: 2034-11-03
金額: 1.9568436811
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.0235175289
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2034
dividend_kind: interim

119

内容を開く

year: 8.106776180698
想定日: 2034-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9663078649

120

内容を開く

year: 8.120465434634
想定日: 2034-12-20
金額: 1.4600001317
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.5109057732
assumed_execution_price_gbp: 24.622307
bought_total_shares_m: 6.13632893
tendered_old_cohort_shares_m: 5.92958291
old_holder_fraction_before: 0.9663078649
old_holder_fraction_after: 0.9663078649
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

121

内容を開く

year: 8.33401779603
想定日: 2035-03-08
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2034
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2035-03-29

122

内容を開く

year: 8.355920602327
想定日: 2035-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9651864014

123

内容を開く

year: 8.366872005476
想定日: 2035-03-20
金額: 1.7070266788
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7685979375
assumed_execution_price_gbp: 25.19045
bought_total_shares_m: 7.02090647
tendered_old_cohort_shares_m: 6.77648345
old_holder_fraction_before: 0.9651864014
old_holder_fraction_after: 0.9651864014
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

124

内容を開く

year: 8.39151266256
想定日: 2035-03-29
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2034
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2035-03-30
payment_date: 2035-05-23
board_declaration_date_assumed: 2035-02-26
usd_per_share: 0.7167628
gbp_per_share: 0.53682052
entitled_old_cohort_shares_m: 678.0888184
issuer_economic_shares_m: 702.547008
old_holder_entitlement_oku: 3.6401198905
issuer_dividend_liability_oku: 3.7714164697
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2035-03-08
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2035-03-29

125

内容を開く

year: 8.542094455852
想定日: 2035-05-23
金額: 3.6401198905
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 3.7714164697
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2034
dividend_kind: final

126

内容を開く

year: 8.605065023956
想定日: 2035-06-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9640145674

127

内容を開く

year: 8.618754277892
想定日: 2035-06-20
金額: 1.7049541757
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7685979375
assumed_execution_price_gbp: 25.78477
bought_total_shares_m: 6.85907973
tendered_old_cohort_shares_m: 6.61225278
old_holder_fraction_before: 0.9640145674
old_holder_fraction_after: 0.9640145674
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

128

内容を開く

year: 8.777549623546
想定日: 2035-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 23.549972
issuer_cash_proceeds_oku: 0.0565199332
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9636825216

129

内容を開く

year: 8.851471594798
想定日: 2035-09-13
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2035
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2035-10-04

130

内容を開く

year: 8.854209445585
想定日: 2035-09-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9625449265

131

内容を開く

year: 8.870636550308
想定日: 2035-09-20
金額: 1.7023549718
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7685979375
assumed_execution_price_gbp: 26.393112
bought_total_shares_m: 6.70098297
tendered_old_cohort_shares_m: 6.44999716
old_holder_fraction_before: 0.9625449265
old_holder_fraction_after: 0.9625449265
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

132

内容を開く

year: 8.908966461328
想定日: 2035-10-04
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2035
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2035-10-05
payment_date: 2035-11-05
board_declaration_date_assumed: 2035-08-03
usd_per_share: 0.4379962
gbp_per_share: 0.32803789
entitled_old_cohort_shares_m: 665.0265685
issuer_economic_shares_m: 690.9044453
old_holder_entitlement_oku: 2.1815390969
issuer_dividend_liability_oku: 2.2664283369
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2035-09-13
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2035-10-04

133

内容を開く

year: 8.996577686516
想定日: 2035-11-05
金額: 2.1815390969
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.2664283369
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2035
dividend_kind: interim

134

内容を開く

year: 9.103353867214
想定日: 2035-12-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9617806854

135

内容を開く

year: 9.119780971937
想定日: 2035-12-20
金額: 1.7010033365
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7685979375
assumed_execution_price_gbp: 27.00896
bought_total_shares_m: 6.54818978
tendered_old_cohort_shares_m: 6.29792245
old_holder_fraction_before: 0.9617806854
old_holder_fraction_after: 0.9617806854
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

136

内容を開く

year: 9.330595482546
想定日: 2036-03-06
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2035
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2036-03-27

137

内容を開く

year: 9.352498288843
想定日: 2036-03-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9606256712

138

内容を開く

year: 9.368925393566
想定日: 2036-03-20
金額: 1.7118050628
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7819688918
assumed_execution_price_gbp: 27.639177
bought_total_shares_m: 6.44725733
tendered_old_cohort_shares_m: 6.1934009
old_holder_fraction_before: 0.9606256712
old_holder_fraction_after: 0.9606256712
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

139

内容を開く

year: 9.388090349076
想定日: 2036-03-27
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2035
dividend_kind: final
date_confirmed: いいえ
ex_date: 未確認
record_date: 2036-03-28
payment_date: 2036-05-28
board_declaration_date_assumed: 2036-02-26
usd_per_share: 0.8336527
gbp_per_share: 0.62436544
entitled_old_cohort_shares_m: 652.5352451
issuer_economic_shares_m: 679.2814982
old_holder_entitlement_oku: 4.074204534
issuer_dividend_liability_oku: 4.2411988936
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2036-03-06
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2036-03-27

140

内容を開く

year: 9.557837097878
想定日: 2036-05-28
金額: 4.074204534
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 4.2411988936
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2035
dividend_kind: final

141

内容を開く

year: 9.609856262834
想定日: 2036-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9594194788

142

内容を開く

year: 9.620807665982
想定日: 2036-06-20
金額: 1.7096556653
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7819688918
assumed_execution_price_gbp: 28.29127
bought_total_shares_m: 6.29865277
tendered_old_cohort_shares_m: 6.04305016
old_holder_fraction_before: 0.9594194788
old_holder_fraction_after: 0.9594194788
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

143

内容を開く

year: 9.774127310062
想定日: 2036-08-15
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 25.826136
issuer_cash_proceeds_oku: 0.0619827253
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9590778847

144

内容を開く

year: 9.848049281314
想定日: 2036-09-11
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 未確認
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2036
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0
ex_date_assumed: 2036-10-02

145

内容を開く

year: 9.86173853525
想定日: 2036-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9579076369

146

内容を開く

year: 9.869952087611
想定日: 2036-09-19
金額: 1.7069616101
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7819688918
assumed_execution_price_gbp: 28.951409
bought_total_shares_m: 6.15503335
tendered_old_cohort_shares_m: 5.89595345
old_holder_fraction_before: 0.9579076369
old_holder_fraction_after: 0.9579076369
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

147

内容を開く

year: 9.905544147844
想定日: 2036-10-02
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2036
dividend_kind: interim
date_confirmed: いいえ
ex_date: 未確認
record_date: 2036-10-03
payment_date: 2036-11-05
board_declaration_date_assumed: 2036-08-04
usd_per_share: 0.5086596
gbp_per_share: 0.38096133
entitled_old_cohort_shares_m: 640.5962415
issuer_economic_shares_m: 668.745312
old_holder_entitlement_oku: 2.4404239563
issuer_dividend_liability_oku: 2.5476610295
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2036-09-11
needs_issuer_confirmation_before_date: はい
ex_date_assumed: 2036-10-02

148

内容を開く

year: 9.998631074606
想定日: 2036-11-05
金額: 2.4404239563
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.5476610295
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2036
dividend_kind: interim

その他の数値・前提

label

最良

scenario_status

analyst_assumption_not_company_guidance

drivers

内容を開く

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.06
Sports_Medicine_ENT: 0.1
Advanced_Wound_Management: 0.07

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: 0.011
Sports_Medicine_ENT: 0.011
Advanced_Wound_Management: 0.011

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.215

terminal_cost_of_equity

0.084

terminal_perpetual_total_FCFE_growth

0.03

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.57

2026_announced_500m_buyback_remaining_completion_fraction_assumed

annual_2027_plus_ESPP_new_shares_m_assumed

0.24

annual_2027_plus_vested_awards_m_assumed

3.05

buyback_execution_GBP_per_share_growth_from_11_61_assumed

0.097

future_fixed_FX_USD_per_GBP

1.3352

annual_ledger

内容を開く

fiscal_year

2026

period_start_inclusive

2026-11-07

期間末

2026-12-31

days_booked

days_full_calendar_year

365

accrual_fraction_of_calendar_year

0.150684931507

is_partial_period

はい

period_status

発行会社実績からの部分期間推計

financials_oku_gbp

内容を開く

year

2026

revenue

7.6631423

revenue_usd_m

1023.18276042

cogs

2.23763755

sga_including_sbc

4.1037155

0.3716624

operating_profit

0.95012685

営業利益率

12.40%

finance_cost_net

0.05898606

associates_profit

0.00858174

pretax_profit

0.89972253

tax_expense

0.20693618

parent_profit_after_sbc

0.69278635

sbc_expense_within_sga

0.07674188

sbc_equity_credit

0.07674188

depreciation_amortization

0.6771342

capital_expenditure

0.49656508

net_working_capital_investment

-0.69622001

cash_acquisitions

lease_principal_paid

0.06997053

fcfe_before_equity_distributions

1.57634683

segment_revenue_usd_m

Orthopaedics: 398.71046875
Sports_Medicine_ENT: 337.7721875
Advanced_Wound_Management: 286.70010416667

geography_revenue_usd_m

未確認

volume_price_region_matrix

未確認

dividend_policy_normalization_usd_m

未確認

dividend_policy_adjusted_profit_proxy_usd_m

未確認

capital

内容を開く

begin_parent_equity_oku: 39.43229479
period_parent_profit_after_sbc_oku: 0.69278635
noncash_sbc_equity_credit_oku: 0.07674188
new_issue_cash_proceeds_oku: 0.00506791
issuer_paid_dividends_oku: 0
issuer_gross_buybacks_oku: 1.1234272
ending_parent_equity_oku: 39.08346372
begin_gross_financing_debt_oku: 28.34781306
begin_cash_oku: 6.05901738
operating_fcfe_before_distributions_oku: 1.57634683
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 2.01700491
ending_gross_financing_debt_oku: 26.33080815
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 21.83080815
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 877.750024
begin_treasury_m: 40.315859
begin_employee_trust_m: 0.2
begin_old_cohort_m: 837.234165
new_issuance_m: 0.048
treasury_or_trust_shares_delivered_to_employees_m: 0.45
issuer_buyback_shares_m: 9.5739106
old_cohort_proportionally_tendered_shares_m: 9.5682192
ending_issued_m: 877.798024
ending_treasury_m: 49.4397696
ending_employee_trust_m: 0.2
ending_economic_shares_m: 828.1582544
ending_old_cohort_shares_m: 827.6659458
ending_old_cohort_economic_fraction: 0.99940553793

old_holder_cash_oku

dividends_received_oku: 0
proportional_tender_proceeds_oku: 1.1227593671
total_received_oku: 1.1227593671

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

complete_calendar_year_projection_reference_not_fully_booked

内容を開く

fy_2026_reported_guidance_sales_usd_m_proxy: 6411
fy_2026_full_year_IFRS_operating_profit_usd_m_estimate: 850
fy_2026_full_year_parent_profit_usd_m_estimate: 585
fy_2026_full_year_capex_usd_m_estimate: 440
fy_2026_full_year_sbc_usd_m_estimate: 68
fy_2026_full_year_fcf_usd_m_company_guidance: 750
h1_actual_sales_usd_m: 3097
q3_actual_sales_usd_m: 1551
q4_full_estimated_sales_usd_m: 1763
q4_post_basis_day_fraction: 0.57291666666667
full_year_is_forecast: はい

内容を開く

fiscal_year

2027

period_start_inclusive

2027-01-01

期間末

2027-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2027

segment_revenue_usd_m

Orthopaedics: 2668.3089
Sports_Medicine_ENT: 2342.00101
Advanced_Wound_Management: 1964.15111

geography_revenue_usd_m

US: 3632.76512
Other_Established: 2131.61654
Emerging: 1210.07936

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 105.7
net_realised_price_index_2026_100: 101.2
revenue_usd_m: 1464.93224
売上高: 10.9716315
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 106.2
net_realised_price_index_2026_100: 101.1
revenue_usd_m: 802.04045
売上高: 6.00689375
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 106.6
net_realised_price_index_2026_100: 100.8
revenue_usd_m: 401.33621
売上高: 3.00581342
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 109.7
net_realised_price_index_2026_100: 101.2
revenue_usd_m: 1285.90296
売上高: 9.6307891
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 110.2
net_realised_price_index_2026_100: 101.1
revenue_usd_m: 680.43887
売上高: 5.09615691
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 110.6
net_realised_price_index_2026_100: 100.8
revenue_usd_m: 375.65918
売上高: 2.81350496
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 106.7
net_realised_price_index_2026_100: 101.2
revenue_usd_m: 881.92992
売上高: 6.60522706
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 107.2
net_realised_price_index_2026_100: 101.1
revenue_usd_m: 649.13722
売上高: 4.86172273
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 107.6
net_realised_price_index_2026_100: 100.8
revenue_usd_m: 433.08397
売上高: 3.24358878
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

52.23532822

revenue_usd_m

6974.46102336

cogs

15.05944512

sga_including_sbc

27.25763965

2.56214285

operating_profit

7.35610059

営業利益率

14.08%

finance_cost_net

1.11926812

associates_profit

0.06740563

pretax_profit

6.30423811

tax_expense

1.44997476

parent_profit_after_sbc

4.85426334

sbc_expense_within_sga

0.59282875

sbc_equity_credit

0.59282875

depreciation_amortization

4.8056502

capital_expenditure

3.96988494

net_working_capital_investment

4.78455018

cash_acquisitions

0.62682394

lease_principal_paid

0.49623562

fcfe_before_equity_distributions

0.37524761

dividend_policy_adjusted_profit_proxy_usd_m

918.75774039

dividend_policy_normalization_usd_m

270.61649893

capital

内容を開く

begin_parent_equity_oku: 39.08346372
period_parent_profit_after_sbc_oku: 4.85426334
noncash_sbc_equity_credit_oku: 0.59282875
new_issue_cash_proceeds_oku: 0.02694937
issuer_paid_dividends_oku: 2.54350434
issuer_gross_buybacks_oku: 0.74895147
ending_parent_equity_oku: 41.26504938
begin_gross_financing_debt_oku: 26.33080815
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 0.37524761
additional_new_debt_borrowings_oku: 2.89025882
debt_principal_repayment_oku: 0
ending_gross_financing_debt_oku: 29.22106697
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 24.72106697
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 877.798024
begin_treasury_m: 49.4397696
begin_employee_trust_m: 0.2
begin_old_cohort_m: 827.6659458
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 6.2434001
old_cohort_proportionally_tendered_shares_m: 6.2396887
ending_issued_m: 878.038024
ending_treasury_m: 52.7331697
ending_employee_trust_m: 0.1
ending_economic_shares_m: 825.2048543
ending_old_cohort_shares_m: 821.4262571
ending_old_cohort_economic_fraction: 0.99542101917

old_holder_cash_oku

dividends_received_oku: 2.537119446
proportional_tender_proceeds_oku: 0.7485062447
total_received_oku: 3.2856256907

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2028

period_start_inclusive

2028-01-01

期間末

2028-12-31

days_booked

366

days_full_calendar_year

366

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2028

segment_revenue_usd_m

Orthopaedics: 2859.39797
Sports_Medicine_ENT: 2604.45798
Advanced_Wound_Management: 2125.56752

geography_revenue_usd_m

US: 3946.8892
Other_Established: 2322.75804
Emerging: 1319.77622

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 111.7249
net_realised_price_index_2026_100: 102.4144
revenue_usd_m: 1567.01458
売上高: 11.73617867
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 112.7844
net_realised_price_index_2026_100: 102.2121
revenue_usd_m: 861.1364
売上高: 6.4494937
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 113.6356
net_realised_price_index_2026_100: 101.6064
revenue_usd_m: 431.24699
売上高: 3.22983068
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 120.3409
net_realised_price_index_2026_100: 102.4144
revenue_usd_m: 1427.56318
売上高: 10.69175536
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 121.4404
net_realised_price_index_2026_100: 102.2121
revenue_usd_m: 758.09192
売上高: 5.67774053
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 122.3236
net_realised_price_index_2026_100: 101.6064
revenue_usd_m: 418.80289
売上高: 3.13663038
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 113.8489
net_realised_price_index_2026_100: 102.4144
revenue_usd_m: 952.31145
売上高: 7.1323506
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 114.9184
net_realised_price_index_2026_100: 102.2121
revenue_usd_m: 703.52972
売上高: 5.2690962
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 115.7776
net_realised_price_index_2026_100: 101.6064
revenue_usd_m: 469.72634
売上高: 3.51802234
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

56.84109845

revenue_usd_m

7589.4234652

cogs

16.17697662

sga_including_sbc

29.37163176

2.81931848

operating_profit

8.47317159

営業利益率

14.91%

finance_cost_net

1.24065899

associates_profit

0.06740563

pretax_profit

7.29991824

tax_expense

1.67898119

parent_profit_after_sbc

5.62093704

sbc_expense_within_sga

0.62577191

sbc_equity_credit

0.62577191

depreciation_amortization

5.22938106

capital_expenditure

4.31992348

net_working_capital_investment

0.59728807

cash_acquisitions

0.68209318

lease_principal_paid

0.53999044

fcfe_before_equity_distributions

5.33679484

dividend_policy_adjusted_profit_proxy_usd_m

1021.41690896

dividend_policy_normalization_usd_m

270.90939518

capital

内容を開く

begin_parent_equity_oku: 41.26504938
period_parent_profit_after_sbc_oku: 5.62093704
noncash_sbc_equity_credit_oku: 0.62577191
new_issue_cash_proceeds_oku: 0.02956908
issuer_paid_dividends_oku: 2.62839798
issuer_gross_buybacks_oku: 1.92721331
ending_parent_equity_oku: 42.98571613
begin_gross_financing_debt_oku: 29.22106697
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 5.33679484
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.81075263
ending_gross_financing_debt_oku: 28.41031434
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 23.91031434
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.038024
begin_treasury_m: 52.7331697
begin_employee_trust_m: 0.1
begin_old_cohort_m: 821.4262571
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 14.126704
old_cohort_proportionally_tendered_shares_m: 14.0260454
ending_issued_m: 878.278024
ending_treasury_m: 63.9098737
ending_employee_trust_m: 0
ending_economic_shares_m: 814.3681503
ending_old_cohort_shares_m: 807.4002117
ending_old_cohort_economic_fraction: 0.99144374854

old_holder_cash_oku

dividends_received_oku: 2.6113609024
proportional_tender_proceeds_oku: 1.9134237249
total_received_oku: 4.5247846273

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2029

period_start_inclusive

2029-01-01

期間末

2029-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2029

segment_revenue_usd_m

Orthopaedics: 3064.18404
Sports_Medicine_ENT: 2896.33769
Advanced_Wound_Management: 2300.25855

geography_revenue_usd_m

US: 4289.34938
Other_Established: 2531.67342
Emerging: 1439.75748

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 118.09322
net_realised_price_index_2026_100: 103.64337
revenue_usd_m: 1676.21042
売上高: 12.55400254
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 119.77703
net_realised_price_index_2026_100: 103.33643
revenue_usd_m: 924.58665
売上高: 6.92470529
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 121.13555
net_realised_price_index_2026_100: 102.41925
revenue_usd_m: 463.38697
売上高: 3.47054351
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 132.01397
net_realised_price_index_2026_100: 103.64337
revenue_usd_m: 1584.82924
売上高: 11.86960189
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 133.82732
net_realised_price_index_2026_100: 103.33643
revenue_usd_m: 844.60688
売上高: 6.32569563
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 135.2899
net_realised_price_index_2026_100: 102.41925
revenue_usd_m: 466.90156
売上高: 3.4968661
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 121.47678
net_realised_price_index_2026_100: 103.64337
revenue_usd_m: 1028.30972
売上高: 7.70154071
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 123.19252
net_realised_price_index_2026_100: 103.33643
revenue_usd_m: 762.47989
売上高: 5.71060431
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 124.5767
net_realised_price_index_2026_100: 102.41925
revenue_usd_m: 509.46895
売上高: 3.81567518
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

61.86923516

revenue_usd_m

8260.78027836

cogs

17.37906816

sga_including_sbc

31.65482286

3.10274214

operating_profit

9.732602

営業利益率

15.73%

finance_cost_net

1.20660738

associates_profit

0.06740563

pretax_profit

8.59340025

tax_expense

1.97648206

parent_profit_after_sbc

6.61691819

sbc_expense_within_sga

0.66065683

sbc_equity_credit

0.66065683

depreciation_amortization

5.69196963

capital_expenditure

4.70206187

net_working_capital_investment

0.65169282

cash_acquisitions

0.74243082

lease_principal_paid

0.58775773

fcfe_before_equity_distributions

6.2856014

dividend_policy_adjusted_profit_proxy_usd_m

1154.34144235

dividend_policy_normalization_usd_m

270.85052502

capital

内容を開く

begin_parent_equity_oku: 42.98571613
period_parent_profit_after_sbc_oku: 6.61691819
noncash_sbc_equity_credit_oku: 0.66065683
new_issue_cash_proceeds_oku: 0.03243522
issuer_paid_dividends_oku: 2.96678941
issuer_gross_buybacks_oku: 2.41977216
ending_parent_equity_oku: 44.9091648
begin_gross_financing_debt_oku: 28.41031434
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 6.2856014
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.93147505
ending_gross_financing_debt_oku: 27.47883929
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 22.97883929
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.278024
begin_treasury_m: 63.9098737
begin_employee_trust_m: 0
begin_old_cohort_m: 807.4002117
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 16.1698662
old_cohort_proportionally_tendered_shares_m: 15.9899291
ending_issued_m: 878.518024
ending_treasury_m: 77.0297399
ending_employee_trust_m: 0
ending_economic_shares_m: 801.4882841
ending_old_cohort_shares_m: 791.4102826
ending_old_cohort_economic_fraction: 0.98742589041

old_holder_cash_oku

dividends_received_oku: 2.935776516
proportional_tender_proceeds_oku: 2.392772271
total_received_oku: 5.328548787

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2030

period_start_inclusive

2030-01-01

期間末

2030-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2030

segment_revenue_usd_m

Orthopaedics: 3283.64978
Sports_Medicine_ENT: 3220.93975
Advanced_Wound_Management: 2489.31664

geography_revenue_usd_m

US: 4662.80878
Other_Established: 2760.07675
Emerging: 1571.02064

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 124.82453
net_realised_price_index_2026_100: 104.88709
revenue_usd_m: 1793.01547
売上高: 13.42881566
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 127.20321
net_realised_price_index_2026_100: 104.47313
revenue_usd_m: 992.71204
売上高: 7.43493143
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 129.1305
net_realised_price_index_2026_100: 103.23861
revenue_usd_m: 497.92227
売上高: 3.72919617
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 144.81932
net_realised_price_index_2026_100: 104.88709
revenue_usd_m: 1759.42037
売上高: 13.17720471
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 147.47771
net_realised_price_index_2026_100: 104.47313
revenue_usd_m: 940.99511
売上高: 7.04759667
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 149.63063
net_realised_price_index_2026_100: 103.23861
revenue_usd_m: 520.52427
売上高: 3.89847418
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 129.61572
net_realised_price_index_2026_100: 104.88709
revenue_usd_m: 1110.37294
売上高: 8.31615446
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 132.06239
net_realised_price_index_2026_100: 104.47313
revenue_usd_m: 826.3696
売上高: 6.18910726
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 134.04453
net_realised_price_index_2026_100: 103.23861
revenue_usd_m: 552.5741
売上高: 4.13851182
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

67.35999237

revenue_usd_m

8993.90618088

cogs

18.67218988

sga_including_sbc

34.12115212

3.41515161

operating_profit

11.15149875

営業利益率

16.56%

finance_cost_net

1.16748543

associates_profit

0.06740563

pretax_profit

10.05141895

tax_expense

2.31182636

parent_profit_after_sbc

7.73959259

sbc_expense_within_sga

0.69760468

sbc_equity_credit

0.69760468

depreciation_amortization

6.1971193

capital_expenditure

5.11935942

net_working_capital_investment

0.71124949

cash_acquisitions

0.80831991

lease_principal_paid

0.63991993

fcfe_before_equity_distributions

7.35546783

dividend_policy_adjusted_profit_proxy_usd_m

1303.80017041

dividend_policy_normalization_usd_m

270.40976743

capital

内容を開く

begin_parent_equity_oku: 44.9091648
period_parent_profit_after_sbc_oku: 7.73959259
noncash_sbc_equity_credit_oku: 0.69760468
new_issue_cash_proceeds_oku: 0.03557017
issuer_paid_dividends_oku: 3.36931096
issuer_gross_buybacks_oku: 2.97908514
ending_parent_equity_oku: 47.03353614
begin_gross_financing_debt_oku: 27.47883929
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 7.35546783
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.82744243
ending_gross_financing_debt_oku: 26.65139686
ending_cash_oku: 4.71519947
ending_simple_net_debt_oku: 21.93619739
ending_required_operating_cash_oku: 4.71519947
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.518024
begin_treasury_m: 77.0297399
begin_employee_trust_m: 0
begin_old_cohort_m: 791.4102826
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 18.148292
old_cohort_proportionally_tendered_shares_m: 17.8728329
ending_issued_m: 878.758024
ending_treasury_m: 92.1280319
ending_employee_trust_m: 0
ending_economic_shares_m: 786.6299921
ending_old_cohort_shares_m: 773.5374497
ending_old_cohort_economic_fraction: 0.98335616164

old_holder_cash_oku

dividends_received_oku: 3.320502907
proportional_tender_proceeds_oku: 2.9337770204
total_received_oku: 6.2542799274

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2031

period_start_inclusive

2031-01-01

期間末

2031-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2031

segment_revenue_usd_m

Orthopaedics: 3518.84843
Sports_Medicine_ENT: 3581.93395
Advanced_Wound_Management: 2693.9242

geography_revenue_usd_m

US: 5070.19026
Other_Established: 3009.85317
Emerging: 1714.66316

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 131.93953
net_realised_price_index_2026_100: 106.14574
revenue_usd_m: 1917.95996
売上高: 14.36458925
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 135.08981
net_realised_price_index_2026_100: 105.62234
revenue_usd_m: 1065.85705
売上高: 7.98275205
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 137.65311
net_realised_price_index_2026_100: 104.06451
revenue_usd_m: 535.03142
売上高: 4.0071257
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 158.8668
net_realised_price_index_2026_100: 106.14574
revenue_usd_m: 1953.24516
売上高: 14.6288583
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 162.52043
net_realised_price_index_2026_100: 105.62234
revenue_usd_m: 1048.38335
売上高: 7.85188249
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 165.49148
net_realised_price_index_2026_100: 104.06451
revenue_usd_m: 580.30544
売上高: 4.34620614
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 138.29997
net_realised_price_index_2026_100: 106.14574
revenue_usd_m: 1198.98515
売上高: 8.97981685
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 141.57088
net_realised_price_index_2026_100: 105.62234
revenue_usd_m: 895.61276
売上高: 6.70770494
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 144.23191
net_realised_price_index_2026_100: 104.06451
revenue_usd_m: 599.32629
売上高: 4.48866303
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

73.35759875

revenue_usd_m

9794.70658533

cogs

20.06330326

sga_including_sbc

36.78573201

3.75957694

operating_profit

12.74898655

営業利益率

17.38%

finance_cost_net

1.12907445

associates_profit

0.06740563

pretax_profit

11.68731773

tax_expense

2.68808308

parent_profit_after_sbc

8.99923465

sbc_expense_within_sga

0.73674459

sbc_equity_credit

0.73674459

depreciation_amortization

6.74889909

capital_expenditure

5.57517751

net_working_capital_investment

0.77646387

cash_acquisitions

0.88029119

lease_principal_paid

0.69689719

fcfe_before_equity_distributions

8.55604858

dividend_policy_adjusted_profit_proxy_usd_m

1471.13272675

dividend_policy_normalization_usd_m

269.55491613

capital

内容を開く

begin_parent_equity_oku: 47.03353614
period_parent_profit_after_sbc_oku: 8.99923465
noncash_sbc_equity_credit_oku: 0.73674459
new_issue_cash_proceeds_oku: 0.03900812
issuer_paid_dividends_oku: 3.79297184
issuer_gross_buybacks_oku: 3.61054274
ending_parent_equity_oku: 49.40500893
begin_gross_financing_debt_oku: 26.65139686
begin_cash_oku: 4.71519947
operating_fcfe_before_distributions_oku: 8.55604858
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.77170967
ending_gross_financing_debt_oku: 25.87968718
ending_cash_oku: 5.13503191
ending_simple_net_debt_oku: 20.74465527
ending_required_operating_cash_oku: 5.13503191
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.758024
begin_treasury_m: 92.1280319
begin_employee_trust_m: 0
begin_old_cohort_m: 773.5374497
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 20.0539528
old_cohort_proportionally_tendered_shares_m: 19.6671499
ending_issued_m: 878.998024
ending_treasury_m: 109.1319847
ending_employee_trust_m: 0
ending_economic_shares_m: 769.8660393
ending_old_cohort_shares_m: 753.8702998
ending_old_cohort_economic_fraction: 0.97922269759

old_holder_cash_oku

dividends_received_oku: 3.7224856102
proportional_tender_proceeds_oku: 3.5407908094
total_received_oku: 7.2632764196

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2032

period_start_inclusive

2032-01-01

期間末

2032-12-31

days_booked

366

days_full_calendar_year

366

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2032

segment_revenue_usd_m

Orthopaedics: 3770.90886
Sports_Medicine_ENT: 3983.40178
Advanced_Wound_Management: 2915.36099

geography_revenue_usd_m

US: 5514.70249
Other_Established: 3283.07644
Emerging: 1871.8927

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 139.46008
net_realised_price_index_2026_100: 107.41949
revenue_usd_m: 2051.61108
売上高: 15.36557129
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 143.46538
net_realised_price_index_2026_100: 106.78418
revenue_usd_m: 1144.39153
売上高: 8.57093718
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 146.73821
net_realised_price_index_2026_100: 104.89703
revenue_usd_m: 574.90625
売上高: 4.30576877
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 174.27688
net_realised_price_index_2026_100: 107.41949
revenue_usd_m: 2168.42246
売上高: 16.24043184
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 179.09752
net_realised_price_index_2026_100: 106.78418
revenue_usd_m: 1168.02696
売上高: 8.74795503
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 183.03357
net_realised_price_index_2026_100: 104.89703
revenue_usd_m: 646.95236
売上高: 4.84535923
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 147.56607
net_realised_price_index_2026_100: 107.41949
revenue_usd_m: 1294.66896
売上高: 9.69644216
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 151.76398
net_realised_price_index_2026_100: 106.78418
revenue_usd_m: 970.65795
売上高: 7.26975695
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 155.19354
net_realised_price_index_2026_100: 104.89703
revenue_usd_m: 650.03409
売上高: 4.86843983
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

79.91066227

revenue_usd_m

10669.67162628

cogs

21.55989668

sga_including_sbc

39.66494793

4.13937231

operating_profit

14.54644536

営業利益率

18.20%

finance_cost_net

1.0895255

associates_profit

0.06740563

pretax_profit

13.52432549

tax_expense

3.11059486

parent_profit_after_sbc

10.41373063

sbc_expense_within_sga

0.77821414

sbc_equity_credit

0.77821414

depreciation_amortization

7.35178093

capital_expenditure

6.07321033

net_working_capital_investment

0.84789299

cash_acquisitions

0.95892795

lease_principal_paid

0.75915129

fcfe_before_equity_distributions

9.90454313

dividend_policy_adjusted_profit_proxy_usd_m

1658.69285732

dividend_policy_normalization_usd_m

268.25154377

capital

内容を開く

begin_parent_equity_oku: 49.40500893
period_parent_profit_after_sbc_oku: 10.41373063
noncash_sbc_equity_credit_oku: 0.77821414
new_issue_cash_proceeds_oku: 0.04282174
issuer_paid_dividends_oku: 4.26467676
issuer_gross_buybacks_oku: 4.32383017
ending_parent_equity_oku: 52.0512685
begin_gross_financing_debt_oku: 25.87968718
begin_cash_oku: 5.13503191
operating_fcfe_before_distributions_oku: 9.90454313
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.90014349
ending_gross_financing_debt_oku: 24.97954369
ending_cash_oku: 5.59374636
ending_simple_net_debt_oku: 19.38579733
ending_required_operating_cash_oku: 5.59374636
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.998024
begin_treasury_m: 109.1319847
begin_employee_trust_m: 0
begin_old_cohort_m: 753.8702998
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 21.8895753
old_cohort_proportionally_tendered_shares_m: 21.3758422
ending_issued_m: 879.238024
ending_treasury_m: 127.97156
ending_employee_trust_m: 0
ending_economic_shares_m: 751.266464
ending_old_cohort_shares_m: 732.4944577
ending_old_cohort_economic_fraction: 0.97501285198

old_holder_cash_oku

dividends_received_oku: 4.1676538799
proportional_tender_proceeds_oku: 4.222215594
total_received_oku: 8.3898694739

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2033

period_start_inclusive

2033-01-01

期間末

2033-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2033

segment_revenue_usd_m

Orthopaedics: 4041.04099
Sports_Medicine_ENT: 4429.88263
Advanced_Wound_Management: 3155.01221

geography_revenue_usd_m

US: 5999.86881
Other_Established: 3582.02844
Emerging: 2044.03858

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 147.40931
net_realised_price_index_2026_100: 108.70852
revenue_usd_m: 2194.57554
売上高: 16.43630576
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 152.36023
net_realised_price_index_2026_100: 107.95881
revenue_usd_m: 1228.71259
売上高: 9.20246098
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 156.42294
net_realised_price_index_2026_100: 105.73621
revenue_usd_m: 617.75286
売上高: 4.6266691
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 191.18173
net_realised_price_index_2026_100: 108.70852
revenue_usd_m: 2407.30455
売上高: 18.02954277
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 197.36546
net_realised_price_index_2026_100: 107.95881
revenue_usd_m: 1301.32453
売上高: 9.74628915
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 202.43513
net_realised_price_index_2026_100: 105.73621
revenue_usd_m: 721.25355
売上高: 5.40183904
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 157.453
net_realised_price_index_2026_100: 108.70852
revenue_usd_m: 1397.98872
売上高: 10.47025703
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 162.69099
net_realised_price_index_2026_100: 107.95881
revenue_usd_m: 1051.99132
売上高: 7.87890442
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 166.98824
net_realised_price_index_2026_100: 105.73621
revenue_usd_m: 705.03217
売上高: 5.28034879
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

87.07261704

revenue_usd_m

11625.93582751

cogs

23.1700234

sga_including_sbc

42.77656632

4.5582515

operating_profit

16.56777582

営業利益率

19.03%

finance_cost_net

1.04392132

associates_profit

0.06740563

pretax_profit

15.59126013

tax_expense

3.58598983

parent_profit_after_sbc

12.0052703

sbc_expense_within_sga

0.82215994

sbc_equity_credit

0.82215994

depreciation_amortization

8.01068077

capital_expenditure

6.6175189

net_working_capital_investment

0.92615049

cash_acquisitions

1.0448714

lease_principal_paid

0.82718986

fcfe_before_equity_distributions

11.42238036

dividend_policy_adjusted_profit_proxy_usd_m

1869.4065481

dividend_policy_normalization_usd_m

266.46285747

capital

内容を開く

begin_parent_equity_oku: 52.0512685
period_parent_profit_after_sbc_oku: 12.0052703
noncash_sbc_equity_credit_oku: 0.82215994
new_issue_cash_proceeds_oku: 0.04697247
issuer_paid_dividends_oku: 4.79122501
issuer_gross_buybacks_oku: 5.13103717
ending_parent_equity_oku: 55.00340904
begin_gross_financing_debt_oku: 24.97954369
begin_cash_oku: 5.59374636
operating_fcfe_before_distributions_oku: 11.42238036
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.04575382
ending_gross_financing_debt_oku: 23.93378987
ending_cash_oku: 6.09508319
ending_simple_net_debt_oku: 17.83870668
ending_required_operating_cash_oku: 6.09508319
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.238024
begin_treasury_m: 127.97156
begin_employee_trust_m: 0
begin_old_cohort_m: 732.4944577
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 23.6792306
old_cohort_proportionally_tendered_shares_m: 23.0224672
ending_issued_m: 879.478024
ending_treasury_m: 148.6007906
ending_employee_trust_m: 0
ending_economic_shares_m: 730.8772334
ending_old_cohort_shares_m: 709.4719905
ending_old_cohort_economic_fraction: 0.97071294338

old_holder_cash_oku

dividends_received_oku: 4.661862678
proportional_tender_proceeds_oku: 4.988556883
total_received_oku: 9.650419561

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2034

period_start_inclusive

2034-01-01

期間末

2034-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2034

segment_revenue_usd_m

Orthopaedics: 4330.54168
Sports_Medicine_ENT: 4926.42521
Advanced_Wound_Management: 3414.37712

geography_revenue_usd_m

US: 6529.55901
Other_Established: 3909.22065
Emerging: 2232.56435

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 155.81164
net_realised_price_index_2026_100: 110.01302
revenue_usd_m: 2347.50235
売上高: 17.58165329
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 161.80656
net_realised_price_index_2026_100: 109.14636
revenue_usd_m: 1319.24659
売上高: 9.88051671
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 166.74685
net_realised_price_index_2026_100: 106.5821
revenue_usd_m: 663.79274
売上高: 4.9714855
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 209.72636
net_realised_price_index_2026_100: 110.01302
revenue_usd_m: 2672.50285
売上高: 20.01574932
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 217.49674
net_realised_price_index_2026_100: 109.14636
revenue_usd_m: 1449.83429
売上高: 10.85855516
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 223.89326
net_realised_price_index_2026_100: 106.5821
revenue_usd_m: 804.08808
売上高: 6.02222945
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 168.00235
net_realised_price_index_2026_100: 110.01302
revenue_usd_m: 1509.55381
売上高: 11.30582542
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 174.40474
net_realised_price_index_2026_100: 109.14636
revenue_usd_m: 1140.13978
売上高: 8.53909358
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 179.67935
net_realised_price_index_2026_100: 106.5821
revenue_usd_m: 764.68353
売上高: 5.72710854
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

94.90221697

revenue_usd_m

12671.34400983

cogs

24.90234173

sga_including_sbc

46.13985176

5.02032728

operating_profit

18.8396962

営業利益率

19.85%

finance_cost_net

0.99147694

associates_profit

0.06740563

pretax_profit

17.91562489

tax_expense

4.12059373

parent_profit_after_sbc

13.79503117

sbc_expense_within_sga

0.86873828

sbc_equity_credit

0.86873828

depreciation_amortization

8.73100396

capital_expenditure

7.21256849

net_working_capital_investment

1.01191243

cash_acquisitions

1.1388266

lease_principal_paid

0.90157106

fcfe_before_equity_distributions

13.12989483

dividend_policy_adjusted_profit_proxy_usd_m

2106.06210694

dividend_policy_normalization_usd_m

264.14954546

capital

内容を開く

begin_parent_equity_oku: 55.00340904
period_parent_profit_after_sbc_oku: 13.79503117
noncash_sbc_equity_credit_oku: 0.86873828
new_issue_cash_proceeds_oku: 0.05152554
issuer_paid_dividends_oku: 5.38020204
issuer_gross_buybacks_oku: 6.04362309
ending_parent_equity_oku: 58.29487889
begin_gross_financing_debt_oku: 23.93378987
begin_cash_oku: 6.09508319
operating_fcfe_before_distributions_oku: 13.12989483
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.20952324
ending_gross_financing_debt_oku: 22.72426663
ending_cash_oku: 6.64315519
ending_simple_net_debt_oku: 16.08111145
ending_required_operating_cash_oku: 6.64315519
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.478024
begin_treasury_m: 148.6007906
begin_employee_trust_m: 0
begin_old_cohort_m: 709.4719905
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 25.4228189
old_cohort_proportionally_tendered_shares_m: 24.6066886
ending_issued_m: 879.718024
ending_treasury_m: 170.9736096
ending_employee_trust_m: 0
ending_economic_shares_m: 708.7444144
ending_old_cohort_shares_m: 684.8653019
ending_old_cohort_economic_fraction: 0.96630786489

old_holder_cash_oku

dividends_received_oku: 5.2115536109
proportional_tender_proceeds_oku: 5.8494092461
total_received_oku: 11.060962857

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2035

period_start_inclusive

2035-01-01

期間末

2035-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2035

segment_revenue_usd_m

Orthopaedics: 4640.80091
Sports_Medicine_ENT: 5478.64471
Advanced_Wound_Management: 3695.07849

geography_revenue_usd_m

US: 7108.0244
Other_Established: 4267.41796
Emerging: 2439.08175

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 164.6929
net_realised_price_index_2026_100: 111.33318
revenue_usd_m: 2511.0857
売上高: 18.80681321
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 171.83857
net_realised_price_index_2026_100: 110.34697
revenue_usd_m: 1416.45132
売上高: 10.60853294
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 177.75214
net_realised_price_index_2026_100: 107.43475
revenue_usd_m: 713.26389
売上高: 5.34200037
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 230.06982
net_realised_price_index_2026_100: 111.33318
revenue_usd_m: 2966.91645
売上高: 22.22076433
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 239.68141
net_realised_price_index_2026_100: 110.34697
revenue_usd_m: 1615.29227
売上高: 12.09775519
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 247.62594
net_realised_price_index_2026_100: 107.43475
revenue_usd_m: 896.43598
売上高: 6.71387046
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 179.25851
net_realised_price_index_2026_100: 111.33318
revenue_usd_m: 1630.02224
売上高: 12.20807551
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 186.96188
net_realised_price_index_2026_100: 110.34697
revenue_usd_m: 1235.67437
売上高: 9.25460131
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 193.33498
net_realised_price_index_2026_100: 107.43475
revenue_usd_m: 829.38188
売上高: 6.21166774
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

103.46408107

revenue_usd_m

13814.52410447

cogs

26.76615777

sga_including_sbc

49.77569389

5.53015513

operating_profit

21.39207428

営業利益率

20.68%

finance_cost_net

0.93135974

associates_profit

0.06740563

pretax_profit

20.52812017

tax_expense

4.72146764

parent_profit_after_sbc

15.80665253

sbc_expense_within_sga

0.91811575

sbc_equity_credit

0.91811575

depreciation_amortization

9.51869546

capital_expenditure

7.86327016

net_working_capital_investment

1.10592389

cash_acquisitions

1.24156897

lease_principal_paid

0.98290877

fcfe_before_equity_distributions

15.04979194

dividend_policy_adjusted_profit_proxy_usd_m

2371.77386025

dividend_policy_normalization_usd_m

261.26961415

capital

内容を開く

begin_parent_equity_oku: 58.29487889
period_parent_profit_after_sbc_oku: 15.80665253
noncash_sbc_equity_credit_oku: 0.91811575
new_issue_cash_proceeds_oku: 0.05651993
issuer_paid_dividends_oku: 6.03784481
issuer_gross_buybacks_oku: 7.07439175
ending_parent_equity_oku: 61.96393054
begin_gross_financing_debt_oku: 22.72426663
begin_cash_oku: 6.64315519
operating_fcfe_before_distributions_oku: 15.04979194
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.39474483
ending_gross_financing_debt_oku: 21.3295218
ending_cash_oku: 7.24248567
ending_simple_net_debt_oku: 14.08703613
ending_required_operating_cash_oku: 7.24248567
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.718024
begin_treasury_m: 170.9736096
begin_employee_trust_m: 0
begin_old_cohort_m: 684.8653019
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 27.129159
old_cohort_proportionally_tendered_shares_m: 26.1366558
ending_issued_m: 879.958024
ending_treasury_m: 195.0527685
ending_employee_trust_m: 0
ending_economic_shares_m: 684.9052555
ending_old_cohort_shares_m: 658.728646
ending_old_cohort_economic_fraction: 0.96178068535

old_holder_cash_oku

dividends_received_oku: 5.8216589875
proportional_tender_proceeds_oku: 6.8153391627
total_received_oku: 12.6369981501

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2036

period_start_inclusive

2036-01-01

期間末

2036-11-06

days_booked

311

days_full_calendar_year

366

accrual_fraction_of_calendar_year

0.849726775956

is_partial_period

はい

period_status

暦年将来予測・最終期途中打切り

financials_oku_gbp

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 4225.953397541
Sports_Medicine_ENT: 5177.2037102732
Advanced_Wound_Management: 3397.9492493169

geography_revenue_usd_m

US: 6576.8313477322
Other_Established: 3959.4420665027
Emerging: 2264.8329428962

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 174.0804
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 2282.42407
売上高: 17.09424856
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 182.49256
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1292.28001
売上高: 9.67855016
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 189.48378
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 651.24931
売上高: 4.87754128
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 252.38659
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 2798.79933
売上高: 20.96164864
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 264.12891
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1529.19606
売上高: 11.45293631
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 273.87429
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 849.20832
売上高: 6.36015823
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 191.26883
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 1495.60796
売上高: 11.20137773
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 200.42314
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1137.96599
売上高: 8.52281299
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 208.02844
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 764.37531
売上高: 5.72480008
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

95.87407397

revenue_usd_m

12801.10635703

cogs

24.44788886

sga_including_sbc

45.63605921

5.17719999

operating_profit

20.6129259

営業利益率

21.50%

finance_cost_net

0.73296738

associates_profit

0.05727637

pretax_profit

19.9372349

tax_expense

4.58556403

parent_profit_after_sbc

15.35167087

sbc_expense_within_sga

0.8246343

sbc_equity_credit

0.8246343

depreciation_amortization

8.82041481

capital_expenditure

7.28642962

net_working_capital_investment

1.02732491

cash_acquisitions

1.15048889

lease_principal_paid

0.9108037

fcfe_before_equity_distributions

14.62167285

dividend_policy_adjusted_profit_proxy_usd_m

2670.03019127

dividend_policy_normalization_usd_m

257.77821509

capital

内容を開く

begin_parent_equity_oku: 61.96393054
period_parent_profit_after_sbc_oku: 15.35167087
noncash_sbc_equity_credit_oku: 0.8246343
new_issue_cash_proceeds_oku: 0.06198273
issuer_paid_dividends_oku: 6.78885992
issuer_gross_buybacks_oku: 5.34590668
ending_parent_equity_oku: 66.06745184
begin_gross_financing_debt_oku: 21.3295218
begin_cash_oku: 7.24248567
operating_fcfe_before_distributions_oku: 14.62167285
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.89332393
ending_gross_financing_debt_oku: 19.43619787
ending_cash_oku: 7.89805072
ending_simple_net_debt_oku: 11.53814715
ending_required_operating_cash_oku: 7.89805072
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.958024
begin_treasury_m: 195.0527685
begin_employee_trust_m: 0
begin_old_cohort_m: 658.728646
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 2.501
issuer_buyback_shares_m: 18.9009435
old_cohort_proportionally_tendered_shares_m: 18.1324045
ending_issued_m: 880.198024
ending_treasury_m: 211.452712
ending_employee_trust_m: 0
ending_economic_shares_m: 668.745312
ending_old_cohort_shares_m: 640.5962415
ending_old_cohort_economic_fraction: 0.95790763686

old_holder_cash_oku

dividends_received_oku: 6.5146284903
proportional_tender_proceeds_oku: 5.1284223381
total_received_oku: 11.6430508285

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

complete_calendar_year_projection_reference_not_fully_booked

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 4973.3085
Sports_Medicine_ENT: 6092.78636
Advanced_Wound_Management: 3998.87275

geography_revenue_usd_m

US: 7739.93657
Other_Established: 4659.66494
Emerging: 2665.3661

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 174.0804
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 2686.0682
売上高: 20.11734718
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 182.49256
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1520.81828
売上高: 11.39019086
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 189.48378
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 766.42202
売上高: 5.74012897
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 252.38659
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 3293.76384
売上高: 24.66869261
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 264.12891
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1799.63266
売上高: 13.47837521
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 273.87429
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 999.38986
売上高: 7.48494505
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 191.26883
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 1760.10454
売上高: 13.18232877
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 200.42314
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1339.21399
売上高: 10.03006287
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 208.02844
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 899.55422
売上高: 6.73722453
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

112.82929606

revenue_usd_m

15064.96760988

cogs

28.7714705

sga_including_sbc

53.70674492

6.09278199

operating_profit

24.25829865

営業利益率

21.50%

finance_cost_net

0.86259184

associates_profit

0.06740563

pretax_profit

23.46311245

tax_expense

5.39651586

parent_profit_after_sbc

18.06659659

sbc_expense_within_sga

0.97046995

sbc_equity_credit

0.97046995

depreciation_amortization

10.38029524

capital_expenditure

8.5750265

net_working_capital_investment

1.20900617

cash_acquisitions

1.35395155

lease_principal_paid

1.07187831

fcfe_before_equity_distributions

17.20749924

dividend_policy_adjusted_profit_proxy_usd_m

2670.03019127

dividend_policy_normalization_usd_m

257.77821509

注記

2036暦年全期の仮定値。11月7日以降の利益・資本・買戻し・配当を終点以前には計上しない。

financials_2026_to_2036_including_partial_periods

内容を開く

fiscal_year

2026

period_start_inclusive

2026-11-07

期間末

2026-12-31

days_booked

days_full_calendar_year

365

accrual_fraction_of_calendar_year

0.150684931507

is_partial_period

はい

period_status

発行会社実績からの部分期間推計

financials_oku_gbp

内容を開く

year

2026

revenue

7.6631423

revenue_usd_m

1023.18276042

cogs

2.23763755

sga_including_sbc

4.1037155

0.3716624

operating_profit

0.95012685

営業利益率

12.40%

finance_cost_net

0.05898606

associates_profit

0.00858174

pretax_profit

0.89972253

tax_expense

0.20693618

parent_profit_after_sbc

0.69278635

sbc_expense_within_sga

0.07674188

sbc_equity_credit

0.07674188

depreciation_amortization

0.6771342

capital_expenditure

0.49656508

net_working_capital_investment

-0.69622001

cash_acquisitions

lease_principal_paid

0.06997053

fcfe_before_equity_distributions

1.57634683

segment_revenue_usd_m

Orthopaedics: 398.71046875
Sports_Medicine_ENT: 337.7721875
Advanced_Wound_Management: 286.70010416667

geography_revenue_usd_m

未確認

volume_price_region_matrix

未確認

dividend_policy_normalization_usd_m

未確認

dividend_policy_adjusted_profit_proxy_usd_m

未確認

capital

内容を開く

begin_parent_equity_oku: 39.43229479
period_parent_profit_after_sbc_oku: 0.69278635
noncash_sbc_equity_credit_oku: 0.07674188
new_issue_cash_proceeds_oku: 0.00506791
issuer_paid_dividends_oku: 0
issuer_gross_buybacks_oku: 1.1234272
ending_parent_equity_oku: 39.08346372
begin_gross_financing_debt_oku: 28.34781306
begin_cash_oku: 6.05901738
operating_fcfe_before_distributions_oku: 1.57634683
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 2.01700491
ending_gross_financing_debt_oku: 26.33080815
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 21.83080815
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 877.750024
begin_treasury_m: 40.315859
begin_employee_trust_m: 0.2
begin_old_cohort_m: 837.234165
new_issuance_m: 0.048
treasury_or_trust_shares_delivered_to_employees_m: 0.45
issuer_buyback_shares_m: 9.5739106
old_cohort_proportionally_tendered_shares_m: 9.5682192
ending_issued_m: 877.798024
ending_treasury_m: 49.4397696
ending_employee_trust_m: 0.2
ending_economic_shares_m: 828.1582544
ending_old_cohort_shares_m: 827.6659458
ending_old_cohort_economic_fraction: 0.99940553793

old_holder_cash_oku

dividends_received_oku: 0
proportional_tender_proceeds_oku: 1.1227593671
total_received_oku: 1.1227593671

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

complete_calendar_year_projection_reference_not_fully_booked

内容を開く

fy_2026_reported_guidance_sales_usd_m_proxy: 6411
fy_2026_full_year_IFRS_operating_profit_usd_m_estimate: 850
fy_2026_full_year_parent_profit_usd_m_estimate: 585
fy_2026_full_year_capex_usd_m_estimate: 440
fy_2026_full_year_sbc_usd_m_estimate: 68
fy_2026_full_year_fcf_usd_m_company_guidance: 750
h1_actual_sales_usd_m: 3097
q3_actual_sales_usd_m: 1551
q4_full_estimated_sales_usd_m: 1763
q4_post_basis_day_fraction: 0.57291666666667
full_year_is_forecast: はい

内容を開く

fiscal_year

2027

period_start_inclusive

2027-01-01

期間末

2027-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2027

segment_revenue_usd_m

Orthopaedics: 2668.3089
Sports_Medicine_ENT: 2342.00101
Advanced_Wound_Management: 1964.15111

geography_revenue_usd_m

US: 3632.76512
Other_Established: 2131.61654
Emerging: 1210.07936

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 105.7
net_realised_price_index_2026_100: 101.2
revenue_usd_m: 1464.93224
売上高: 10.9716315
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 106.2
net_realised_price_index_2026_100: 101.1
revenue_usd_m: 802.04045
売上高: 6.00689375
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 106.6
net_realised_price_index_2026_100: 100.8
revenue_usd_m: 401.33621
売上高: 3.00581342
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 109.7
net_realised_price_index_2026_100: 101.2
revenue_usd_m: 1285.90296
売上高: 9.6307891
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 110.2
net_realised_price_index_2026_100: 101.1
revenue_usd_m: 680.43887
売上高: 5.09615691
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 110.6
net_realised_price_index_2026_100: 100.8
revenue_usd_m: 375.65918
売上高: 2.81350496
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 106.7
net_realised_price_index_2026_100: 101.2
revenue_usd_m: 881.92992
売上高: 6.60522706
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 107.2
net_realised_price_index_2026_100: 101.1
revenue_usd_m: 649.13722
売上高: 4.86172273
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 107.6
net_realised_price_index_2026_100: 100.8
revenue_usd_m: 433.08397
売上高: 3.24358878
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

52.23532822

revenue_usd_m

6974.46102336

cogs

15.05944512

sga_including_sbc

27.25763965

2.56214285

operating_profit

7.35610059

営業利益率

14.08%

finance_cost_net

1.11926812

associates_profit

0.06740563

pretax_profit

6.30423811

tax_expense

1.44997476

parent_profit_after_sbc

4.85426334

sbc_expense_within_sga

0.59282875

sbc_equity_credit

0.59282875

depreciation_amortization

4.8056502

capital_expenditure

3.96988494

net_working_capital_investment

4.78455018

cash_acquisitions

0.62682394

lease_principal_paid

0.49623562

fcfe_before_equity_distributions

0.37524761

dividend_policy_adjusted_profit_proxy_usd_m

918.75774039

dividend_policy_normalization_usd_m

270.61649893

capital

内容を開く

begin_parent_equity_oku: 39.08346372
period_parent_profit_after_sbc_oku: 4.85426334
noncash_sbc_equity_credit_oku: 0.59282875
new_issue_cash_proceeds_oku: 0.02694937
issuer_paid_dividends_oku: 2.54350434
issuer_gross_buybacks_oku: 0.74895147
ending_parent_equity_oku: 41.26504938
begin_gross_financing_debt_oku: 26.33080815
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 0.37524761
additional_new_debt_borrowings_oku: 2.89025882
debt_principal_repayment_oku: 0
ending_gross_financing_debt_oku: 29.22106697
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 24.72106697
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 877.798024
begin_treasury_m: 49.4397696
begin_employee_trust_m: 0.2
begin_old_cohort_m: 827.6659458
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 6.2434001
old_cohort_proportionally_tendered_shares_m: 6.2396887
ending_issued_m: 878.038024
ending_treasury_m: 52.7331697
ending_employee_trust_m: 0.1
ending_economic_shares_m: 825.2048543
ending_old_cohort_shares_m: 821.4262571
ending_old_cohort_economic_fraction: 0.99542101917

old_holder_cash_oku

dividends_received_oku: 2.537119446
proportional_tender_proceeds_oku: 0.7485062447
total_received_oku: 3.2856256907

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2028

period_start_inclusive

2028-01-01

期間末

2028-12-31

days_booked

366

days_full_calendar_year

366

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2028

segment_revenue_usd_m

Orthopaedics: 2859.39797
Sports_Medicine_ENT: 2604.45798
Advanced_Wound_Management: 2125.56752

geography_revenue_usd_m

US: 3946.8892
Other_Established: 2322.75804
Emerging: 1319.77622

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 111.7249
net_realised_price_index_2026_100: 102.4144
revenue_usd_m: 1567.01458
売上高: 11.73617867
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 112.7844
net_realised_price_index_2026_100: 102.2121
revenue_usd_m: 861.1364
売上高: 6.4494937
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 113.6356
net_realised_price_index_2026_100: 101.6064
revenue_usd_m: 431.24699
売上高: 3.22983068
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 120.3409
net_realised_price_index_2026_100: 102.4144
revenue_usd_m: 1427.56318
売上高: 10.69175536
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 121.4404
net_realised_price_index_2026_100: 102.2121
revenue_usd_m: 758.09192
売上高: 5.67774053
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 122.3236
net_realised_price_index_2026_100: 101.6064
revenue_usd_m: 418.80289
売上高: 3.13663038
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 113.8489
net_realised_price_index_2026_100: 102.4144
revenue_usd_m: 952.31145
売上高: 7.1323506
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 114.9184
net_realised_price_index_2026_100: 102.2121
revenue_usd_m: 703.52972
売上高: 5.2690962
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 115.7776
net_realised_price_index_2026_100: 101.6064
revenue_usd_m: 469.72634
売上高: 3.51802234
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

56.84109845

revenue_usd_m

7589.4234652

cogs

16.17697662

sga_including_sbc

29.37163176

2.81931848

operating_profit

8.47317159

営業利益率

14.91%

finance_cost_net

1.24065899

associates_profit

0.06740563

pretax_profit

7.29991824

tax_expense

1.67898119

parent_profit_after_sbc

5.62093704

sbc_expense_within_sga

0.62577191

sbc_equity_credit

0.62577191

depreciation_amortization

5.22938106

capital_expenditure

4.31992348

net_working_capital_investment

0.59728807

cash_acquisitions

0.68209318

lease_principal_paid

0.53999044

fcfe_before_equity_distributions

5.33679484

dividend_policy_adjusted_profit_proxy_usd_m

1021.41690896

dividend_policy_normalization_usd_m

270.90939518

capital

内容を開く

begin_parent_equity_oku: 41.26504938
period_parent_profit_after_sbc_oku: 5.62093704
noncash_sbc_equity_credit_oku: 0.62577191
new_issue_cash_proceeds_oku: 0.02956908
issuer_paid_dividends_oku: 2.62839798
issuer_gross_buybacks_oku: 1.92721331
ending_parent_equity_oku: 42.98571613
begin_gross_financing_debt_oku: 29.22106697
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 5.33679484
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.81075263
ending_gross_financing_debt_oku: 28.41031434
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 23.91031434
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.038024
begin_treasury_m: 52.7331697
begin_employee_trust_m: 0.1
begin_old_cohort_m: 821.4262571
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 14.126704
old_cohort_proportionally_tendered_shares_m: 14.0260454
ending_issued_m: 878.278024
ending_treasury_m: 63.9098737
ending_employee_trust_m: 0
ending_economic_shares_m: 814.3681503
ending_old_cohort_shares_m: 807.4002117
ending_old_cohort_economic_fraction: 0.99144374854

old_holder_cash_oku

dividends_received_oku: 2.6113609024
proportional_tender_proceeds_oku: 1.9134237249
total_received_oku: 4.5247846273

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2029

period_start_inclusive

2029-01-01

期間末

2029-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2029

segment_revenue_usd_m

Orthopaedics: 3064.18404
Sports_Medicine_ENT: 2896.33769
Advanced_Wound_Management: 2300.25855

geography_revenue_usd_m

US: 4289.34938
Other_Established: 2531.67342
Emerging: 1439.75748

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 118.09322
net_realised_price_index_2026_100: 103.64337
revenue_usd_m: 1676.21042
売上高: 12.55400254
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 119.77703
net_realised_price_index_2026_100: 103.33643
revenue_usd_m: 924.58665
売上高: 6.92470529
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 121.13555
net_realised_price_index_2026_100: 102.41925
revenue_usd_m: 463.38697
売上高: 3.47054351
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 132.01397
net_realised_price_index_2026_100: 103.64337
revenue_usd_m: 1584.82924
売上高: 11.86960189
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 133.82732
net_realised_price_index_2026_100: 103.33643
revenue_usd_m: 844.60688
売上高: 6.32569563
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 135.2899
net_realised_price_index_2026_100: 102.41925
revenue_usd_m: 466.90156
売上高: 3.4968661
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 121.47678
net_realised_price_index_2026_100: 103.64337
revenue_usd_m: 1028.30972
売上高: 7.70154071
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 123.19252
net_realised_price_index_2026_100: 103.33643
revenue_usd_m: 762.47989
売上高: 5.71060431
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 124.5767
net_realised_price_index_2026_100: 102.41925
revenue_usd_m: 509.46895
売上高: 3.81567518
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

61.86923516

revenue_usd_m

8260.78027836

cogs

17.37906816

sga_including_sbc

31.65482286

3.10274214

operating_profit

9.732602

営業利益率

15.73%

finance_cost_net

1.20660738

associates_profit

0.06740563

pretax_profit

8.59340025

tax_expense

1.97648206

parent_profit_after_sbc

6.61691819

sbc_expense_within_sga

0.66065683

sbc_equity_credit

0.66065683

depreciation_amortization

5.69196963

capital_expenditure

4.70206187

net_working_capital_investment

0.65169282

cash_acquisitions

0.74243082

lease_principal_paid

0.58775773

fcfe_before_equity_distributions

6.2856014

dividend_policy_adjusted_profit_proxy_usd_m

1154.34144235

dividend_policy_normalization_usd_m

270.85052502

capital

内容を開く

begin_parent_equity_oku: 42.98571613
period_parent_profit_after_sbc_oku: 6.61691819
noncash_sbc_equity_credit_oku: 0.66065683
new_issue_cash_proceeds_oku: 0.03243522
issuer_paid_dividends_oku: 2.96678941
issuer_gross_buybacks_oku: 2.41977216
ending_parent_equity_oku: 44.9091648
begin_gross_financing_debt_oku: 28.41031434
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 6.2856014
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.93147505
ending_gross_financing_debt_oku: 27.47883929
ending_cash_oku: 4.5
ending_simple_net_debt_oku: 22.97883929
ending_required_operating_cash_oku: 4.5
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.278024
begin_treasury_m: 63.9098737
begin_employee_trust_m: 0
begin_old_cohort_m: 807.4002117
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 16.1698662
old_cohort_proportionally_tendered_shares_m: 15.9899291
ending_issued_m: 878.518024
ending_treasury_m: 77.0297399
ending_employee_trust_m: 0
ending_economic_shares_m: 801.4882841
ending_old_cohort_shares_m: 791.4102826
ending_old_cohort_economic_fraction: 0.98742589041

old_holder_cash_oku

dividends_received_oku: 2.935776516
proportional_tender_proceeds_oku: 2.392772271
total_received_oku: 5.328548787

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2030

period_start_inclusive

2030-01-01

期間末

2030-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2030

segment_revenue_usd_m

Orthopaedics: 3283.64978
Sports_Medicine_ENT: 3220.93975
Advanced_Wound_Management: 2489.31664

geography_revenue_usd_m

US: 4662.80878
Other_Established: 2760.07675
Emerging: 1571.02064

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 124.82453
net_realised_price_index_2026_100: 104.88709
revenue_usd_m: 1793.01547
売上高: 13.42881566
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 127.20321
net_realised_price_index_2026_100: 104.47313
revenue_usd_m: 992.71204
売上高: 7.43493143
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 129.1305
net_realised_price_index_2026_100: 103.23861
revenue_usd_m: 497.92227
売上高: 3.72919617
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 144.81932
net_realised_price_index_2026_100: 104.88709
revenue_usd_m: 1759.42037
売上高: 13.17720471
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 147.47771
net_realised_price_index_2026_100: 104.47313
revenue_usd_m: 940.99511
売上高: 7.04759667
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 149.63063
net_realised_price_index_2026_100: 103.23861
revenue_usd_m: 520.52427
売上高: 3.89847418
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 129.61572
net_realised_price_index_2026_100: 104.88709
revenue_usd_m: 1110.37294
売上高: 8.31615446
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 132.06239
net_realised_price_index_2026_100: 104.47313
revenue_usd_m: 826.3696
売上高: 6.18910726
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 134.04453
net_realised_price_index_2026_100: 103.23861
revenue_usd_m: 552.5741
売上高: 4.13851182
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

67.35999237

revenue_usd_m

8993.90618088

cogs

18.67218988

sga_including_sbc

34.12115212

3.41515161

operating_profit

11.15149875

営業利益率

16.56%

finance_cost_net

1.16748543

associates_profit

0.06740563

pretax_profit

10.05141895

tax_expense

2.31182636

parent_profit_after_sbc

7.73959259

sbc_expense_within_sga

0.69760468

sbc_equity_credit

0.69760468

depreciation_amortization

6.1971193

capital_expenditure

5.11935942

net_working_capital_investment

0.71124949

cash_acquisitions

0.80831991

lease_principal_paid

0.63991993

fcfe_before_equity_distributions

7.35546783

dividend_policy_adjusted_profit_proxy_usd_m

1303.80017041

dividend_policy_normalization_usd_m

270.40976743

capital

内容を開く

begin_parent_equity_oku: 44.9091648
period_parent_profit_after_sbc_oku: 7.73959259
noncash_sbc_equity_credit_oku: 0.69760468
new_issue_cash_proceeds_oku: 0.03557017
issuer_paid_dividends_oku: 3.36931096
issuer_gross_buybacks_oku: 2.97908514
ending_parent_equity_oku: 47.03353614
begin_gross_financing_debt_oku: 27.47883929
begin_cash_oku: 4.5
operating_fcfe_before_distributions_oku: 7.35546783
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.82744243
ending_gross_financing_debt_oku: 26.65139686
ending_cash_oku: 4.71519947
ending_simple_net_debt_oku: 21.93619739
ending_required_operating_cash_oku: 4.71519947
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.518024
begin_treasury_m: 77.0297399
begin_employee_trust_m: 0
begin_old_cohort_m: 791.4102826
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 18.148292
old_cohort_proportionally_tendered_shares_m: 17.8728329
ending_issued_m: 878.758024
ending_treasury_m: 92.1280319
ending_employee_trust_m: 0
ending_economic_shares_m: 786.6299921
ending_old_cohort_shares_m: 773.5374497
ending_old_cohort_economic_fraction: 0.98335616164

old_holder_cash_oku

dividends_received_oku: 3.320502907
proportional_tender_proceeds_oku: 2.9337770204
total_received_oku: 6.2542799274

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2031

period_start_inclusive

2031-01-01

期間末

2031-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2031

segment_revenue_usd_m

Orthopaedics: 3518.84843
Sports_Medicine_ENT: 3581.93395
Advanced_Wound_Management: 2693.9242

geography_revenue_usd_m

US: 5070.19026
Other_Established: 3009.85317
Emerging: 1714.66316

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 131.93953
net_realised_price_index_2026_100: 106.14574
revenue_usd_m: 1917.95996
売上高: 14.36458925
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 135.08981
net_realised_price_index_2026_100: 105.62234
revenue_usd_m: 1065.85705
売上高: 7.98275205
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 137.65311
net_realised_price_index_2026_100: 104.06451
revenue_usd_m: 535.03142
売上高: 4.0071257
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 158.8668
net_realised_price_index_2026_100: 106.14574
revenue_usd_m: 1953.24516
売上高: 14.6288583
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 162.52043
net_realised_price_index_2026_100: 105.62234
revenue_usd_m: 1048.38335
売上高: 7.85188249
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 165.49148
net_realised_price_index_2026_100: 104.06451
revenue_usd_m: 580.30544
売上高: 4.34620614
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 138.29997
net_realised_price_index_2026_100: 106.14574
revenue_usd_m: 1198.98515
売上高: 8.97981685
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 141.57088
net_realised_price_index_2026_100: 105.62234
revenue_usd_m: 895.61276
売上高: 6.70770494
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 144.23191
net_realised_price_index_2026_100: 104.06451
revenue_usd_m: 599.32629
売上高: 4.48866303
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

73.35759875

revenue_usd_m

9794.70658533

cogs

20.06330326

sga_including_sbc

36.78573201

3.75957694

operating_profit

12.74898655

営業利益率

17.38%

finance_cost_net

1.12907445

associates_profit

0.06740563

pretax_profit

11.68731773

tax_expense

2.68808308

parent_profit_after_sbc

8.99923465

sbc_expense_within_sga

0.73674459

sbc_equity_credit

0.73674459

depreciation_amortization

6.74889909

capital_expenditure

5.57517751

net_working_capital_investment

0.77646387

cash_acquisitions

0.88029119

lease_principal_paid

0.69689719

fcfe_before_equity_distributions

8.55604858

dividend_policy_adjusted_profit_proxy_usd_m

1471.13272675

dividend_policy_normalization_usd_m

269.55491613

capital

内容を開く

begin_parent_equity_oku: 47.03353614
period_parent_profit_after_sbc_oku: 8.99923465
noncash_sbc_equity_credit_oku: 0.73674459
new_issue_cash_proceeds_oku: 0.03900812
issuer_paid_dividends_oku: 3.79297184
issuer_gross_buybacks_oku: 3.61054274
ending_parent_equity_oku: 49.40500893
begin_gross_financing_debt_oku: 26.65139686
begin_cash_oku: 4.71519947
operating_fcfe_before_distributions_oku: 8.55604858
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.77170967
ending_gross_financing_debt_oku: 25.87968718
ending_cash_oku: 5.13503191
ending_simple_net_debt_oku: 20.74465527
ending_required_operating_cash_oku: 5.13503191
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.758024
begin_treasury_m: 92.1280319
begin_employee_trust_m: 0
begin_old_cohort_m: 773.5374497
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 20.0539528
old_cohort_proportionally_tendered_shares_m: 19.6671499
ending_issued_m: 878.998024
ending_treasury_m: 109.1319847
ending_employee_trust_m: 0
ending_economic_shares_m: 769.8660393
ending_old_cohort_shares_m: 753.8702998
ending_old_cohort_economic_fraction: 0.97922269759

old_holder_cash_oku

dividends_received_oku: 3.7224856102
proportional_tender_proceeds_oku: 3.5407908094
total_received_oku: 7.2632764196

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2032

period_start_inclusive

2032-01-01

期間末

2032-12-31

days_booked

366

days_full_calendar_year

366

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2032

segment_revenue_usd_m

Orthopaedics: 3770.90886
Sports_Medicine_ENT: 3983.40178
Advanced_Wound_Management: 2915.36099

geography_revenue_usd_m

US: 5514.70249
Other_Established: 3283.07644
Emerging: 1871.8927

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 139.46008
net_realised_price_index_2026_100: 107.41949
revenue_usd_m: 2051.61108
売上高: 15.36557129
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 143.46538
net_realised_price_index_2026_100: 106.78418
revenue_usd_m: 1144.39153
売上高: 8.57093718
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 146.73821
net_realised_price_index_2026_100: 104.89703
revenue_usd_m: 574.90625
売上高: 4.30576877
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 174.27688
net_realised_price_index_2026_100: 107.41949
revenue_usd_m: 2168.42246
売上高: 16.24043184
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 179.09752
net_realised_price_index_2026_100: 106.78418
revenue_usd_m: 1168.02696
売上高: 8.74795503
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 183.03357
net_realised_price_index_2026_100: 104.89703
revenue_usd_m: 646.95236
売上高: 4.84535923
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 147.56607
net_realised_price_index_2026_100: 107.41949
revenue_usd_m: 1294.66896
売上高: 9.69644216
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 151.76398
net_realised_price_index_2026_100: 106.78418
revenue_usd_m: 970.65795
売上高: 7.26975695
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 155.19354
net_realised_price_index_2026_100: 104.89703
revenue_usd_m: 650.03409
売上高: 4.86843983
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

79.91066227

revenue_usd_m

10669.67162628

cogs

21.55989668

sga_including_sbc

39.66494793

4.13937231

operating_profit

14.54644536

営業利益率

18.20%

finance_cost_net

1.0895255

associates_profit

0.06740563

pretax_profit

13.52432549

tax_expense

3.11059486

parent_profit_after_sbc

10.41373063

sbc_expense_within_sga

0.77821414

sbc_equity_credit

0.77821414

depreciation_amortization

7.35178093

capital_expenditure

6.07321033

net_working_capital_investment

0.84789299

cash_acquisitions

0.95892795

lease_principal_paid

0.75915129

fcfe_before_equity_distributions

9.90454313

dividend_policy_adjusted_profit_proxy_usd_m

1658.69285732

dividend_policy_normalization_usd_m

268.25154377

capital

内容を開く

begin_parent_equity_oku: 49.40500893
period_parent_profit_after_sbc_oku: 10.41373063
noncash_sbc_equity_credit_oku: 0.77821414
new_issue_cash_proceeds_oku: 0.04282174
issuer_paid_dividends_oku: 4.26467676
issuer_gross_buybacks_oku: 4.32383017
ending_parent_equity_oku: 52.0512685
begin_gross_financing_debt_oku: 25.87968718
begin_cash_oku: 5.13503191
operating_fcfe_before_distributions_oku: 9.90454313
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 0.90014349
ending_gross_financing_debt_oku: 24.97954369
ending_cash_oku: 5.59374636
ending_simple_net_debt_oku: 19.38579733
ending_required_operating_cash_oku: 5.59374636
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 878.998024
begin_treasury_m: 109.1319847
begin_employee_trust_m: 0
begin_old_cohort_m: 753.8702998
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 21.8895753
old_cohort_proportionally_tendered_shares_m: 21.3758422
ending_issued_m: 879.238024
ending_treasury_m: 127.97156
ending_employee_trust_m: 0
ending_economic_shares_m: 751.266464
ending_old_cohort_shares_m: 732.4944577
ending_old_cohort_economic_fraction: 0.97501285198

old_holder_cash_oku

dividends_received_oku: 4.1676538799
proportional_tender_proceeds_oku: 4.222215594
total_received_oku: 8.3898694739

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2033

period_start_inclusive

2033-01-01

期間末

2033-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2033

segment_revenue_usd_m

Orthopaedics: 4041.04099
Sports_Medicine_ENT: 4429.88263
Advanced_Wound_Management: 3155.01221

geography_revenue_usd_m

US: 5999.86881
Other_Established: 3582.02844
Emerging: 2044.03858

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 147.40931
net_realised_price_index_2026_100: 108.70852
revenue_usd_m: 2194.57554
売上高: 16.43630576
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 152.36023
net_realised_price_index_2026_100: 107.95881
revenue_usd_m: 1228.71259
売上高: 9.20246098
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 156.42294
net_realised_price_index_2026_100: 105.73621
revenue_usd_m: 617.75286
売上高: 4.6266691
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 191.18173
net_realised_price_index_2026_100: 108.70852
revenue_usd_m: 2407.30455
売上高: 18.02954277
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 197.36546
net_realised_price_index_2026_100: 107.95881
revenue_usd_m: 1301.32453
売上高: 9.74628915
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 202.43513
net_realised_price_index_2026_100: 105.73621
revenue_usd_m: 721.25355
売上高: 5.40183904
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 157.453
net_realised_price_index_2026_100: 108.70852
revenue_usd_m: 1397.98872
売上高: 10.47025703
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 162.69099
net_realised_price_index_2026_100: 107.95881
revenue_usd_m: 1051.99132
売上高: 7.87890442
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 166.98824
net_realised_price_index_2026_100: 105.73621
revenue_usd_m: 705.03217
売上高: 5.28034879
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

87.07261704

revenue_usd_m

11625.93582751

cogs

23.1700234

sga_including_sbc

42.77656632

4.5582515

operating_profit

16.56777582

営業利益率

19.03%

finance_cost_net

1.04392132

associates_profit

0.06740563

pretax_profit

15.59126013

tax_expense

3.58598983

parent_profit_after_sbc

12.0052703

sbc_expense_within_sga

0.82215994

sbc_equity_credit

0.82215994

depreciation_amortization

8.01068077

capital_expenditure

6.6175189

net_working_capital_investment

0.92615049

cash_acquisitions

1.0448714

lease_principal_paid

0.82718986

fcfe_before_equity_distributions

11.42238036

dividend_policy_adjusted_profit_proxy_usd_m

1869.4065481

dividend_policy_normalization_usd_m

266.46285747

capital

内容を開く

begin_parent_equity_oku: 52.0512685
period_parent_profit_after_sbc_oku: 12.0052703
noncash_sbc_equity_credit_oku: 0.82215994
new_issue_cash_proceeds_oku: 0.04697247
issuer_paid_dividends_oku: 4.79122501
issuer_gross_buybacks_oku: 5.13103717
ending_parent_equity_oku: 55.00340904
begin_gross_financing_debt_oku: 24.97954369
begin_cash_oku: 5.59374636
operating_fcfe_before_distributions_oku: 11.42238036
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.04575382
ending_gross_financing_debt_oku: 23.93378987
ending_cash_oku: 6.09508319
ending_simple_net_debt_oku: 17.83870668
ending_required_operating_cash_oku: 6.09508319
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.238024
begin_treasury_m: 127.97156
begin_employee_trust_m: 0
begin_old_cohort_m: 732.4944577
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 23.6792306
old_cohort_proportionally_tendered_shares_m: 23.0224672
ending_issued_m: 879.478024
ending_treasury_m: 148.6007906
ending_employee_trust_m: 0
ending_economic_shares_m: 730.8772334
ending_old_cohort_shares_m: 709.4719905
ending_old_cohort_economic_fraction: 0.97071294338

old_holder_cash_oku

dividends_received_oku: 4.661862678
proportional_tender_proceeds_oku: 4.988556883
total_received_oku: 9.650419561

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2034

period_start_inclusive

2034-01-01

期間末

2034-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2034

segment_revenue_usd_m

Orthopaedics: 4330.54168
Sports_Medicine_ENT: 4926.42521
Advanced_Wound_Management: 3414.37712

geography_revenue_usd_m

US: 6529.55901
Other_Established: 3909.22065
Emerging: 2232.56435

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 155.81164
net_realised_price_index_2026_100: 110.01302
revenue_usd_m: 2347.50235
売上高: 17.58165329
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 161.80656
net_realised_price_index_2026_100: 109.14636
revenue_usd_m: 1319.24659
売上高: 9.88051671
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 166.74685
net_realised_price_index_2026_100: 106.5821
revenue_usd_m: 663.79274
売上高: 4.9714855
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 209.72636
net_realised_price_index_2026_100: 110.01302
revenue_usd_m: 2672.50285
売上高: 20.01574932
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 217.49674
net_realised_price_index_2026_100: 109.14636
revenue_usd_m: 1449.83429
売上高: 10.85855516
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 223.89326
net_realised_price_index_2026_100: 106.5821
revenue_usd_m: 804.08808
売上高: 6.02222945
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 168.00235
net_realised_price_index_2026_100: 110.01302
revenue_usd_m: 1509.55381
売上高: 11.30582542
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 174.40474
net_realised_price_index_2026_100: 109.14636
revenue_usd_m: 1140.13978
売上高: 8.53909358
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 179.67935
net_realised_price_index_2026_100: 106.5821
revenue_usd_m: 764.68353
売上高: 5.72710854
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

94.90221697

revenue_usd_m

12671.34400983

cogs

24.90234173

sga_including_sbc

46.13985176

5.02032728

operating_profit

18.8396962

営業利益率

19.85%

finance_cost_net

0.99147694

associates_profit

0.06740563

pretax_profit

17.91562489

tax_expense

4.12059373

parent_profit_after_sbc

13.79503117

sbc_expense_within_sga

0.86873828

sbc_equity_credit

0.86873828

depreciation_amortization

8.73100396

capital_expenditure

7.21256849

net_working_capital_investment

1.01191243

cash_acquisitions

1.1388266

lease_principal_paid

0.90157106

fcfe_before_equity_distributions

13.12989483

dividend_policy_adjusted_profit_proxy_usd_m

2106.06210694

dividend_policy_normalization_usd_m

264.14954546

capital

内容を開く

begin_parent_equity_oku: 55.00340904
period_parent_profit_after_sbc_oku: 13.79503117
noncash_sbc_equity_credit_oku: 0.86873828
new_issue_cash_proceeds_oku: 0.05152554
issuer_paid_dividends_oku: 5.38020204
issuer_gross_buybacks_oku: 6.04362309
ending_parent_equity_oku: 58.29487889
begin_gross_financing_debt_oku: 23.93378987
begin_cash_oku: 6.09508319
operating_fcfe_before_distributions_oku: 13.12989483
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.20952324
ending_gross_financing_debt_oku: 22.72426663
ending_cash_oku: 6.64315519
ending_simple_net_debt_oku: 16.08111145
ending_required_operating_cash_oku: 6.64315519
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.478024
begin_treasury_m: 148.6007906
begin_employee_trust_m: 0
begin_old_cohort_m: 709.4719905
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 25.4228189
old_cohort_proportionally_tendered_shares_m: 24.6066886
ending_issued_m: 879.718024
ending_treasury_m: 170.9736096
ending_employee_trust_m: 0
ending_economic_shares_m: 708.7444144
ending_old_cohort_shares_m: 684.8653019
ending_old_cohort_economic_fraction: 0.96630786489

old_holder_cash_oku

dividends_received_oku: 5.2115536109
proportional_tender_proceeds_oku: 5.8494092461
total_received_oku: 11.060962857

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2035

period_start_inclusive

2035-01-01

期間末

2035-12-31

days_booked

365

days_full_calendar_year

365

accrual_fraction_of_calendar_year

is_partial_period

いいえ

period_status

将来予測

financials_oku_gbp

内容を開く

year

2035

segment_revenue_usd_m

Orthopaedics: 4640.80091
Sports_Medicine_ENT: 5478.64471
Advanced_Wound_Management: 3695.07849

geography_revenue_usd_m

US: 7108.0244
Other_Established: 4267.41796
Emerging: 2439.08175

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 164.6929
net_realised_price_index_2026_100: 111.33318
revenue_usd_m: 2511.0857
売上高: 18.80681321
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 171.83857
net_realised_price_index_2026_100: 110.34697
revenue_usd_m: 1416.45132
売上高: 10.60853294
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 177.75214
net_realised_price_index_2026_100: 107.43475
revenue_usd_m: 713.26389
売上高: 5.34200037
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 230.06982
net_realised_price_index_2026_100: 111.33318
revenue_usd_m: 2966.91645
売上高: 22.22076433
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 239.68141
net_realised_price_index_2026_100: 110.34697
revenue_usd_m: 1615.29227
売上高: 12.09775519
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 247.62594
net_realised_price_index_2026_100: 107.43475
revenue_usd_m: 896.43598
売上高: 6.71387046
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 179.25851
net_realised_price_index_2026_100: 111.33318
revenue_usd_m: 1630.02224
売上高: 12.20807551
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 186.96188
net_realised_price_index_2026_100: 110.34697
revenue_usd_m: 1235.67437
売上高: 9.25460131
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 193.33498
net_realised_price_index_2026_100: 107.43475
revenue_usd_m: 829.38188
売上高: 6.21166774
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

103.46408107

revenue_usd_m

13814.52410447

cogs

26.76615777

sga_including_sbc

49.77569389

5.53015513

operating_profit

21.39207428

営業利益率

20.68%

finance_cost_net

0.93135974

associates_profit

0.06740563

pretax_profit

20.52812017

tax_expense

4.72146764

parent_profit_after_sbc

15.80665253

sbc_expense_within_sga

0.91811575

sbc_equity_credit

0.91811575

depreciation_amortization

9.51869546

capital_expenditure

7.86327016

net_working_capital_investment

1.10592389

cash_acquisitions

1.24156897

lease_principal_paid

0.98290877

fcfe_before_equity_distributions

15.04979194

dividend_policy_adjusted_profit_proxy_usd_m

2371.77386025

dividend_policy_normalization_usd_m

261.26961415

capital

内容を開く

begin_parent_equity_oku: 58.29487889
period_parent_profit_after_sbc_oku: 15.80665253
noncash_sbc_equity_credit_oku: 0.91811575
new_issue_cash_proceeds_oku: 0.05651993
issuer_paid_dividends_oku: 6.03784481
issuer_gross_buybacks_oku: 7.07439175
ending_parent_equity_oku: 61.96393054
begin_gross_financing_debt_oku: 22.72426663
begin_cash_oku: 6.64315519
operating_fcfe_before_distributions_oku: 15.04979194
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.39474483
ending_gross_financing_debt_oku: 21.3295218
ending_cash_oku: 7.24248567
ending_simple_net_debt_oku: 14.08703613
ending_required_operating_cash_oku: 7.24248567
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.718024
begin_treasury_m: 170.9736096
begin_employee_trust_m: 0
begin_old_cohort_m: 684.8653019
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 3.05
issuer_buyback_shares_m: 27.129159
old_cohort_proportionally_tendered_shares_m: 26.1366558
ending_issued_m: 879.958024
ending_treasury_m: 195.0527685
ending_employee_trust_m: 0
ending_economic_shares_m: 684.9052555
ending_old_cohort_shares_m: 658.728646
ending_old_cohort_economic_fraction: 0.96178068535

old_holder_cash_oku

dividends_received_oku: 5.8216589875
proportional_tender_proceeds_oku: 6.8153391627
total_received_oku: 12.6369981501

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

内容を開く

fiscal_year

2036

period_start_inclusive

2036-01-01

期間末

2036-11-06

days_booked

311

days_full_calendar_year

366

accrual_fraction_of_calendar_year

0.849726775956

is_partial_period

はい

period_status

暦年将来予測・最終期途中打切り

financials_oku_gbp

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 4225.953397541
Sports_Medicine_ENT: 5177.2037102732
Advanced_Wound_Management: 3397.9492493169

geography_revenue_usd_m

US: 6576.8313477322
Other_Established: 3959.4420665027
Emerging: 2264.8329428962

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 174.0804
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 2282.42407
売上高: 17.09424856
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 182.49256
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1292.28001
売上高: 9.67855016
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 189.48378
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 651.24931
売上高: 4.87754128
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 252.38659
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 2798.79933
売上高: 20.96164864
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 264.12891
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1529.19606
売上高: 11.45293631
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 273.87429
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 849.20832
売上高: 6.36015823
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 191.26883
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 1495.60796
売上高: 11.20137773
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 200.42314
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1137.96599
売上高: 8.52281299
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 208.02844
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 764.37531
売上高: 5.72480008
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

95.87407397

revenue_usd_m

12801.10635703

cogs

24.44788886

sga_including_sbc

45.63605921

5.17719999

operating_profit

20.6129259

営業利益率

21.50%

finance_cost_net

0.73296738

associates_profit

0.05727637

pretax_profit

19.9372349

tax_expense

4.58556403

parent_profit_after_sbc

15.35167087

sbc_expense_within_sga

0.8246343

sbc_equity_credit

0.8246343

depreciation_amortization

8.82041481

capital_expenditure

7.28642962

net_working_capital_investment

1.02732491

cash_acquisitions

1.15048889

lease_principal_paid

0.9108037

fcfe_before_equity_distributions

14.62167285

dividend_policy_adjusted_profit_proxy_usd_m

2670.03019127

dividend_policy_normalization_usd_m

257.77821509

capital

内容を開く

begin_parent_equity_oku: 61.96393054
period_parent_profit_after_sbc_oku: 15.35167087
noncash_sbc_equity_credit_oku: 0.8246343
new_issue_cash_proceeds_oku: 0.06198273
issuer_paid_dividends_oku: 6.78885992
issuer_gross_buybacks_oku: 5.34590668
ending_parent_equity_oku: 66.06745184
begin_gross_financing_debt_oku: 21.3295218
begin_cash_oku: 7.24248567
operating_fcfe_before_distributions_oku: 14.62167285
additional_new_debt_borrowings_oku: 0
debt_principal_repayment_oku: 1.89332393
ending_gross_financing_debt_oku: 19.43619787
ending_cash_oku: 7.89805072
ending_simple_net_debt_oku: 11.53814715
ending_required_operating_cash_oku: 7.89805072
other_comprehensive_income_assumed_oku: 0
sbc_transfer_book_value_equity_effect_assumed_oku: 0
lease_liability_replenishment_assumption: リース元本支払相当の新規リースを想定し、借入残高への純変動ゼロ・FCFEには現金支払を反映

株数

内容を開く

begin_issued_m: 879.958024
begin_treasury_m: 195.0527685
begin_employee_trust_m: 0
begin_old_cohort_m: 658.728646
new_issuance_m: 0.24
treasury_or_trust_shares_delivered_to_employees_m: 2.501
issuer_buyback_shares_m: 18.9009435
old_cohort_proportionally_tendered_shares_m: 18.1324045
ending_issued_m: 880.198024
ending_treasury_m: 211.452712
ending_employee_trust_m: 0
ending_economic_shares_m: 668.745312
ending_old_cohort_shares_m: 640.5962415
ending_old_cohort_economic_fraction: 0.95790763686

old_holder_cash_oku

dividends_received_oku: 6.5146284903
proportional_tender_proceeds_oku: 5.1284223381
total_received_oku: 11.6430508285

income_statement_technical

内容を開く

rd_already_expensed_in_operating_profit: はい
sbc_expense_included_in_IFRS_operating_costs_and_profit: はい
consolidation_NCI_profit_assumed: 0
equity_settled_sbc_credit_is_not_cash_proceeds: はい

period_reconciliation_absolute_errors

内容を開く

equity_bridge_abs_error: 0
cash_bridge_abs_error: 0
shares_bridge_abs_error_m: 0
old_holder_shares_bridge_abs_error_m: 0
income_statement_abs_error_oku: 0
attributable_profit_abs_error_oku: 0
fcfe_cash_identity_abs_error_oku: 0

complete_calendar_year_projection_reference_not_fully_booked

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 4973.3085
Sports_Medicine_ENT: 6092.78636
Advanced_Wound_Management: 3998.87275

geography_revenue_usd_m

US: 7739.93657
Other_Established: 4659.66494
Emerging: 2665.3661

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 174.0804
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 2686.0682
売上高: 20.11734718
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 182.49256
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1520.81828
売上高: 11.39019086
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 189.48378
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 766.42202
売上高: 5.74012897
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 252.38659
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 3293.76384
売上高: 24.66869261
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 264.12891
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1799.63266
売上高: 13.47837521
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 273.87429
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 999.38986
売上高: 7.48494505
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 191.26883
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 1760.10454
売上高: 13.18232877
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 200.42314
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1339.21399
売上高: 10.03006287
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 208.02844
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 899.55422
売上高: 6.73722453
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

112.82929606

revenue_usd_m

15064.96760988

cogs

28.7714705

sga_including_sbc

53.70674492

6.09278199

operating_profit

24.25829865

営業利益率

21.50%

finance_cost_net

0.86259184

associates_profit

0.06740563

pretax_profit

23.46311245

tax_expense

5.39651586

parent_profit_after_sbc

18.06659659

sbc_expense_within_sga

0.97046995

sbc_equity_credit

0.97046995

depreciation_amortization

10.38029524

capital_expenditure

8.5750265

net_working_capital_investment

1.20900617

cash_acquisitions

1.35395155

lease_principal_paid

1.07187831

fcfe_before_equity_distributions

17.20749924

dividend_policy_adjusted_profit_proxy_usd_m

2670.03019127

dividend_policy_normalization_usd_m

257.77821509

注記

2036暦年全期の仮定値。11月7日以降の利益・資本・買戻し・配当を終点以前には計上しない。

dividend_timetable_ex_dates

内容を開く

fiscal_year: 2026
kind: final
declaration_date_assumed: 2027-02-26
ex_date: 2027-03-25
record_date: 2027-03-26
payment_date: 2027-05-26
状態: all_future_dates_assumed
usd_per_share: 0.25
gbp_per_share_fixed_fx: 0.1872379
recheck_date_assumed: 2027-03-04
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2027
kind: interim
declaration_date_assumed: 2027-08-04
ex_date: 2027-10-07
record_date: 2027-10-08
payment_date: 2027-11-05
状態: all_future_dates_assumed
usd_per_share: 0.1624
gbp_per_share_fixed_fx: 0.1216297
recheck_date_assumed: 2027-09-16
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2027
kind: final
declaration_date_assumed: 2028-02-25
ex_date: 2028-03-30
record_date: 2028-03-31
payment_date: 2028-05-24
状態: all_future_dates_assumed
usd_per_share: 0.2591715
gbp_per_share_fixed_fx: 0.1941069
recheck_date_assumed: 2028-03-09
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2028
kind: interim
declaration_date_assumed: 2028-08-04
ex_date: 2028-10-05
record_date: 2028-10-06
payment_date: 2028-11-03
状態: all_future_dates_assumed
usd_per_share: 0.1686286
gbp_per_share_fixed_fx: 0.1262946
recheck_date_assumed: 2028-09-14
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2028
kind: final
declaration_date_assumed: 2029-02-26
ex_date: 2029-03-29
record_date: 2029-03-30
payment_date: 2029-05-23
状態: all_future_dates_assumed
usd_per_share: 0.3017254
gbp_per_share_fixed_fx: 0.2259777
recheck_date_assumed: 2029-03-08
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2029
kind: interim
declaration_date_assumed: 2029-08-03
ex_date: 2029-10-04
record_date: 2029-10-05
payment_date: 2029-11-05
状態: all_future_dates_assumed
usd_per_share: 0.1881416
gbp_per_share_fixed_fx: 0.1409089
recheck_date_assumed: 2029-09-13
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2029
kind: final
declaration_date_assumed: 2030-02-26
ex_date: 2030-03-28
record_date: 2030-03-29
payment_date: 2030-05-22
状態: all_future_dates_assumed
usd_per_share: 0.3504965
gbp_per_share_fixed_fx: 0.2625049
recheck_date_assumed: 2030-03-07
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2030
kind: interim
declaration_date_assumed: 2030-08-02
ex_date: 2030-10-03
record_date: 2030-10-04
payment_date: 2030-11-05
状態: all_future_dates_assumed
usd_per_share: 0.2154553
gbp_per_share_fixed_fx: 0.1613655
recheck_date_assumed: 2030-09-12
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2030
kind: final
declaration_date_assumed: 2031-02-26
ex_date: 2031-03-27
record_date: 2031-03-28
payment_date: 2031-05-28
状態: all_future_dates_assumed
usd_per_share: 0.4026998
gbp_per_share_fixed_fx: 0.3016026
recheck_date_assumed: 2031-03-06
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2031
kind: interim
declaration_date_assumed: 2031-08-04
ex_date: 2031-10-02
record_date: 2031-10-03
payment_date: 2031-11-05
状態: all_future_dates_assumed
usd_per_share: 0.247262
gbp_per_share_fixed_fx: 0.1851873
recheck_date_assumed: 2031-09-11
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2031
kind: final
declaration_date_assumed: 2032-02-26
ex_date: 2032-03-25
record_date: 2032-03-26
payment_date: 2032-05-26
状態: all_future_dates_assumed
usd_per_share: 0.463403
gbp_per_share_fixed_fx: 0.3470664
recheck_date_assumed: 2032-03-04
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2032
kind: interim
declaration_date_assumed: 2032-08-04
ex_date: 2032-10-07
record_date: 2032-10-08
payment_date: 2032-11-05
状態: all_future_dates_assumed
usd_per_share: 0.284266
gbp_per_share_fixed_fx: 0.2129015
recheck_date_assumed: 2032-09-16
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2032
kind: final
declaration_date_assumed: 2033-02-25
ex_date: 2033-03-31
record_date: 2033-04-01
payment_date: 2033-05-25
状態: all_future_dates_assumed
usd_per_share: 0.5344521
gbp_per_share_fixed_fx: 0.4002787
recheck_date_assumed: 2033-03-10
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2033
kind: interim
declaration_date_assumed: 2033-08-04
ex_date: 2033-10-06
record_date: 2033-10-07
payment_date: 2033-11-04
状態: all_future_dates_assumed
usd_per_share: 0.3274873
gbp_per_share_fixed_fx: 0.2452721
recheck_date_assumed: 2033-09-15
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2033
kind: final
declaration_date_assumed: 2034-02-24
ex_date: 2034-03-30
record_date: 2034-03-31
payment_date: 2034-05-24
状態: all_future_dates_assumed
usd_per_share: 0.618082
gbp_per_share_fixed_fx: 0.4629134
recheck_date_assumed: 2034-03-09
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2034
kind: interim
declaration_date_assumed: 2034-08-04
ex_date: 2034-10-05
record_date: 2034-10-06
payment_date: 2034-11-03
状態: all_future_dates_assumed
usd_per_share: 0.3782277
gbp_per_share_fixed_fx: 0.2832742
recheck_date_assumed: 2034-09-14
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2034
kind: final
declaration_date_assumed: 2035-02-26
ex_date: 2035-03-29
record_date: 2035-03-30
payment_date: 2035-05-23
状態: all_future_dates_assumed
usd_per_share: 0.7167628
gbp_per_share_fixed_fx: 0.5368205
recheck_date_assumed: 2035-03-08
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2035
kind: interim
declaration_date_assumed: 2035-08-03
ex_date: 2035-10-04
record_date: 2035-10-05
payment_date: 2035-11-05
状態: all_future_dates_assumed
usd_per_share: 0.4379962
gbp_per_share_fixed_fx: 0.3280379
recheck_date_assumed: 2035-09-13
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2035
kind: final
declaration_date_assumed: 2036-02-26
ex_date: 2036-03-27
record_date: 2036-03-28
payment_date: 2036-05-28
状態: all_future_dates_assumed
usd_per_share: 0.8336527
gbp_per_share_fixed_fx: 0.6243654
recheck_date_assumed: 2036-03-06
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

内容を開く

fiscal_year: 2036
kind: interim
declaration_date_assumed: 2036-08-04
ex_date: 2036-10-02
record_date: 2036-10-03
payment_date: 2036-11-05
状態: all_future_dates_assumed
usd_per_share: 0.5086596
gbp_per_share_fixed_fx: 0.3809613
recheck_date_assumed: 2036-09-11
ex_date_is_issuer_confirmed: いいえ
ex_date_status: future_assumed_reconfirm_before_ex_date

終価

305.346555055

期間内株主受取

81.16057569

terminal_2036_11_06

内容を開く

終了日

2036-11-06

date_status

forecast_not_announced

terminal_year_actual_days_over_365_25

10.001368925394

company_issued_shares_m

880.198024

treasury_shares_m

211.452712

employee_trust_shares_m

company_economic_shares_m

668.745312

old_cohort_remaining_shares_m

640.5962415

old_cohort_fraction

0.9579076369

company_parent_equity_book_oku

66.06745184

company_gross_debt_oku

19.43619787

company_cash_oku

7.89805072

company_simple_net_debt_oku

11.53814715

forward_12_months_2036_11_07_to_2037_11_06_company_fcfe_oku

18.60371372

forward_fcfe_blend

2036_year_end_55_days_over_leap_366: 0.150273224
2037_to_Nov06_310_days_over_365: 0.8493150685

long_run_total_company_fcfe_growth

0.03

next_12m_vested_and_new_shares_m

3.29

post_horizon_annual_share_dilution_fraction

0.004919660656

post_horizon_cohort_fcfe_growth_after_dilution

未確認

cashflow_to_old_cohort_forward_year_after_dilution_oku

17.9217601

terminal_k

0.084

terminal_denominator_k_minus_effective_old_growth

未確認

terminal_company_equivalent_value_without_extra_cash_oku

318.76408883

old_cohort_operating_terminal_oku

305.34655505

nonoperating_excess_cash_company_oku

nonoperating_excess_cash_old_cohort_oku

terminal_old_cohort_total_oku

305.34655505

terminal_remaining_cohort_implied_price_per_share_gbp

47.66599229

IFRS_2036_full_calendar_year_reference_not_booked_in_full

内容を開く

year

2036

segment_revenue_usd_m

Orthopaedics: 4973.3085
Sports_Medicine_ENT: 6092.78636
Advanced_Wound_Management: 3998.87275

geography_revenue_usd_m

US: 7739.93657
Other_Established: 4659.66494
Emerging: 2665.3661

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 174.0804
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 2686.0682
売上高: 20.11734718
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 182.49256
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1520.81828
売上高: 11.39019086
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 189.48378
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 766.42202
売上高: 5.74012897
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 252.38659
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 3293.76384
売上高: 24.66869261
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 264.12891
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1799.63266
売上高: 13.47837521
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 273.87429
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 999.38986
売上高: 7.48494505
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 191.26883
net_realised_price_index_2026_100: 112.66918
revenue_usd_m: 1760.10454
売上高: 13.18232877
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 200.42314
net_realised_price_index_2026_100: 111.56078
revenue_usd_m: 1339.21399
売上高: 10.03006287
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 208.02844
net_realised_price_index_2026_100: 108.29423
revenue_usd_m: 899.55422
売上高: 6.73722453
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

112.82929606

revenue_usd_m

15064.96760988

cogs

28.7714705

sga_including_sbc

53.70674492

6.09278199

operating_profit

24.25829865

営業利益率

21.50%

finance_cost_net

0.86259184

associates_profit

0.06740563

pretax_profit

23.46311245

tax_expense

5.39651586

parent_profit_after_sbc

18.06659659

sbc_expense_within_sga

0.97046995

sbc_equity_credit

0.97046995

depreciation_amortization

10.38029524

capital_expenditure

8.5750265

net_working_capital_investment

1.20900617

cash_acquisitions

1.35395155

lease_principal_paid

1.07187831

fcfe_before_equity_distributions

17.20749924

dividend_policy_adjusted_profit_proxy_usd_m

2670.03019127

dividend_policy_normalization_usd_m

257.77821509

注記

2036暦年全期の仮定値。11月7日以降の利益・資本・買戻し・配当を終点以前には計上しない。

IFRS_2037_full_calendar_year_forward_reference

内容を開く

year

2037

segment_revenue_usd_m

Orthopaedics: 5329.66131
Sports_Medicine_ENT: 6775.79616
Advanced_Wound_Management: 4327.66103

geography_revenue_usd_m

US: 8430.43013
Other_Established: 5089.31497
Emerging: 2913.37341

volume_price_region_matrix

内容を開く

segment: Orthopaedics
region: US
volume_index_2026_100: 184.00298
net_realised_price_index_2026_100: 114.02121
revenue_usd_m: 2873.24417
売上高: 21.51920441
volume_growth_assumed: 0.057
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Other_Established
volume_index_2026_100: 193.8071
net_realised_price_index_2026_100: 112.78795
revenue_usd_m: 1632.87522
売上高: 12.22944291
volume_growth_assumed: 0.062
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Orthopaedics
region: Emerging
volume_index_2026_100: 201.98971
net_realised_price_index_2026_100: 109.16058
revenue_usd_m: 823.54192
売上高: 6.1679293
volume_growth_assumed: 0.066
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: US
volume_index_2026_100: 276.86809
net_realised_price_index_2026_100: 114.02121
revenue_usd_m: 3656.61804
売上高: 27.38629447
volume_growth_assumed: 0.097
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Other_Established
volume_index_2026_100: 291.07006
net_realised_price_index_2026_100: 112.78795
revenue_usd_m: 2005.01034
売上高: 15.01655435
volume_growth_assumed: 0.102
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Sports_Medicine_ENT
region: Emerging
volume_index_2026_100: 302.90497
net_realised_price_index_2026_100: 109.16058
revenue_usd_m: 1114.16779
売上高: 8.34457602
volume_growth_assumed: 0.106
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: US
volume_index_2026_100: 204.08384
net_realised_price_index_2026_100: 114.02121
revenue_usd_m: 1900.56792
売上高: 14.23433133
volume_growth_assumed: 0.067
net_price_growth_assumed: 0.012
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Other_Established
volume_index_2026_100: 214.8536
net_realised_price_index_2026_100: 112.78795
revenue_usd_m: 1451.42941
売上高: 10.87050189
volume_growth_assumed: 0.072
net_price_growth_assumed: 0.011
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

内容を開く

segment: Advanced_Wound_Management
region: Emerging
volume_index_2026_100: 223.8386
net_realised_price_index_2026_100: 109.16058
revenue_usd_m: 975.6637
売上高: 7.30724762
volume_growth_assumed: 0.076
net_price_growth_assumed: 0.008
actual_procedure_counts: 未確認
actual_net_asp: 未確認
unknown_reason: 会社が当該事業×地域の処置数量・純単価を一貫して開示していないため、2026=100の数量・単価指数による予測代理値

revenue

123.0760823

revenue_usd_m

16433.1185087

cogs

31.38440099

sga_including_sbc

58.58421517

6.64610844

operating_profit

26.46135769

営業利益率

21.50%

finance_cost_net

0.77192762

associates_profit

0.06740563

pretax_profit

25.7568357

tax_expense

5.92407221

parent_profit_after_sbc

19.83276349

sbc_expense_within_sga

1.02599025

sbc_equity_credit

1.02599025

depreciation_amortization

11.32299957

capital_expenditure

9.35378225

net_working_capital_investment

1.32206472

cash_acquisitions

1.47691299

lease_principal_paid

1.16922278

fcfe_before_equity_distributions

18.85977057

dividend_policy_adjusted_profit_proxy_usd_m

2901.69804254

dividend_policy_normalization_usd_m

253.62746127

perpetuity_continuation_mode

zero_further_discretionary_buybacks;constant_absolute_annual_free_SBC_and_paid_employee_shares;paid_issue_subscriptions_immediately_pass_through_to_preissue_equity_holders;post_issue_share_count_increases;no_double_debt_deduction

neutral_repurchase_cost_sensitivity

内容を開く

方法: at_year_end_repurchase_exactly_free_awards_plus_paid_issued_shares_at_endogenous_policy_fair_price;paid_subscription_funds_offset_gross_repurchase_spending
policy: alternative_only_do_not_combine_with_dilution_terminal
old_cohort_tender_rule: For comparison assume shares repurchased from each year's newly delivered employee cohort, so old cohort has no repurchase proceeds and maintains same original share count; not a forecast of actual corporate repurchase allocation.
new_shares_per_year_m: 3.29
free_award_shares_per_year_m: 3.05
paid_employee_shares_per_year_m: 0.24
price_for_replacement_gbp_per_share_endogenous: 48.78455467
replacement_policy_2036_terminal_equilibrium_price_GBP: 47.36364531
replacement_policy_2037_year_end_price_GBP: 48.78455467
employee_paid_subscription_price_GBP: 43.9060992
required_cash_oku_per_year: 1.605011849
gross_market_repurchase_oku_2037: 1.605011849
employee_subscription_proceeds_oku_2037: 0.105374638
incremental_net_cash_needed_oku_2037: 1.49963721
market_neutral_share_equivalent_dilution_m: 3.074
SBC_expense_recognised_in_IFRS_profit_next_year_oku: 1.01722463
SBC_expense_reference_period: 2036-11-07 to 2037-11-06 blend: 55/366 FY2036 SBC plus 310/365 FY2037 SBC, matching FCFE forward year
SBC_non_cash_addback_to_company_FCFE_next_year_oku: 1.01722463
additional_cash_required_minus_SBC_accounting_expense_oku: 0.482412583
company_forward_FCFE_after_cash_replacement_oku: 17.10407651
neutral_company_terminal_oku_excess_cash_excluded: 316.74215758
neutral_old_cohort_terminal_value_oku_including_separate_excess_cash: 303.409731675
cashflow_and_shares_reconcile: はい
計算式: P0 = 100*FCFE1 / [S0*(k-g)+(1+g)*(q_free+(1-h)*q_paid)]; P1=P0*(1+g); gross buyback=(q_free+q_paid)*P1/100; employee cash=q_paid*h*P1/100; net cash=(q_free+(1-h)*q_paid)*P1/100.
注記: 会社は全付与・発行株を時価買戻し、申込金は支払額から一度だけ控除する。SBC会計費用は既にIFRS費用に計上されFCFEで非現金戻入済みなので、追加費用として重複控除しない。

post_horizon_model_revision

v2_constant_absolute_shares_paid_issuance_cash_included

next_12m_free_SBC_deliveries_m

3.05

next_12m_employee_paid_issuance_m

0.24

post_horizon_annual_share_dilution_fraction_description

FIRST YEAR ONLY: q/S0; every future year uses q/(S0+(t-1)q).

post_horizon_cohort_fcfe_growth_after_dilution_reason

S_t=S_0+t*q, constant absolute q implies year-varying percentage dilution; single Gordon-growth rate is mathematically invalid.

cashflow_to_old_cohort_forward_year_after_dilution_note

先に旧株主へ配分されるFCFE及び有償申込金。交付後希薄化は次年度以降の分母に反映。

terminal_denominator_k_minus_effective_old_growth_reason

旧式の一定d永久成長分母を廃止。未来1100期間を年次株数で逆算。

post_horizon_year2_share_increase_fraction

0.004895576082

continuation_financing_dilution_audit

内容を開く

方法

constant_number_annual_issue_dynamic_share_denominator_1100_step_backward_recursion

future_issuer_cash_policy

All annual paid employee share plan capital proceeds assumed distributed to shareholders who held shares just before that year's new deliveries, as a separate capital distribution. No capital proceeds kept in cash or reinvested; this prevents double recognition. Future gross FCFE remains operating FCFE only.

first_continuation_year_2036_11_07_to_2037_11_06

はい

timing_convention

All employee deliveries/subscriptions and their pass-through are aggregated at the END of each 12-month continuation year. This is a valuation modeling convention, not an exercise or ex-date prediction.

from_company_2025_20f

内容を開く

2025_12_31_share_options_outstanding_m

3.259

2025_share_option_range_gbp_per_share

1: 8.43
2: 12.35

2025_maximum_long_term_awards_m

7.542

2037_options_terms_known

いいえ

source_key

company_fy2025_20f

pre2036_calendar_year_subscription_proceeds_recorded_in_equity_cash_ledger

はい

post2036_start_economic_shares_m

668.745312

post2036_start_old_remaining_shares_m

640.5962415

annual_free_SBC_shares_m

3.05

annual_paid_employee_new_shares_m

0.24

annual_total_new_economic_shares_m

3.29

annual_paid_issuance_discount_factor_of_endogenous_market_price

0.9

discount_and_issue_volume_are_analyst_assumptions_not_issuer_confirmations

はい

2037_post_issue_fair_GBP_per_share_endogenous

48.872267006

2037_employee_subscription_price_GBP

43.985040306

2037_company_subscription_cash_oku

0.1055640967

2037_forward_12m_SBC_expense_oku_55days_2036_plus_310days_2037

1.017224628

FY2036_full_SBC_oku_reference

0.97046995

FY2037_full_SBC_oku_reference

1.02599025

2037_company_operating_FCFE_excluding_paid_subscription_oku

18.60371372

2037_company_cash_to_equity_preissue_oku

18.709277817

2037_old_operating_cash_oku

17.820639447

2037_old_subscription_cash_oku

0.101120654

2037_old_total_cash_oku

17.921760101

2037_end_economic_shares_m

672.035312

2037_end_old_fraction

0.953218127175

2038_year2_dilution_fraction

0.004895576082

annual_issue_cash_not_recorded_as_IFRS_profit_or_operating_FCFE

はい

SBC_non_cash_addback_in_FCFE_and_dilution_recognized_once_each

はい

if_subscription_funds_were_reinvested_or_retained_policy_would_need_new_explicit_cash_asset_valuation

はい

first_20_continuation_years_annual_ledger

内容を開く

continuation_year: 1
period_start: 2036-11-07
期間末: 2037-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 668.745312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 672.035312
old_cohort_m: 640.5962415
old_fraction_open: 0.957907636891
old_fraction_close: 0.953218127175
share_count_increase_fraction_of_opening: 0.004919660656
future_operating_FCFE_before_subscriptions_oku: 18.60371372
market_price_post_annual_issue_GBP_endogenous: 48.87226701
paid_issue_price_GBP_per_share_assumed: 43.98504031
issuer_paid_subscription_cash_oku: 0.105564097
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.105564097
issuer_payout_from_operations_oku: 18.60371372
issuer_total_cash_to_preissue_shares_oku: 18.709277817
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 17.820639447
old_cohort_subscription_proceeds_cash_oku: 0.101120654
old_cohort_total_cash_oku: 17.921760101
old_cohort_cash_PV_at_terminal_oku: 16.532989023
old_cohort_residual_shares_value_oku: 313.073905578
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 2
period_start: 2037-11-07
期間末: 2038-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 672.035312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 675.325312
old_cohort_m: 640.5962415
old_fraction_open: 0.953218127175
old_fraction_close: 0.948574309473
share_count_increase_fraction_of_opening: 0.004895576082
future_operating_FCFE_before_subscriptions_oku: 19.161825132
market_price_post_annual_issue_GBP_endogenous: 50.11011921
paid_issue_price_GBP_per_share_assumed: 45.09910729
issuer_paid_subscription_cash_oku: 0.108237858
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.108237858
issuer_payout_from_operations_oku: 19.161825132
issuer_total_cash_to_preissue_shares_oku: 19.270062989
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 18.265399065
old_cohort_subscription_proceeds_cash_oku: 0.103174288
old_cohort_total_cash_oku: 18.368573353
old_cohort_cash_PV_at_terminal_oku: 15.632083367
old_cohort_residual_shares_value_oku: 321.003540293
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 3
period_start: 2038-11-07
期間末: 2039-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 675.325312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 678.615312
old_cohort_m: 640.5962415
old_fraction_open: 0.948574309473
old_fraction_close: 0.943975519226
share_count_increase_fraction_of_opening: 0.004871726176
future_operating_FCFE_before_subscriptions_oku: 19.736679886
market_price_post_annual_issue_GBP_endogenous: 51.38039135
paid_issue_price_GBP_per_share_assumed: 46.24235221
issuer_paid_subscription_cash_oku: 0.110981645
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.110981645
issuer_payout_from_operations_oku: 19.736679886
issuer_total_cash_to_preissue_shares_oku: 19.847661531
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 18.721707494
old_cohort_subscription_proceeds_cash_oku: 0.105274338
old_cohort_total_cash_oku: 18.826981831
old_cohort_cash_PV_at_terminal_oku: 14.780626983
old_cohort_residual_shares_value_oku: 329.140855847
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 4
period_start: 2039-11-07
期間末: 2040-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 678.615312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 681.905312
old_cohort_m: 640.5962415
old_fraction_open: 0.943975519226
old_fraction_close: 0.9394211047
share_count_increase_fraction_of_opening: 0.004848107524
future_operating_FCFE_before_subscriptions_oku: 20.328780282
market_price_post_annual_issue_GBP_endogenous: 52.68394865
paid_issue_price_GBP_per_share_assumed: 47.41555378
issuer_paid_subscription_cash_oku: 0.113797329
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.113797329
issuer_payout_from_operations_oku: 20.328780282
issuer_total_cash_to_preissue_shares_oku: 20.442577611
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 19.189870922
old_cohort_subscription_proceeds_cash_oku: 0.107421893
old_cohort_total_cash_oku: 19.297292815
old_cohort_cash_PV_at_terminal_oku: 13.975883056
old_cohort_residual_shares_value_oku: 337.491394923
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 5
period_start: 2040-11-07
期間末: 2041-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 681.905312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 685.195312
old_cohort_m: 640.5962415
old_fraction_open: 0.9394211047
old_fraction_close: 0.934910426678
share_count_increase_fraction_of_opening: 0.004824716778
future_operating_FCFE_before_subscriptions_oku: 20.938643691
market_price_post_annual_issue_GBP_endogenous: 54.02167978
paid_issue_price_GBP_per_share_assumed: 48.6195118
issuer_paid_subscription_cash_oku: 0.116686828
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.116686828
issuer_payout_from_operations_oku: 20.938643691
issuer_total_cash_to_preissue_shares_oku: 21.055330519
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 19.670203787
old_cohort_subscription_proceeds_cash_oku: 0.109618069
old_cohort_total_cash_oku: 19.779821856
old_cohort_cash_PV_at_terminal_oku: 13.215267695
old_cohort_residual_shares_value_oku: 346.060850241
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 6
period_start: 2041-11-07
期間末: 2042-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 685.195312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 688.485312
old_cohort_m: 640.5962415
old_fraction_open: 0.934910426678
old_fraction_close: 0.930442858162
share_count_increase_fraction_of_opening: 0.004801550656
future_operating_FCFE_before_subscriptions_oku: 21.566803001
market_price_post_annual_issue_GBP_endogenous: 55.39449745
paid_issue_price_GBP_per_share_assumed: 49.8550477
issuer_paid_subscription_cash_oku: 0.119652114
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.119652114
issuer_payout_from_operations_oku: 21.566803001
issuer_total_cash_to_preissue_shares_oku: 21.686455116
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 20.163028996
old_cohort_subscription_proceeds_cash_oku: 0.111864009
old_cohort_total_cash_oku: 20.274893005
old_cohort_cash_PV_at_terminal_oku: 12.496341291
old_cohort_residual_shares_value_oku: 354.855068655
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 7
period_start: 2042-11-07
期間末: 2043-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 688.485312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 691.775312
old_cohort_m: 640.5962415
old_fraction_open: 0.930442858162
old_fraction_close: 0.926017784081
share_count_increase_fraction_of_opening: 0.004778605938
future_operating_FCFE_before_subscriptions_oku: 22.213807091
market_price_post_annual_issue_GBP_endogenous: 56.80333911
paid_issue_price_GBP_per_share_assumed: 51.1230052
issuer_paid_subscription_cash_oku: 0.122695212
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.122695212
issuer_payout_from_operations_oku: 22.213807091
issuer_total_cash_to_preissue_shares_oku: 22.336502304
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 20.668678161
old_cohort_subscription_proceeds_cash_oku: 0.114160884
old_cohort_total_cash_oku: 20.782839045
old_cohort_cash_PV_at_terminal_oku: 11.816800371
old_cohort_residual_shares_value_oku: 363.880055377
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 8
period_start: 2043-11-07
期間末: 2044-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 691.775312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 695.065312
old_cohort_m: 640.5962415
old_fraction_open: 0.926017784081
old_fraction_close: 0.921634601009
share_count_increase_fraction_of_opening: 0.004755879464
future_operating_FCFE_before_subscriptions_oku: 22.880221304
market_price_post_annual_issue_GBP_endogenous: 58.24916759
paid_issue_price_GBP_per_share_assumed: 52.42425083
issuer_paid_subscription_cash_oku: 0.125818202
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.125818202
issuer_payout_from_operations_oku: 22.880221304
issuer_total_cash_to_preissue_shares_oku: 23.006039506
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 21.187491831
old_cohort_subscription_proceeds_cash_oku: 0.116509893
old_cohort_total_cash_oku: 21.304001724
old_cohort_cash_PV_at_terminal_oku: 11.174469924
old_cohort_residual_shares_value_oku: 373.141978305
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 9
period_start: 2044-11-07
期間末: 2045-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 695.065312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 698.355312
old_cohort_m: 640.5962415
old_fraction_open: 0.921634601009
old_fraction_close: 0.917292716891
share_count_increase_fraction_of_opening: 0.004733368136
future_operating_FCFE_before_subscriptions_oku: 23.566627943
market_price_post_annual_issue_GBP_endogenous: 59.73297183
paid_issue_price_GBP_per_share_assumed: 53.75967465
issuer_paid_subscription_cash_oku: 0.129023219
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.129023219
issuer_payout_from_operations_oku: 23.566627943
issuer_total_cash_to_preissue_shares_oku: 23.695651162
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 21.719819742
old_cohort_subscription_proceeds_cash_oku: 0.118912263
old_cohort_total_cash_oku: 21.838732005
old_cohort_cash_PV_at_terminal_oku: 10.567296157
old_cohort_residual_shares_value_oku: 382.647172478
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 10
period_start: 2045-11-07
期間末: 2046-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 698.355312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 701.645312
old_cohort_m: 640.5962415
old_fraction_open: 0.917292716891
old_fraction_close: 0.912991550779
share_count_increase_fraction_of_opening: 0.004711068912
future_operating_FCFE_before_subscriptions_oku: 24.273626781
market_price_post_annual_issue_GBP_endogenous: 61.25576755
paid_issue_price_GBP_per_share_assumed: 55.1301908
issuer_paid_subscription_cash_oku: 0.132312458
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.132312458
issuer_payout_from_operations_oku: 24.273626781
issuer_total_cash_to_preissue_shares_oku: 24.405939239
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 22.266021059
old_cohort_subscription_proceeds_cash_oku: 0.121369254
old_cohort_total_cash_oku: 22.387390313
old_cohort_cash_PV_at_terminal_oku: 9.993339666
old_cohort_residual_shares_value_oku: 392.402144653
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 11
period_start: 2046-11-07
期間末: 2047-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 701.645312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 704.935312
old_cohort_m: 640.5962415
old_fraction_open: 0.912991550779
old_fraction_close: 0.908730532568
share_count_increase_fraction_of_opening: 0.00468897881
future_operating_FCFE_before_subscriptions_oku: 25.001835585
market_price_post_annual_issue_GBP_endogenous: 62.81859804
paid_issue_price_GBP_per_share_assumed: 56.53673824
issuer_paid_subscription_cash_oku: 0.135688172
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.135688172
issuer_payout_from_operations_oku: 25.001835585
issuer_total_cash_to_preissue_shares_oku: 25.137523757
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 22.826464643
old_cohort_subscription_proceeds_cash_oku: 0.123882154
old_cohort_total_cash_oku: 22.950346797
old_cohort_cash_PV_at_terminal_oku: 9.450769003
old_cohort_residual_shares_value_oku: 402.413578007
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 12
period_start: 2047-11-07
期間末: 2048-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 704.935312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 708.225312
old_cohort_m: 640.5962415
old_fraction_open: 0.908730532568
old_fraction_close: 0.904509102747
share_count_increase_fraction_of_opening: 0.004667094901
future_operating_FCFE_before_subscriptions_oku: 25.751890652
market_price_post_annual_issue_GBP_endogenous: 64.42253486
paid_issue_price_GBP_per_share_assumed: 57.98028137
issuer_paid_subscription_cash_oku: 0.139152675
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.139152675
issuer_payout_from_operations_oku: 25.751890652
issuer_total_cash_to_preissue_shares_oku: 25.891043328
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 23.401529307
old_cohort_subscription_proceeds_cash_oku: 0.126452285
old_cohort_total_cash_oku: 23.527981592
old_cohort_cash_PV_at_terminal_oku: 8.937854599
old_cohort_residual_shares_value_oku: 412.688336967
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 13
period_start: 2048-11-07
期間末: 2049-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 708.225312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 711.515312
old_cohort_m: 640.5962415
old_fraction_open: 0.904509102747
old_fraction_close: 0.900326712154
share_count_increase_fraction_of_opening: 0.004645414311
future_operating_FCFE_before_subscriptions_oku: 26.524447372
market_price_post_annual_issue_GBP_endogenous: 66.06867864
paid_issue_price_GBP_per_share_assumed: 59.46181078
issuer_paid_subscription_cash_oku: 0.142708346
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.142708346
issuer_payout_from_operations_oku: 26.524447372
issuer_total_cash_to_preissue_shares_oku: 26.667155718
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 23.991604093
old_cohort_subscription_proceeds_cash_oku: 0.129080998
old_cohort_total_cash_oku: 24.120685091
old_cohort_cash_PV_at_terminal_oku: 8.452963041
old_cohort_residual_shares_value_oku: 423.233472181
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 14
period_start: 2049-11-07
期間末: 2050-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 711.515312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 714.805312
old_cohort_m: 640.5962415
old_fraction_open: 0.900326712154
old_fraction_close: 0.896182821736
share_count_increase_fraction_of_opening: 0.004623934221
future_operating_FCFE_before_subscriptions_oku: 27.320180793
market_price_post_annual_issue_GBP_endogenous: 67.7581599
paid_issue_price_GBP_per_share_assumed: 60.98234391
issuer_paid_subscription_cash_oku: 0.146357625
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.146357625
issuer_payout_from_operations_oku: 27.320180793
issuer_total_cash_to_preissue_shares_oku: 27.466538419
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 24.597088549
old_cohort_subscription_proceeds_cash_oku: 0.13176968
old_cohort_total_cash_oku: 24.728858229
old_cohort_cash_PV_at_terminal_oku: 7.994551673
old_cohort_residual_shares_value_oku: 434.056225616
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 15
period_start: 2050-11-07
期間末: 2051-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 714.805312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 718.095312
old_cohort_m: 640.5962415
old_fraction_open: 0.896182821736
old_fraction_close: 0.892076902321
share_count_increase_fraction_of_opening: 0.004602651862
future_operating_FCFE_before_subscriptions_oku: 28.139786217
market_price_post_annual_issue_GBP_endogenous: 69.49213982
paid_issue_price_GBP_per_share_assumed: 62.54292583
issuer_paid_subscription_cash_oku: 0.150103022
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.150103022
issuer_payout_from_operations_oku: 28.139786217
issuer_total_cash_to_preissue_shares_oku: 28.289889239
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 25.218393015
old_cohort_subscription_proceeds_cash_oku: 0.13451975
old_cohort_total_cash_oku: 25.352912765
old_cohort_cash_PV_at_terminal_oku: 7.561163498
old_cohort_residual_shares_value_oku: 445.164035803
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 16
period_start: 2051-11-07
期間末: 2052-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 718.095312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 721.385312
old_cohort_m: 640.5962415
old_fraction_open: 0.892076902321
old_fraction_close: 0.888008434389
share_count_increase_fraction_of_opening: 0.004581564515
future_operating_FCFE_before_subscriptions_oku: 28.983979804
market_price_post_annual_issue_GBP_endogenous: 71.27181111
paid_issue_price_GBP_per_share_assumed: 64.14463
issuer_paid_subscription_cash_oku: 0.153947112
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.153947112
issuer_payout_from_operations_oku: 28.983979804
issuer_total_cash_to_preissue_shares_oku: 29.137926916
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 25.85593892
old_cohort_subscription_proceeds_cash_oku: 0.137332663
old_cohort_total_cash_oku: 25.993271583
old_cohort_cash_PV_at_terminal_oku: 7.151422378
old_cohort_residual_shares_value_oku: 456.564543227
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 17
period_start: 2052-11-07
期間末: 2053-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 721.385312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 724.675312
old_cohort_m: 640.5962415
old_fraction_open: 0.888008434389
old_fraction_close: 0.883976907854
share_count_increase_fraction_of_opening: 0.004560669514
future_operating_FCFE_before_subscriptions_oku: 29.853499198
market_price_post_annual_issue_GBP_endogenous: 73.09839889
paid_issue_price_GBP_per_share_assumed: 65.788559
issuer_paid_subscription_cash_oku: 0.157892542
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.157892542
issuer_payout_from_operations_oku: 29.853499198
issuer_total_cash_to_preissue_shares_oku: 30.011391739
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 26.510159084
old_cohort_subscription_proceeds_cash_oku: 0.140209909
old_cohort_total_cash_oku: 26.650368992
old_cohort_cash_PV_at_terminal_oku: 6.764028504
old_cohort_residual_shares_value_oku: 468.265595866
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 18
period_start: 2053-11-07
期間末: 2054-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 724.675312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 727.965312
old_cohort_m: 640.5962415
old_fraction_open: 0.883976907854
old_fraction_close: 0.879981821854
share_count_increase_fraction_of_opening: 0.004539964237
future_operating_FCFE_before_subscriptions_oku: 30.749104174
market_price_post_annual_issue_GBP_endogenous: 74.97316153
paid_issue_price_GBP_per_share_assumed: 67.47584537
issuer_paid_subscription_cash_oku: 0.161942029
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.161942029
issuer_payout_from_operations_oku: 30.749104174
issuer_total_cash_to_preissue_shares_oku: 30.911046202
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 27.181498027
old_cohort_subscription_proceeds_cash_oku: 0.143153014
old_cohort_total_cash_oku: 27.324651041
old_cohort_cash_PV_at_terminal_oku: 6.397754113
old_cohort_residual_shares_value_oku: 480.275254879
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 19
period_start: 2054-11-07
期間末: 2055-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 727.965312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 731.255312
old_cohort_m: 640.5962415
old_fraction_open: 0.879981821854
old_fraction_close: 0.876022684537
share_count_increase_fraction_of_opening: 0.004519446113
future_operating_FCFE_before_subscriptions_oku: 31.671577299
market_price_post_annual_issue_GBP_endogenous: 76.89739161
paid_issue_price_GBP_per_share_assumed: 69.20765245
issuer_paid_subscription_cash_oku: 0.166098366
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.166098366
issuer_payout_from_operations_oku: 31.671577299
issuer_total_cash_to_preissue_shares_oku: 31.837675665
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 27.870412292
old_cohort_subscription_proceeds_cash_oku: 0.146163543
old_cohort_total_cash_oku: 28.016575835
old_cohort_cash_PV_at_terminal_oku: 6.051439465
old_cohort_residual_shares_value_oku: 492.601800453
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

内容を開く

continuation_year: 20
period_start: 2055-11-07
期間末: 2056-11-06
classification: long_run_model_assumption_not_issuer_event_guidance
shares_open_economic_m: 731.255312
free_SBC_shares_delivered_m: 3.05
paid_employee_subscribed_shares_m: 0.24
issued_total_m: 3.29
shares_close_economic_m: 734.545312
old_cohort_m: 640.5962415
old_fraction_open: 0.876022684537
old_fraction_close: 0.872099012865
share_count_increase_fraction_of_opening: 0.004499112616
future_operating_FCFE_before_subscriptions_oku: 32.621724618
market_price_post_annual_issue_GBP_endogenous: 78.87241683
paid_issue_price_GBP_per_share_assumed: 70.98517515
issuer_paid_subscription_cash_oku: 0.17036442
issuer_subscription_cash_classification: equity_financing_not_operating_profit_not_FCFE
issuer_cash_passed_through_to_preissue_shareholders_oku: 0.17036442
issuer_payout_from_operations_oku: 32.621724618
issuer_total_cash_to_preissue_shares_oku: 32.792089038
issuer_paid_proceeds_ending_cash_retained_oku: 0
old_cohort_operating_cash_oku: 28.577370774
old_cohort_subscription_proceeds_cash_oku: 0.149243097
old_cohort_total_cash_oku: 28.726613871
old_cohort_cash_PV_at_terminal_oku: 5.723989031
old_cohort_residual_shares_value_oku: 505.253737821
discount_rate: 0.084
ex_date_or_transaction_date_observed: いいえ
注記: 定常計算の期末一括認識。実際の行使・交付・配当日予告ではない。

first_20_years_PV_old_cash_oku

204.671032838

end_20yr_residual_PV_old_oku

100.675522216

reconstructed_old_operating_terminal_PV_oku

305.346555055

reconstruction_abs_error_oku

3.99E-10

tail_years_used

1100

approximation_years_900_vs_1100_price_difference_GBP

per_share_recursive_equation

P[t-1] = (100 * FCFE[t] / S[t-1] + (1 + paid_discount * paid_shares / S[t-1]) * P[t]) / (1 + k); S[t] = S[t-1] + free_shares + paid_shares; F[t]=F[1]*(1+g)^(t-1).

per_share_gbp_price_at_terminal_ex_excess_cash

47.665992285

discounting_coc_is_scenario_specific

0.084

counterfactual_paid_issue_cash_ignored_but_same_share_dilution_terminal_old_oku

303.742477153

value_added_by_paid_subscriptions_vs_omission_oku

1.604077901

counterfactual_paid_issue_at_full_fair_market_terminal_old_oku

305.525763726

counterfactual_no_2037plus_share_issuance_terminal_old_oku

330.01184161

counterfactual_no_paid_employee_shares_but_free_awards_remain_old_oku

305.401410894

verified_fully_paid_fair_market_invariance_vs_no_issuance_GBP_price_abs_error

comparison_original_v1_terminal_old_oku

300.349987929

terminal_old_value_change_vs_v1_oku

4.996567126

y10

内容を開く

キャッシュフローの算出方法

timed_holder_cashflows_v1

開始日

2026-11-06

終了日

2036-11-06

期間内株主受取

81.16057569

終価

305.346555055

日付別キャッシュフロー

内容を開く

year: 0.106776180698
想定日: 2026-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.45
source_treasury_shares_m: 0.45
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9994628047

内容を開く

year: 0.112251882272
想定日: 2026-12-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.048
discounted_issuer_subscription_gbp: 10.558154
issuer_cash_proceeds_oku: 0.005067914
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9994055379

内容を開く

year: 0.11498973306
想定日: 2026-12-18
金額: 1.1227593671
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.1234272019
assumed_execution_price_gbp: 11.734256
bought_total_shares_m: 9.57391057
tendered_old_cohort_shares_m: 9.56821924
old_holder_fraction_before: 0.9994055379
old_holder_fraction_after: 0.9994055379
program_classification: announced_remaining_assumed
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 0.323066392882
想定日: 2027-03-04
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2027-03-25
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2026
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 0.35318275154
想定日: 2027-03-15
金額: 0.7485062447
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.7489514679
assumed_execution_price_gbp: 11.995891
bought_total_shares_m: 6.24340013
tendered_old_cohort_shares_m: 6.23968867
old_holder_fraction_before: 0.9994055379
old_holder_fraction_after: 0.9994055379
program_classification: announced_remaining_assumed
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 0.355920602327
想定日: 2027-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.7965
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9984052072

内容を開く

year: 0.380561259411
想定日: 2027-03-25
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2026
dividend_kind: final
date_confirmed: いいえ
ex_date: 2027-03-25
record_date: 2027-03-26
payment_date: 2027-05-26
board_declaration_date_assumed: 2027-02-26
usd_per_share: 0.25
gbp_per_share: 0.18723787
entitled_old_cohort_shares_m: 821.4262571
issuer_economic_shares_m: 822.7383543
old_holder_entitlement_oku: 1.5380210026
issuer_dividend_liability_oku: 1.5404777455
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2027-03-04
needs_issuer_confirmation_before_date: はい

内容を開く

year: 0.550308008214
想定日: 2027-05-26
金額: 1.5380210026
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.5404777455
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2026
dividend_kind: final

内容を開く

year: 0.607802874743
想定日: 2027-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.826
source_employee_trust_shares_m: 0.028
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9973699401

内容を開く

year: 0.777549623546
想定日: 2027-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 11.228904
issuer_cash_proceeds_oku: 0.0269493701
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9970793849

内容を開く

year: 0.859685147159
想定日: 2027-09-16
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2027-10-07
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2027
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 0.859685147159
想定日: 2027-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.7965
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.996083703

内容を開く

year: 0.917180013689
想定日: 2027-10-07
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2027
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2027-10-07
record_date: 2027-10-08
payment_date: 2027-11-05
board_declaration_date_assumed: 2027-08-04
usd_per_share: 0.1624
gbp_per_share: 0.12162972
entitled_old_cohort_shares_m: 821.4262571
issuer_economic_shares_m: 824.6558543
old_holder_entitlement_oku: 0.9990984433
issuer_dividend_liability_oku: 1.0030265933
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2027-09-16
needs_issuer_confirmation_before_date: はい

内容を開く

year: 0.996577686516
想定日: 2027-11-05
金額: 0.9990984433
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.0030265933
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2027
dividend_kind: interim

内容を開く

year: 1.108829568789
想定日: 2027-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.531
source_employee_trust_shares_m: 0.018
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9954210192

内容を開く

year: 1.338809034908
想定日: 2028-03-09
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2028-03-30
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2027
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 1.357973990418
想定日: 2028-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.7965
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.994428645

内容を開く

year: 1.368925393566
想定日: 2028-03-20
金額: 0.4791190307
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.4818033281
assumed_execution_price_gbp: 13.178685
bought_total_shares_m: 3.65592857
tendered_old_cohort_shares_m: 3.6355601
old_holder_fraction_before: 0.994428645
old_holder_fraction_after: 0.994428645
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.396303901437
想定日: 2028-03-30
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2027
dividend_kind: final
date_confirmed: いいえ
ex_date: 2028-03-30
record_date: 2028-03-31
payment_date: 2028-05-24
board_declaration_date_assumed: 2028-02-25
usd_per_share: 0.2591715
gbp_per_share: 0.1941069
entitled_old_cohort_shares_m: 817.790697
issuer_economic_shares_m: 822.3724257
old_holder_entitlement_oku: 1.587388145
issuer_dividend_liability_oku: 1.5962815965
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2028-03-09
needs_issuer_confirmation_before_date: はい

内容を開く

year: 1.54688569473
想定日: 2028-05-24
金額: 1.587388145
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.5962815965
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2027
dividend_kind: final

内容を開く

year: 1.609856262834
想定日: 2028-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.826
source_employee_trust_shares_m: 0.028
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9933970429

内容を開く

year: 1.620807665982
想定日: 2028-06-20
金額: 0.4786220014
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.4818033281
assumed_execution_price_gbp: 13.489611
bought_total_shares_m: 3.5716621
tendered_old_cohort_shares_m: 3.54807857
old_holder_fraction_before: 0.9933970429
old_holder_fraction_after: 0.9933970429
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.779603011636
想定日: 2028-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 12.32045
issuer_cash_proceeds_oku: 0.0295690796
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9931062553

内容を開く

year: 1.856262833676
想定日: 2028-09-14
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2028-10-05
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2028
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 1.859000684463
想定日: 2028-09-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.7965
source_employee_trust_shares_m: 0.027
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.992109783

内容を開く

year: 1.872689938398
想定日: 2028-09-20
金額: 0.4780017952
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.4818033281
assumed_execution_price_gbp: 13.807872
bought_total_shares_m: 3.48933791
tendered_old_cohort_shares_m: 3.46180628
old_holder_fraction_before: 0.992109783
old_holder_fraction_after: 0.992109783
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 1.913757700205
想定日: 2028-10-05
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2028
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2028-10-05
record_date: 2028-10-06
payment_date: 2028-11-03
board_declaration_date_assumed: 2028-08-04
usd_per_share: 0.1686286
gbp_per_share: 0.12629465
entitled_old_cohort_shares_m: 810.7808121
issuer_economic_shares_m: 817.2289257
old_holder_entitlement_oku: 1.0239727575
issuer_dividend_liability_oku: 1.0321163797
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2028-09-14
needs_issuer_confirmation_before_date: はい

内容を開く

year: 1.993155373032
想定日: 2028-11-03
金額: 1.0239727575
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.0321163797
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2028
dividend_kind: interim

内容を開く

year: 2.108145106092
想定日: 2028-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.531
source_employee_trust_shares_m: 0.018
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9914437485

内容を開く

year: 2.121834360027
想定日: 2028-12-20
金額: 0.4776808976
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.4818033281
assumed_execution_price_gbp: 14.130061
bought_total_shares_m: 3.40977539
tendered_old_cohort_shares_m: 3.38060049
old_holder_fraction_before: 0.9914437485
old_holder_fraction_after: 0.9914437485
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.335386721424
想定日: 2029-03-08
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2029-03-29
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2028
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 2.357289527721
想定日: 2029-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9904422001

内容を開く

year: 2.368240930869
想定日: 2029-03-20
金額: 0.5991611166
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.6049430411
assumed_execution_price_gbp: 14.456102
bought_total_shares_m: 4.18468993
tendered_old_cohort_shares_m: 4.14469351
old_holder_fraction_before: 0.9904422001
old_holder_fraction_after: 0.9904422001
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.392881587953
想定日: 2029-03-29
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2028
dividend_kind: final
date_confirmed: いいえ
ex_date: 2029-03-29
record_date: 2029-03-30
payment_date: 2029-05-23
board_declaration_date_assumed: 2029-02-26
usd_per_share: 0.3017254
gbp_per_share: 0.22597769
entitled_old_cohort_shares_m: 803.2555181
issuer_economic_shares_m: 811.0069604
old_holder_entitlement_oku: 1.815178281
issuer_dividend_liability_oku: 1.8326948113
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2029-03-08
needs_issuer_confirmation_before_date: はい

内容を開く

year: 2.543463381246
想定日: 2029-05-23
金額: 1.815178281
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.8326948113
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2028
dividend_kind: final

内容を開く

year: 2.60643394935
想定日: 2029-06-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9894003497

内容を開く

year: 2.620123203285
想定日: 2029-06-20
金額: 0.5985308565
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.6049430411
assumed_execution_price_gbp: 14.797166
bought_total_shares_m: 4.0882359
tendered_old_cohort_shares_m: 4.04490203
old_holder_fraction_before: 0.9894003497
old_holder_fraction_after: 0.9894003497
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.778918548939
想定日: 2029-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 13.514677
issuer_cash_proceeds_oku: 0.0324352249
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9891064731

内容を開く

year: 2.852840520192
想定日: 2029-09-13
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2029-10-04
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2029
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 2.855578370979
想定日: 2029-09-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9880994346

内容を開く

year: 2.872005475702
想定日: 2029-09-20
金額: 0.5977438769
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.6049430411
assumed_execution_price_gbp: 15.146276
bought_total_shares_m: 3.99400506
tendered_old_cohort_shares_m: 3.94647414
old_holder_fraction_before: 0.9880994346
old_holder_fraction_after: 0.9880994346
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 2.910335386721
想定日: 2029-10-04
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2029
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2029-10-04
record_date: 2029-10-05
payment_date: 2029-11-05
board_declaration_date_assumed: 2029-08-03
usd_per_share: 0.1881416
gbp_per_share: 0.14090894
entitled_old_cohort_shares_m: 795.264142
issuer_economic_shares_m: 804.8422194
old_holder_entitlement_oku: 1.1205982349
issuer_dividend_liability_oku: 1.1340946019
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2029-09-13
needs_issuer_confirmation_before_date: はい

内容を開く

year: 2.99794661191
想定日: 2029-11-05
金額: 1.1205982349
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.1340946019
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2029
dividend_kind: interim

内容を開く

year: 3.104722792608
想定日: 2029-12-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9874258904

内容を開く

year: 3.121149897331
想定日: 2029-12-20
金額: 0.597336421
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.6049430411
assumed_execution_price_gbp: 15.499694
bought_total_shares_m: 3.90293532
tendered_old_cohort_shares_m: 3.85385938
old_holder_fraction_before: 0.9874258904
old_holder_fraction_after: 0.9874258904
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.33196440794
想定日: 2030-03-07
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2030-03-28
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2029
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 3.353867214237
想定日: 2030-03-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9864123876

内容を開く

year: 3.367556468172
想定日: 2030-03-20
金額: 0.7346516215
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.744771285
assumed_execution_price_gbp: 15.857339
bought_total_shares_m: 4.69669778
tendered_old_cohort_shares_m: 4.63288087
old_holder_fraction_before: 0.9864123876
old_holder_fraction_after: 0.9864123876
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.38945927447
想定日: 2030-03-28
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2029
dividend_kind: final
date_confirmed: いいえ
ex_date: 2030-03-28
record_date: 2030-03-29
payment_date: 2030-05-22
board_declaration_date_assumed: 2030-02-26
usd_per_share: 0.3504965
gbp_per_share: 0.26250489
entitled_old_cohort_shares_m: 786.7774017
issuer_economic_shares_m: 797.6150863
old_holder_entitlement_oku: 2.0653291728
issuer_dividend_liability_oku: 2.0937786251
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2030-03-07
needs_issuer_confirmation_before_date: はい

内容を開く

year: 3.540041067762
想定日: 2030-05-22
金額: 2.0653291728
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.0937786251
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2029
dividend_kind: final

内容を開く

year: 3.603011635866
想定日: 2030-06-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9853573735

内容を開く

year: 3.619438740589
想定日: 2030-06-20
金額: 0.7338658772
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.744771285
assumed_execution_price_gbp: 16.231462
bought_total_shares_m: 4.58844234
tendered_old_cohort_shares_m: 4.52125549
old_holder_fraction_before: 0.9853573735
old_holder_fraction_after: 0.9853573735
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.775496235455
想定日: 2030-08-16
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 14.820904
issuer_cash_proceeds_oku: 0.0355701701
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9850595777

内容を開く

year: 3.849418206708
想定日: 2030-09-12
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2030-10-03
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2030
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 3.860369609856
想定日: 2030-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.984039133

内容を開く

year: 3.871321013005
想定日: 2030-09-20
金額: 0.7328840896
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.744771285
assumed_execution_price_gbp: 16.614412
bought_total_shares_m: 4.48268211
tendered_old_cohort_shares_m: 4.41113462
old_holder_fraction_before: 0.984039133
old_holder_fraction_after: 0.984039133
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 3.906913073238
想定日: 2030-10-03
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2030
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2030-10-03
record_date: 2030-10-04
payment_date: 2030-11-05
board_declaration_date_assumed: 2030-08-02
usd_per_share: 0.2154553
gbp_per_share: 0.16136553
entitled_old_cohort_shares_m: 777.8450116
issuer_economic_shares_m: 790.4614619
old_holder_entitlement_oku: 1.2551737342
issuer_dividend_liability_oku: 1.2755323362
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2030-09-12
needs_issuer_confirmation_before_date: はい

内容を開く

year: 3.997262149213
想定日: 2030-11-05
金額: 1.2551737342
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.2755323362
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2030
dividend_kind: interim

内容を開く

year: 4.109514031485
想定日: 2030-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9833561616

内容を開く

year: 4.120465434634
想定日: 2030-12-20
金額: 0.7323754321
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.744771285
assumed_execution_price_gbp: 17.002087
bought_total_shares_m: 4.38046974
tendered_old_cohort_shares_m: 4.30756191
old_holder_fraction_before: 0.9833561616
old_holder_fraction_after: 0.9833561616
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.328542094456
想定日: 2031-03-06
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2031-03-27
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2030
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 4.350444900753
想定日: 2031-03-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9823277913

内容を開く

year: 4.366872005476
想定日: 2031-03-20
金額: 0.8866841188
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.9026356849
assumed_execution_price_gbp: 17.394399
bought_total_shares_m: 5.18923194
tendered_old_cohort_shares_m: 5.09752675
old_holder_fraction_before: 0.9823277913
old_holder_fraction_after: 0.9823277913
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.386036960986
想定日: 2031-03-27
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2030
dividend_kind: final
date_confirmed: いいえ
ex_date: 2031-03-27
record_date: 2031-03-28
payment_date: 2031-05-28
board_declaration_date_assumed: 2031-02-26
usd_per_share: 0.4026998
gbp_per_share: 0.30160263
entitled_old_cohort_shares_m: 768.4399229
issuer_economic_shares_m: 782.2642602
old_holder_entitlement_oku: 2.3176350419
issuer_dividend_liability_oku: 2.359329607
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2031-03-06
needs_issuer_confirmation_before_date: はい

内容を開く

year: 4.555783709788
想定日: 2031-05-28
金額: 2.3176350419
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.359329607
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2030
dividend_kind: final

内容を開く

year: 4.607802874743
想定日: 2031-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9812565509

内容を開く

year: 4.618754277892
想定日: 2031-06-20
金額: 0.8857171789
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.9026356849
assumed_execution_price_gbp: 17.804786
bought_total_shares_m: 5.06962395
tendered_old_cohort_shares_m: 4.97460172
old_holder_fraction_before: 0.9812565509
old_holder_fraction_after: 0.9812565509
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.772073921971
想定日: 2031-08-15
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 16.253381
issuer_cash_proceeds_oku: 0.0390081155
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9809539619

内容を開く

year: 4.845995893224
想定日: 2031-09-11
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2031-10-02
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2031
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 4.859685147159
想定日: 2031-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9799171207

内容を開く

year: 4.867898699521
想定日: 2031-09-19
金額: 0.8845081614
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.9026356849
assumed_execution_price_gbp: 18.220236
bought_total_shares_m: 4.95402837
tendered_old_cohort_shares_m: 4.85453721
old_holder_fraction_before: 0.9799171207
old_holder_fraction_after: 0.9799171207
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 4.903490759754
想定日: 2031-10-02
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2031
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2031-10-02
record_date: 2031-10-03
payment_date: 2031-11-05
board_declaration_date_assumed: 2031-08-04
usd_per_share: 0.247262
gbp_per_share: 0.18518727
entitled_old_cohort_shares_m: 758.610784
issuer_economic_shares_m: 774.1581079
old_holder_entitlement_oku: 1.4048505683
issuer_dividend_liability_oku: 1.4336422322
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2031-09-11
needs_issuer_confirmation_before_date: はい

内容を開く

year: 4.996577686516
想定日: 2031-11-05
金額: 1.4048505683
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.4336422322
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2031
dividend_kind: interim

内容を開く

year: 5.108829568789
想定日: 2031-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9792226976

内容を開く

year: 5.11704312115
想定日: 2031-12-19
金額: 0.8838813503
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 0.9026356849
assumed_execution_price_gbp: 18.645381
bought_total_shares_m: 4.84106855
tendered_old_cohort_shares_m: 4.7404842
old_holder_fraction_before: 0.9792226976
old_holder_fraction_after: 0.9792226976
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.325119780972
想定日: 2032-03-04
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2032-03-25
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2031
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 5.357973990418
想定日: 2032-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.978176375

内容を開く

year: 5.366187542779
想定日: 2032-03-19
金額: 1.0573671307
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.0809575428
assumed_execution_price_gbp: 19.080446
bought_total_shares_m: 5.66526348
tendered_old_cohort_shares_m: 5.54162689
old_holder_fraction_before: 0.978176375
old_holder_fraction_after: 0.978176375
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.382614647502
想定日: 2032-03-25
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2031
dividend_kind: final
date_confirmed: いいえ
ex_date: 2032-03-25
record_date: 2032-03-26
payment_date: 2032-05-26
board_declaration_date_assumed: 2032-02-26
usd_per_share: 0.463403
gbp_per_share: 0.34706636
entitled_old_cohort_shares_m: 748.3286729
issuer_economic_shares_m: 765.0242758
old_holder_entitlement_oku: 2.5971970896
issuer_dividend_liability_oku: 2.655141911
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2032-03-04
needs_issuer_confirmation_before_date: はい

内容を開く

year: 5.552361396304
想定日: 2032-05-26
金額: 2.5971970896
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.655141911
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2031
dividend_kind: final

内容を開く

year: 5.609856262834
想定日: 2032-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9770856499

内容を開く

year: 5.615331964408
想定日: 2032-06-18
金額: 1.0561881033
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.0809575428
assumed_execution_price_gbp: 19.525663
bought_total_shares_m: 5.53608635
tendered_old_cohort_shares_m: 5.40923053
old_holder_fraction_before: 0.9770856499
old_holder_fraction_after: 0.9770856499
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.779603011636
想定日: 2032-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 17.842392
issuer_cash_proceeds_oku: 0.0428217406
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9767773327

内容を開く

year: 5.86173853525
想定日: 2032-09-16
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2032-10-07
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2032
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 5.86173853525
想定日: 2032-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9757208971

内容を開く

year: 5.872689938398
想定日: 2032-09-20
金額: 1.0547128634
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.0809575428
assumed_execution_price_gbp: 19.996467
bought_total_shares_m: 5.40574256
tendered_old_cohort_shares_m: 5.27449598
old_holder_fraction_before: 0.9757208971
old_holder_fraction_after: 0.9757208971
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 5.91923340178
想定日: 2032-10-07
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2032
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2032-10-07
record_date: 2032-10-08
payment_date: 2032-11-05
board_declaration_date_assumed: 2032-08-04
usd_per_share: 0.284266
gbp_per_share: 0.21290145
entitled_old_cohort_shares_m: 737.6449464
issuer_economic_shares_m: 755.9999469
old_holder_entitlement_oku: 1.5704567903
issuer_dividend_liability_oku: 1.6095348526
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2032-09-16
needs_issuer_confirmation_before_date: はい

内容を開く

year: 5.998631074606
想定日: 2032-11-05
金額: 1.5704567903
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.6095348526
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2032
dividend_kind: interim

内容を開く

year: 6.110882956879
想定日: 2032-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.975012852

内容を開く

year: 6.121834360027
想定日: 2032-12-20
金額: 1.0539474967
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.0809575428
assumed_execution_price_gbp: 20.463058
bought_total_shares_m: 5.28248293
tendered_old_cohort_shares_m: 5.15048875
old_holder_fraction_before: 0.975012852
old_holder_fraction_after: 0.975012852
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.340862422998
想定日: 2033-03-10
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2033-03-31
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2032
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

内容を開く

year: 6.357289527721
想定日: 2033-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9739452628

内容を開く

year: 6.362765229295
想定日: 2033-03-18
金額: 1.2493373359
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.2827592921
assumed_execution_price_gbp: 20.924619
bought_total_shares_m: 6.13038313
tendered_old_cohort_shares_m: 5.97065761
old_holder_fraction_before: 0.9739452628
old_holder_fraction_after: 0.9739452628
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.398357289528
想定日: 2033-03-31
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2032
dividend_kind: final
date_confirmed: いいえ
ex_date: 2033-03-31
record_date: 2033-04-01
payment_date: 2033-05-25
board_declaration_date_assumed: 2033-02-25
usd_per_share: 0.5344521
gbp_per_share: 0.4002787
entitled_old_cohort_shares_m: 726.5238
issuer_economic_shares_m: 745.9595809
old_holder_entitlement_oku: 2.9081199965
issuer_dividend_liability_oku: 2.9859172866
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2033-03-10
needs_issuer_confirmation_before_date: はい

内容を開く

year: 6.54893908282
想定日: 2033-05-25
金額: 2.9081199965
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.9859172866
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2032
dividend_kind: final

内容を開く

year: 6.609171800137
想定日: 2033-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9728315321

内容を開く

year: 6.620123203285
想定日: 2033-06-20
金額: 1.2479086874
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.2827592921
assumed_execution_price_gbp: 21.429155
bought_total_shares_m: 5.98604699
tendered_old_cohort_shares_m: 5.82341526
old_holder_fraction_before: 0.9728315321
old_holder_fraction_after: 0.9728315321
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

内容を開く

year: 6.778918548939
想定日: 2033-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 19.571864
issuer_cash_proceeds_oku: 0.0469724729
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9725164737

内容を開く

year: 6.858316221766
想定日: 2033-09-15
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2033-10-06
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2033
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

100

内容を開く

year: 6.861054072553
想定日: 2033-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9714369791

101

内容を開く

year: 6.872005475702
想定日: 2033-09-20
金額: 1.2461198116
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.2827592921
assumed_execution_price_gbp: 21.934735
bought_total_shares_m: 5.84807299
tendered_old_cohort_shares_m: 5.68103436
old_holder_fraction_before: 0.9714369791
old_holder_fraction_after: 0.9714369791
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

102

内容を開く

year: 6.915811088296
想定日: 2033-10-06
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2033
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2033-10-06
record_date: 2033-10-07
payment_date: 2033-11-04
board_declaration_date_assumed: 2033-08-04
usd_per_share: 0.3274873
gbp_per_share: 0.24527206
entitled_old_cohort_shares_m: 715.0193504
issuer_economic_shares_m: 736.0429609
old_holder_entitlement_oku: 1.7537426815
issuer_dividend_liability_oku: 1.8053077237
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2033-09-15
needs_issuer_confirmation_before_date: はい

103

内容を開く

year: 6.995208761123
想定日: 2033-11-04
金額: 1.7537426815
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 1.8053077237
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2033
dividend_kind: interim

104

内容を開く

year: 7.110198494182
想定日: 2033-12-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9707129434

105

内容を開く

year: 7.121149897331
想定日: 2033-12-20
金額: 1.2451910481
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.2827592921
assumed_execution_price_gbp: 22.446552
bought_total_shares_m: 5.71472752
tendered_old_cohort_shares_m: 5.54735997
old_holder_fraction_before: 0.9707129434
old_holder_fraction_after: 0.9707129434
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

106

内容を開く

year: 7.337440109514
想定日: 2034-03-09
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2034-03-30
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2033
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

107

内容を開く

year: 7.356605065024
想定日: 2034-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9696204447

108

内容を開く

year: 7.367556468172
想定日: 2034-03-20
金額: 1.4650051276
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.5109057732
assumed_execution_price_gbp: 22.964491
bought_total_shares_m: 6.57931321
tendered_old_cohort_shares_m: 6.3794366
old_holder_fraction_before: 0.9696204447
old_holder_fraction_after: 0.9696204447
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

109

内容を開く

year: 7.394934976044
想定日: 2034-03-30
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2033
dividend_kind: final
date_confirmed: いいえ
ex_date: 2034-03-30
record_date: 2034-03-31
payment_date: 2034-05-24
board_declaration_date_assumed: 2034-02-24
usd_per_share: 0.618082
gbp_per_share: 0.46291344
entitled_old_cohort_shares_m: 703.0925538
issuer_economic_shares_m: 725.1214202
old_holder_entitlement_oku: 3.2547099298
issuer_dividend_liability_oku: 3.3566845127
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2034-03-09
needs_issuer_confirmation_before_date: はい

110

内容を開く

year: 7.545516769336
想定日: 2034-05-24
金額: 3.2547099298
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 3.3566845127
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2033
dividend_kind: final

111

内容を開く

year: 7.60848733744
想定日: 2034-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9684798332

112

内容を開く

year: 7.619438740589
想定日: 2034-06-20
金額: 1.4632817712
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.5109057732
assumed_execution_price_gbp: 23.506294
bought_total_shares_m: 6.42766487
tendered_old_cohort_shares_m: 6.2250638
old_holder_fraction_before: 0.9684798332
old_holder_fraction_after: 0.9684798332
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

113

内容を開く

year: 7.778234086242
想定日: 2034-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 21.468974
issuer_cash_proceeds_oku: 0.0515255376
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9681569114

114

内容を開く

year: 7.854893908282
想定日: 2034-09-14
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2034-10-05
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2034
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

115

内容を開く

year: 7.857631759069
想定日: 2034-09-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9670505213

116

内容を開く

year: 7.871321013005
想定日: 2034-09-20
金額: 1.4611222155
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.5109057732
assumed_execution_price_gbp: 24.060879
bought_total_shares_m: 6.27951191
tendered_old_cohort_shares_m: 6.07260526
old_holder_fraction_before: 0.9670505213
old_holder_fraction_after: 0.9670505213
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

117

内容を開く

year: 7.912388774812
想定日: 2034-10-05
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2034
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2034-10-05
record_date: 2034-10-06
payment_date: 2034-11-03
board_declaration_date_assumed: 2034-08-04
usd_per_share: 0.3782277
gbp_per_share: 0.2832742
entitled_old_cohort_shares_m: 690.7948848
issuer_economic_shares_m: 714.3317434
old_holder_entitlement_oku: 1.9568436811
issuer_dividend_liability_oku: 2.0235175289
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2034-09-14
needs_issuer_confirmation_before_date: はい

118

内容を開く

year: 7.991786447639
想定日: 2034-11-03
金額: 1.9568436811
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.0235175289
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2034
dividend_kind: interim

119

内容を開く

year: 8.106776180698
想定日: 2034-12-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9663078649

120

内容を開く

year: 8.120465434634
想定日: 2034-12-20
金額: 1.4600001317
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.5109057732
assumed_execution_price_gbp: 24.622307
bought_total_shares_m: 6.13632893
tendered_old_cohort_shares_m: 5.92958291
old_holder_fraction_before: 0.9663078649
old_holder_fraction_after: 0.9663078649
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

121

内容を開く

year: 8.33401779603
想定日: 2035-03-08
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2035-03-29
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2034
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

122

内容を開く

year: 8.355920602327
想定日: 2035-03-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9651864014

123

内容を開く

year: 8.366872005476
想定日: 2035-03-20
金額: 1.7070266788
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7685979375
assumed_execution_price_gbp: 25.19045
bought_total_shares_m: 7.02090647
tendered_old_cohort_shares_m: 6.77648345
old_holder_fraction_before: 0.9651864014
old_holder_fraction_after: 0.9651864014
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

124

内容を開く

year: 8.39151266256
想定日: 2035-03-29
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2034
dividend_kind: final
date_confirmed: いいえ
ex_date: 2035-03-29
record_date: 2035-03-30
payment_date: 2035-05-23
board_declaration_date_assumed: 2035-02-26
usd_per_share: 0.7167628
gbp_per_share: 0.53682052
entitled_old_cohort_shares_m: 678.0888184
issuer_economic_shares_m: 702.547008
old_holder_entitlement_oku: 3.6401198905
issuer_dividend_liability_oku: 3.7714164697
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2035-03-08
needs_issuer_confirmation_before_date: はい

125

内容を開く

year: 8.542094455852
想定日: 2035-05-23
金額: 3.6401198905
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 3.7714164697
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2034
dividend_kind: final

126

内容を開く

year: 8.605065023956
想定日: 2035-06-15
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9640145674

127

内容を開く

year: 8.618754277892
想定日: 2035-06-20
金額: 1.7049541757
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7685979375
assumed_execution_price_gbp: 25.78477
bought_total_shares_m: 6.85907973
tendered_old_cohort_shares_m: 6.61225278
old_holder_fraction_before: 0.9640145674
old_holder_fraction_after: 0.9640145674
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

128

内容を開く

year: 8.777549623546
想定日: 2035-08-17
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 23.549972
issuer_cash_proceeds_oku: 0.0565199332
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9636825216

129

内容を開く

year: 8.851471594798
想定日: 2035-09-13
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2035-10-04
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2035
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

130

内容を開く

year: 8.854209445585
想定日: 2035-09-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9625449265

131

内容を開く

year: 8.870636550308
想定日: 2035-09-20
金額: 1.7023549718
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7685979375
assumed_execution_price_gbp: 26.393112
bought_total_shares_m: 6.70098297
tendered_old_cohort_shares_m: 6.44999716
old_holder_fraction_before: 0.9625449265
old_holder_fraction_after: 0.9625449265
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

132

内容を開く

year: 8.908966461328
想定日: 2035-10-04
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2035
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2035-10-04
record_date: 2035-10-05
payment_date: 2035-11-05
board_declaration_date_assumed: 2035-08-03
usd_per_share: 0.4379962
gbp_per_share: 0.32803789
entitled_old_cohort_shares_m: 665.0265685
issuer_economic_shares_m: 690.9044453
old_holder_entitlement_oku: 2.1815390969
issuer_dividend_liability_oku: 2.2664283369
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2035-09-13
needs_issuer_confirmation_before_date: はい

133

内容を開く

year: 8.996577686516
想定日: 2035-11-05
金額: 2.1815390969
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.2664283369
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2035
dividend_kind: interim

134

内容を開く

year: 9.103353867214
想定日: 2035-12-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.549
source_treasury_shares_m: 0.549
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9617806854

135

内容を開く

year: 9.119780971937
想定日: 2035-12-20
金額: 1.7010033365
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7685979375
assumed_execution_price_gbp: 27.00896
bought_total_shares_m: 6.54818978
tendered_old_cohort_shares_m: 6.29792245
old_holder_fraction_before: 0.9617806854
old_holder_fraction_after: 0.9617806854
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

136

内容を開く

year: 9.330595482546
想定日: 2036-03-06
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2036-03-27
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2035
dividend_kind: final
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

137

内容を開く

year: 9.352498288843
想定日: 2036-03-14
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9606256712

138

内容を開く

year: 9.368925393566
想定日: 2036-03-20
金額: 1.7118050628
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7819688918
assumed_execution_price_gbp: 27.639177
bought_total_shares_m: 6.44725733
tendered_old_cohort_shares_m: 6.1934009
old_holder_fraction_before: 0.9606256712
old_holder_fraction_after: 0.9606256712
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

139

内容を開く

year: 9.388090349076
想定日: 2036-03-27
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2035
dividend_kind: final
date_confirmed: いいえ
ex_date: 2036-03-27
record_date: 2036-03-28
payment_date: 2036-05-28
board_declaration_date_assumed: 2036-02-26
usd_per_share: 0.8336527
gbp_per_share: 0.62436544
entitled_old_cohort_shares_m: 652.5352451
issuer_economic_shares_m: 679.2814982
old_holder_entitlement_oku: 4.074204534
issuer_dividend_liability_oku: 4.2411988936
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2036-03-06
needs_issuer_confirmation_before_date: はい

140

内容を開く

year: 9.557837097878
想定日: 2036-05-28
金額: 4.074204534
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 4.2411988936
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2035
dividend_kind: final

141

内容を開く

year: 9.609856262834
想定日: 2036-06-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.854
source_treasury_shares_m: 0.854
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9594194788

142

内容を開く

year: 9.620807665982
想定日: 2036-06-20
金額: 1.7096556653
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7819688918
assumed_execution_price_gbp: 28.29127
bought_total_shares_m: 6.29865277
tendered_old_cohort_shares_m: 6.04305016
old_holder_fraction_before: 0.9594194788
old_holder_fraction_after: 0.9594194788
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

143

内容を開く

year: 9.774127310062
想定日: 2036-08-15
金額: 0
種類: employee_share_plan_issuance_no_holder_cashflow
date_status: 仮定
金額の単位: 億GBP
issued_shares_m: 0.24
discounted_issuer_subscription_gbp: 25.826136
issuer_cash_proceeds_oku: 0.0619827253
old_holder_shares_change_m: 0
old_holder_fraction_after: 0.9590778847

144

内容を開く

year: 9.848049281314
想定日: 2036-09-11
金額: 0
種類: dividend_ex_date_preannouncement_recheck_no_cashflow
date_status: future_assumed_review_date_not_performed
金額の単位: 億GBP
ex_date: 2036-10-02
ex_date_status: future_unconfirmed_assumption
assumed_ex_date_published_by_issuer: いいえ
fiscal_year: 2036
dividend_kind: interim
required_action: 当該日以降に会社RNS・株主情報・取引所情報で権利落ち/支払予定を確認し、変更時にはtimed_cashflowsを更新。自動監視はしていない。
old_holder_cash_receipt_oku: 0

145

内容を開く

year: 9.86173853525
想定日: 2036-09-16
金額: 0
種類: sbc_share_delivery_no_cashflow
date_status: 仮定
金額の単位: 億GBP
delivered_shares_m: 0.8235
source_treasury_shares_m: 0.8235
source_employee_trust_shares_m: 0
old_holder_shares_change_m: 0
issuer_cash_paid_oku: 0
equity_book_value_transfer_net_total_oku: 0
old_holder_fraction_after: 0.9579076369

146

内容を開く

year: 9.869952087611
想定日: 2036-09-19
金額: 1.7069616101
種類: proportional_old_holder_buyback_tender
date_status: 仮定
金額の単位: 億GBP
issuer_buyback_cash_oku: 1.7819688918
assumed_execution_price_gbp: 28.951409
bought_total_shares_m: 6.15503335
tendered_old_cohort_shares_m: 5.89595345
old_holder_fraction_before: 0.9579076369
old_holder_fraction_after: 0.9579076369
program_classification: discretionary_unannounced
price_is_scenario_assumption_not_a_terminal_multiple: はい

147

内容を開く

year: 9.905544147844
想定日: 2036-10-02
金額: 0
種類: dividend_ex_date
date_status: future_assumed_not_confirmed
金額の単位: 億GBP
fiscal_year: 2036
dividend_kind: interim
date_confirmed: いいえ
ex_date: 2036-10-02
record_date: 2036-10-03
payment_date: 2036-11-05
board_declaration_date_assumed: 2036-08-04
usd_per_share: 0.5086596
gbp_per_share: 0.38096133
entitled_old_cohort_shares_m: 640.5962415
issuer_economic_shares_m: 668.745312
old_holder_entitlement_oku: 2.4404239563
issuer_dividend_liability_oku: 2.5476610295
ex_date_status: future_unconfirmed_assumption
recheck_date_assumed: 2036-09-11
needs_issuer_confirmation_before_date: はい

148

内容を開く

year: 9.998631074606
想定日: 2036-11-05
金額: 2.4404239563
種類: dividend_payment
date_status: 仮定
金額の単位: 億GBP
issuer_total_distribution_oku: 2.5476610295
old_cohort_entitlement_locked_at_ex_date: はい
fiscal_year: 2036
dividend_kind: interim

valuation

内容を開く

initial_old_cohort_market_cap_oku: 97.20288656
pv_old_holder_cashflows_oku_at_coc_k: 47.70613727
pv_old_cohort_terminal_oku_at_coc_k: 123.19636047
total_present_value_oku_at_coc_k: 170.90249774
NPV_oku: 73.69961118
value_to_market_ratio: 1.75820394
IRR_timed_old_holder: 0.1701055776
comparison_v1_IRR_timed_old_holder: 0.1685798416
comparison_no_future_paid_subscription_proceeds_IRR_timed: 0.1696178637
comparison_full_market_paid_subscription_IRR_timed: 0.170159943
comparison_market_repurchase_neutral_IRR_timed: 0.169516446

audits

内容を開く

number_of_full_forecast_fiscal_years_2027_to_2036: 10
number_of_partial_period_ledger_rows: 2
end_excluded_future_period_days_in_2036: 55
total_unique_cashflow_events: 148
cashflow_events_with_zero_amount: 91
max_row_identity_error: 0
sum_timed_cashflow_oku: 81.16057569
sum_yearly_legacy_cashflow_oku: 81.16057569
initial_old_cohort_equals_current_economic_float: はい
all_event_dates_after_basis_and_not_after_endpoint: はい
event_year_computed_by_exact_days_div_365_25: はい
terminal_value_not_deducting_book_debt_twice: はい
year_2036_after_11_06_flows_not_included: はい
stock_compensation_cashflow_zero: はい
pre_ex_date_rechecks_included_count: 20
post_horizon_constant_absolute_share_delivery_mode_verified: はい
post_horizon_paid_issue_cash_included_once_and_separate_from_FCFE: はい
future_paid_issue_reinvestment_or_retention_assumed: いいえ
original_2026_2036_ledger_SHA256_unchanged: a67ab6a8b4b7e5b01bccdf926c4036ea419ebf17cb0749a98dd17593a8ba4420

売上高

112.82929606

営業利益

24.25829865

純利益

18.06659659

equity_oku

66.06745184

期間内の親会社利益合計（億）

101.89608766

multiple

kind

dcf

why

2037年以降の発行株数、有償引受と旧株主持分を毎年更新した継続価値。

detail

内容を開く

version

v2_2026_11_08

理由

1: Paid new issue capital proceeds missing from v1 terminal
2: Fixed annual shares incorrectly treated with perpetually fixed issuance ratio
3: Future ex-dates need separate pre-ex reconfirmation events

source_file

smith_nephew_aiv2_eu_20261106_full.json

all_years_2026_to_2036_ledgers_preserved_verbatim

はい

company_issuer_future_paid_cash_not_operating_FCFE

はい

issuer_cash_assumed_passed_through_to_preissue_holders_not_retained

はい

mathematical_cash_treatment

Paid cash enters one time; no separate addition to company terminal equity and no double subtraction of buyback expenses.

future_review_events_are_not_automated_reminders

はい

scenario_corrections

内容を開く

id: very_bear
label: 最悪
確率: 10.00%
free_SBC_m: 3.4
paid_issued_m: 0.4
total_issued_m: 3.8
old_2036_terminal_oku: 10.678822546
corrected_2036_terminal_oku: 10.770428062326
old_2036_IRR: -0.1531105824
corrected_2036_IRR: -0.1526010931
old_PV_oku: 16.64944402
corrected_PV_oku: 16.68640356
start_2036_economic_shares_m: 867.0366575
2037_post_economic_shares_m: 870.8366575
2037_issuer_paid_subscriptions_oku: 0.0046566245895818
2037_paid_issue_per_share_GBP: 1.1641561473954
2037_fair_price_after_issue_GBP: 1.2935068304394
2037_fair_price_market_buyback_policy_GBP: 1.2975825267948
2037_gross_repurchase_market_oku: 0.049308136018204
2037_paid_issue_cash_market_neutral_policy_oku: 0.0046712970964614
2037_net_cash_required_market_neutral_policy_oku: 0.044636838921743
2037_future_SBC_expense_oku: 0.45626728043192
no_future_paid_issuance_terminal_old_oku: 10.772984454596
ignored_paid_proceeds_2036_terminal_oku: 10.737024536969
full_fair_market_paid_proceeds_2036_terminal_oku: 10.774151977858
market_neutral_repurchase_2036_terminal_oku: 10.758565446598
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: c1a3b546cd8847dce8be9cfad727549c050a3f2e81a70832280f68783a48a4f3

内容を開く

id: bear
label: 弱気
確率: 20.00%
free_SBC_m: 3.15
paid_issued_m: 0.28
total_issued_m: 3.43
old_2036_terminal_oku: 41.949231702
corrected_2036_terminal_oku: 42.301083592521
old_2036_IRR: -0.0424760546
corrected_2036_IRR: -0.0418433201
old_PV_oku: 34.2419803
corrected_PV_oku: 34.38393989
start_2036_economic_shares_m: 836.1709874
2037_post_economic_shares_m: 839.6009874
2037_issuer_paid_subscriptions_oku: 0.013337295340245
2037_paid_issue_per_share_GBP: 4.7633197643733
2037_fair_price_after_issue_GBP: 5.2925775159703
2037_fair_price_market_buyback_policy_GBP: 5.3055846700607
2037_gross_repurchase_market_oku: 0.18198155418308
2037_paid_issue_cash_market_neutral_policy_oku: 0.013370073368553
2037_net_cash_required_market_neutral_policy_oku: 0.16861148081453
2037_future_SBC_expense_oku: 0.56106876163074
no_future_paid_issuance_terminal_old_oku: 42.30951074455
ignored_paid_proceeds_2036_terminal_oku: 42.182331118377
full_fair_market_paid_proceeds_2036_terminal_oku: 42.314318079806
market_neutral_repurchase_2036_terminal_oku: 42.237692980634
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: a2e5b5ea6f11ae27f99b0e9ef7fb45ccfb193bd7e58dd3d6ecefffce2ba154f2

内容を開く

id: base
label: 中立
確率: 40.00%
free_SBC_m: 2.9
paid_issued_m: 0.2
total_issued_m: 3.1
old_2036_terminal_oku: 114.63489927
corrected_2036_terminal_oku: 115.75462821196
old_2036_IRR: 0.0635234669
corrected_2036_IRR: 0.0643258394
old_PV_oku: 76.78471106
corrected_PV_oku: 77.23648145
start_2036_economic_shares_m: 730.2724252
2037_post_economic_shares_m: 733.3724252
2037_issuer_paid_subscriptions_oku: 0.03008847851086
2037_paid_issue_per_share_GBP: 15.04423925543
2037_fair_price_after_issue_GBP: 16.715821394922
2037_fair_price_market_buyback_policy_GBP: 16.739661132638
2037_gross_repurchase_market_oku: 0.51892949511179
2037_paid_issue_cash_market_neutral_policy_oku: 0.030131390038749
2037_net_cash_required_market_neutral_policy_oku: 0.48879810507304
2037_future_SBC_expense_oku: 0.70783231206378
no_future_paid_issuance_terminal_old_oku: 115.77471799239
ignored_paid_proceeds_2036_terminal_oku: 115.41430820689
full_fair_market_paid_proceeds_2036_terminal_oku: 115.79255978604
market_neutral_repurchase_2036_terminal_oku: 115.45189520245
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: 86bf5243f42d553f0bdf9d6126c77ba8638d36579d68bbc75616192591e11fe5

内容を開く

id: bull
label: 強気
確率: 22.00%
free_SBC_m: 2.9
paid_issued_m: 0.2
total_issued_m: 3.1
old_2036_terminal_oku: 203.684307187
corrected_2036_terminal_oku: 206.18132779122
old_2036_IRR: 0.1254535399
corrected_2036_IRR: 0.1265285363
old_PV_oku: 122.1404103
corrected_PV_oku: 123.14786837
start_2036_economic_shares_m: 687.4005414
2037_post_economic_shares_m: 690.5005414
2037_issuer_paid_subscriptions_oku: 0.057310035570423
2037_paid_issue_per_share_GBP: 28.655017785211
2037_fair_price_after_issue_GBP: 31.838908650235
2037_fair_price_market_buyback_policy_GBP: 31.844463999628
2037_gross_repurchase_market_oku: 0.98717838398848
2037_paid_issue_cash_market_neutral_policy_oku: 0.057320035199331
2037_net_cash_required_market_neutral_policy_oku: 0.92985834878915
2037_future_SBC_expense_oku: 0.86055882766899
no_future_paid_issuance_terminal_old_oku: 206.21758591791
ignored_paid_proceeds_2036_terminal_oku: 205.42105562617
full_fair_market_paid_proceeds_2036_terminal_oku: 206.26613094086
market_neutral_repurchase_2036_terminal_oku: 205.34347903854
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: f1f361d13021796ed8f9b406e365682ab4eaf0d6db69b4cfc986b8a2f1dce40a

内容を開く

id: very_bull
label: 最良
確率: 8.00%
free_SBC_m: 3.05
paid_issued_m: 0.24
total_issued_m: 3.29
old_2036_terminal_oku: 300.349987929
corrected_2036_terminal_oku: 305.34655505458
old_2036_IRR: 0.1685798416
corrected_2036_IRR: 0.1701055776
old_PV_oku: 168.88656248
corrected_PV_oku: 170.90249774
start_2036_economic_shares_m: 668.745312
2037_post_economic_shares_m: 672.035312
2037_issuer_paid_subscriptions_oku: 0.10556409673347
2037_paid_issue_per_share_GBP: 43.985040305614
2037_fair_price_after_issue_GBP: 48.872267006237
2037_fair_price_market_buyback_policy_GBP: 48.784554666435
2037_gross_repurchase_market_oku: 1.6050118485257
2037_paid_issue_cash_market_neutral_policy_oku: 0.1053746380795
2037_net_cash_required_market_neutral_policy_oku: 1.4996372104462
2037_future_SBC_expense_oku: 1.0172246276761
no_future_paid_issuance_terminal_old_oku: 305.40141089449
ignored_paid_proceeds_2036_terminal_oku: 303.74247715319
full_fair_market_paid_proceeds_2036_terminal_oku: 305.52576372641
market_neutral_repurchase_2036_terminal_oku: 303.40973167543
ex_date_rechecks_count: 20
FY_ledger_2026_to_2036_SHA256: a67ab6a8b4b7e5b01bccdf926c4036ea419ebf17cb0749a98dd17593a8ba4420

v1_expected_IRR

0.0687102009

v2_expected_IRR

0.0697092425

v1_expected_PV_oku

79.60904015

v2_expected_PV_oku

80.204751772

old_10y_cash_receipts_sum_expected_unchanged

はい

scenario_annual_rows

first_20year_future_sensitivity_ledger_rows

100

future_pre_ex_date_review_zero_cash_events_added

100

強気（確率 22.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.044
Sports_Medicine_ENT: 0.08
Advanced_Wound_Management: 0.053

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: 0.006
Sports_Medicine_ENT: 0.009
Advanced_Wound_Management: 0.007

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.195

terminal_cost_of_equity

0.088

terminal_perpetual_total_FCFE_growth

0.024

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.5

2026_announced_500m_buyback_remaining_completion_fraction_assumed

annual_2027_plus_ESPP_new_shares_m_assumed

0.2

annual_2027_plus_vested_awards_m_assumed

2.9

buyback_execution_GBP_per_share_growth_from_11_61_assumed

0.072

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

このシナリオの数値・キャッシュフローを開く →

中立（確率 40.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.024
Sports_Medicine_ENT: 0.06
Advanced_Wound_Management: 0.035

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: 0.002
Sports_Medicine_ENT: 0.006
Advanced_Wound_Management: 0.003

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.165

terminal_cost_of_equity

0.095

terminal_perpetual_total_FCFE_growth

0.018

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.43

2026_announced_500m_buyback_remaining_completion_fraction_assumed

annual_2027_plus_ESPP_new_shares_m_assumed

0.2

annual_2027_plus_vested_awards_m_assumed

2.9

buyback_execution_GBP_per_share_growth_from_11_61_assumed

0.042

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

このシナリオの数値・キャッシュフローを開く →

弱気（確率 20.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: 0.004
Sports_Medicine_ENT: 0.025
Advanced_Wound_Management: 0.01

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: -0.006
Sports_Medicine_ENT: 0
Advanced_Wound_Management: -0.004

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.12

terminal_cost_of_equity

0.108

terminal_perpetual_total_FCFE_growth

0.008

future_discretionary_buybacks_fraction_of_FCFE_surplus

0.12

2026_announced_500m_buyback_remaining_completion_fraction_assumed

0.8

annual_2027_plus_ESPP_new_shares_m_assumed

0.28

annual_2027_plus_vested_awards_m_assumed

3.15

buyback_execution_GBP_per_share_growth_from_11_61_assumed

-0.006

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

このシナリオの数値・キャッシュフローを開く →

最悪（確率 10.0%）

annual_2027_to_2036_segment_base_vol_growth

Orthopaedics: -0.02
Sports_Medicine_ENT: 0
Advanced_Wound_Management: -0.012

annual_2027_to_2036_segment_base_realised_net_price_growth

Orthopaedics: -0.013
Sports_Medicine_ENT: -0.005
Advanced_Wound_Management: -0.01

region_volume_adjustments

US: -0.003
Other_Established: 0.002
Emerging: 0.006

region_net_price_adjustments

US: 0.001
Other_Established: 0
Emerging: -0.003

2036_full_year_IFRS_operating_margin

0.08

terminal_cost_of_equity

0.125

terminal_perpetual_total_FCFE_growth

future_discretionary_buybacks_fraction_of_FCFE_surplus

2026_announced_500m_buyback_remaining_completion_fraction_assumed

0.5

annual_2027_plus_ESPP_new_shares_m_assumed

0.4

annual_2027_plus_vested_awards_m_assumed

3.4

buyback_execution_GBP_per_share_growth_from_11_61_assumed

-0.03

future_fixed_FX_USD_per_GBP

1.3352

確率の根拠

需要、価格、利益率と資本政策に関する分析上の確率仮定。

このシナリオの数値・キャッシュフローを開く →

単位の説明

money: 億GBP
one_oku_gbp: 100,000,000 GBP
reported_actuals: USD million
株数: million shares (m) except where stated
rates: decimal
events: amount=億GBP、date_assumed=YYYY-MM-DD、year=daycount/365.25

分析基準とデータ

価格・単価

11.61

株価基準日

2026-11-06

株数

837234165

株価の出所

https://shareprices.com/lse/sn./

株数の出所

https://www.smith-nephew.com/en/investors

detail

内容を開く

価格・単価

内容を開く

日付: 2026-11-06
exchange: London Stock Exchange
gbp_pence: 1161
gbp_per_share: 11.61
source_key: ft_price_20261106
状態: 現地主上場市場の二次情報で確認済み終値

株数

内容を開く

reference_date: 2026-10-31
date_published: 2026-11-02
発行済株式数: 877750024
自己株式数: 40315859
voting_rights_shares: 837434165
employee_trust_held_shares_2025_12_31_approx: 400000
employee_trust_shares_at_basis_proxy: 200000
employee_trust_at_basis_strictly_verified: いいえ
economic_shares_m_at_basis_proxy: 837.234165
market_cap_oku_GBP_using_voting_rights: 97.22610656
market_cap_oku_GBP_using_economic_denominator_proxy: 97.20288656
ordinary_issued_changes_Nov1_to_Nov6_verified: いいえ
denominator_basis: 発行済−自己株−2026年11月6日時点未確認の従業員信託0.2百万株代理。自己株と信託を重複控除しない。
source_key: lse_total_voting_rights_20261031
sensitivity_no_trust_mcap_oku: 97.22610656
sensitivity_trust_0_4_mcap_oku: 97.17966656

内容を開く

GBPUSD: 1.3352
日付: 2026-11-06
historical_market_spot_source: gbpusd_20261106
forecast_conversion_rule: 全予測2026-2037年でGBPUSD=1.3352固定。現実には変動し、感応度で見直す。

financial_actual_2025_IFRS_usdm

内容を開く

sales: 6164
costs_including_sbc: 5370
operating_profit: 794
profit_before_tax: 779
parent_attributable_profit_after_sbc: 625
parent_equity: 5289
cash: 557
gross_debt_incl_lease: 3327
simple_net_debt: 2770
company_reported_net_debt: 2759
cash_capex: 433
SBC_expense: 43
dividends_paid: 330
purchase_own_shares_paid: 502
FY2025_trading_profit_nonIFRS: 1211
US_sales: 3306
Other_Established_sales: 1855
Emerging_sales: 1003
source_key: company_fy2025_20f

financial_actual_H1_2026_IFRS_usdm

内容を開く

期間末: 2026-06-27
sales: 3097
COGS: 901
SGA_including_SBC: 1598
RD: 150
operating_profit: 448
net_interest_income: 10
interest_expense: 65
other_finance_cost: 18
associate_income: 5
profit_before_tax: 380
income_tax: 77
parent_attributable_profit_after_sbc: 303
noncontrolling_interest: 0
parent_equity: 5180
cash: 754
gross_borrowings_including_lease: 3785
company_reported_net_debt: 3019
simple_net_debt: 3031
company_net_debt_vs_simple_gap_explained_by_definition_usdm: -12
cash_capex: 190
SBC_expense_equity_settled: 34
dividends_paid: 205
cash_paid_for_own_shares_H1: 116
H1_equity_reduction_for_buyback_including_obligations: 250
H1_buyback_purchased_shares: 9076588
H1_buyback_purchased_cost_usdm: 137
H1_buyback_forward_contract_commitment_usdm: 113
H1_contingent_acquisition_consideration_liability: 286
source_key: company_h1_2026_6k

Q3_2026_actual_revenue_usdm

内容を開く

quarter_end: 2026-09-26
consolidated: 1551
sports_medicine_ENT: 507
advanced_wound: 454
orthopaedics: 590
US: 812
Other_Established: 456
Emerging: 283
source_key: company_q3_2026

2026_Q4_full_projection_from_guidance_usdm

内容を開く

consolidated

1763

by_segment

Orthopaedics: 687
Sports_Medicine_ENT: 582
Advanced_Wound_Management: 494

reported_2026_full_sales

6411

company_guidance_trading_profit_usdm_around

1250

company_guidance_free_cash_flow_usdm_around

750

company_guidance_underlying_revenue_growth

0.03

comment

2026Q4=6411−3097−1551; 6411は2025年6164に会社示唆約4.0%報告成長を適用した予測、確定実績ではない

at_asof_2026_11_06_financial_proxy_usdm

内容を開く

H1_2026_reported_parent_equity: 5180
post_H1_to_Nov06_parent_profit_forecast: 190
post_H1_to_Nov06_SBC_non_cash_equity_credit_forecast: 26
interim_dividend_declared_and_paid_post_H1_estimate: 131
extra_H2_buyback_equity_debit_before_Nov06_assumed: 0
post_H1_OCI_assumed: 0
calculated_proxy_parent_equity: 5265
cash_at_H1: 754
post_H1_pre_basis_fcf_proxy: 320
post_H1_pre_basis_prior_buyback_obligation_cash_settlement_proxy: 134
interim_dividend_payment_proxy: 131
estimated_cash_at_Nov06: 809
estimated_gross_borrowings_at_Nov06: 3785
unreconciled_exact_post_H1_event_data: 未確認
uncertainty: 2026-06-27から2026-11-06の実際の損益・現金・SBC交付・取得決済は未公表。2.50億USDの買戻しはH1資本に既に計上済みで、当該決済を再び資本控除しない。

prior_ex_div_payment_excluded_from_future_holder_flows

内容を開く

fiscal_year: 2026
kind: interim
usd_per_share: 0.156
confirmed_ex_date: 2026-10-01
confirmed_record_date: 2026-10-02
confirmed_payment_date: 2026-11-06
date_status: confirmed_by_issuer
cashflow_in_y10: いいえ
理由: 基準日11月6日終値から買う/同日終値で評価する旧株主群に新しい権利は付かず、基準日前に権利が分離済み。

追加データ・検証記録

分析ごとに収録された追加の前提、年度別データ、検証上の注意を確認できます。

追加データを開く →

分析に使用した資料

← AI銘柄分析一覧へ戻る　ヒートマップを見る →